PRESS RELEASE
Q2 2023 — Press release
Q2 2023PDF · 98 pages722 KB
Barclays PLC
Interim Results Announcement
30 June 2023
-- 1 of 98 --
Results Announcement Page
Notes 1
Performance Highlights 2
Group Finance Director’s Review 6
Results by Business
• Barclays UK 8
• Barclays International 11
• Head Office 16
Quarterly Results Summary 17
Quarterly Results by Business 18
Performance Management
• Margins and Balances 24
Risk Management
• Risk Management and Principal Risks 25
• Credit Risk 26
• Market Risk 48
• Treasury and Capital Risk 49
Statement of Directors' Responsibilities 59
Independent Review Report to Barclays PLC 60
Condensed Consolidated Financial Statements 62
Financial Statement Notes 68
Appendix: Non-IFRS Performance Measures 89
Shareholder Information 96
BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.
Table of Contents
Barclays PLC
-- 2 of 98 --
The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares
the six months ended 30 June 2023 to the corresponding six months of 2022 and balance sheet analysis as at 30 June 2023 with comparatives
relating to 31 December 2022 and 30 June 2022. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling
respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and
‘€bn’ represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing
adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting
Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.
The information in this announcement, which was approved by the Board of Directors on 26 July 2023, does not comprise statutory accounts within
the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2022, which contained an unmodified
audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) will
be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication.
Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC’s website at www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings.
Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these
results and other matters relating to the Group.
Non-IFRS performance measures
Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of
the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial
periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence
or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and
performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS
measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 89 to 95 for further information and calculations of
non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as
amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-
looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ
materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate
only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’,
‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made
in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in
connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the
Group’s future financial position, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory
ratios, capital distributions (including dividend policy and share buybacks), return on tangible equity, projected levels of growth in banking and
financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets),
business strategy, plans and objectives for future operations and other statements that are not historical or current facts. By their nature, forward-
looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at
the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in
legislation, regulation and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the
interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings
and regulatory investigations; the policies and actions of governmental and regulatory authorities; the Group’s ability along with governments and
other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and
incidents and similar events beyond the Group’s control; the impact of competition; capital, leverage and other regulatory rules applicable to past,
current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital
markets; market related risks such as changes in interest rates and foreign exchange rates; higher or lower asset valuations; changes in credit ratings
of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect
consequences of the Russia-Ukraine war on European and global macroeconomic conditions, political stability and financial markets; direct and
indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the EU-
UK Trade and Cooperation Agreement and any disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information
or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of
acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group’s control. As a result, the Group’s actual
financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ
materially from the statements or guidance set forth in the Group’s forward-looking statements. Additional risks and factors which may impact the
Group’s future financial condition and performance are identified in Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s
Annual Report on Form 20-F for the financial year ended 31 December 2022), which are available on the SEC’s website at www.sec.gov.
Subject to Barclays PLC’s obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and
the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
Notes
Barclays PLC 1
-- 3 of 98 --
Barclays delivered return on tangible equity (RoTE) of 11.4% in Q223 and 13.2% in H123, with a
half year dividend of 2.7p per share and intends to initiate a share buyback of up to £750m
C. S. Venkatakrishnan, Group Chief Executive, commented
“We have positioned Barclays carefully for this mixed macroeconomic environment and delivered a consistent performance
in the second quarter. Through our diverse sources of income, prudent risk management, and ongoing cost discipline we
have again demonstrated the stability and strength of the franchise we have built over many years. This means we are able
to distribute increased capital returns to shareholders, while providing targeted support to our customers and clients.
Looking forward we are very confident of meeting our targets for the full year.”
• Q223 RoTE of 11.4% and H123 of 13.2%, with double-digit RoTE across all operating divisions in both periods
• Announced H123 dividend of 2.7p per share and a share buyback of up to £750m
• Strong balance sheet with Common Equity Tier 1 (CET1) ratio of 13.8% and Liquidity Coverage Ratio (LCR) of 158%
Key financial metrics:
Income
Cost:
income
ratio
LLR
Profit
before
tax
Attributable
profit RoTE EPS TNAV
per share
CET1
ratio
Total
capital
return1
Q223 £6.3bn 63% 37bps £2.0bn £1.3bn 11.4% 8.6p 291p 13.8% c.7.5p
H123 £13.5bn 60% 44bps £4.6bn £3.1bn 13.2% 19.9p
Q223 Performance highlights:
• Group RoTE of 11.4% with profit before tax increased to £2.0bn (Q222: £1.5bn). The prior year includes impacts from
the Over-issuance of Securities2; £0.8bn income gain and £1.1bn litigation and conduct charges. Excluding these
impacts:
– Group income, up 6% year-on-year to £6.3bn, reflects diverse sources of income across Barclays:
– Barclays UK income increased 14% to £2.0bn, primarily driven by net interest income growth from higher rates,
including continued structural hedge income, partially offset by product dynamics in deposits and mortgages
– Corporate and Investment Bank (CIB) income decreased 3% to £3.2bn, reflecting lower client activity in Global
Markets and Investment Banking fees, more than offsetting a strong performance in Transaction Banking from
higher rates
– Consumer, Cards and Payments (CC&P) increased 18% to £1.3bn reflecting higher balances in US cards
(including the Gap portfolio3), growth in client assets and liabilities, and higher rates in Private Bank
– Group total operating expenses were £4.0bn, up 2% year-on-year, as inflation and business growth were partially
offset by efficiency savings and lower litigation and conduct charges
– Cost: income ratio was 63% as the Group delivered positive cost: income jaws
• Credit impairment charges were £0.4bn, with a loss loan rate (LLR) of 37bps
• CET1 ratio of 13.8%, based on broadly stable risk weighted assets (RWAs) of £336.9bn, and tangible net asset value
(TNAV) per share of 291p
H123 Performance highlights:
• Group RoTE was 13.2%, well positioned to achieve our greater than 10% target for 2023
• Excluding the impact of Over-issuance of Securities in the prior year4:
– Group income of £13.5bn, up 9% year-on-year
– Group total operating expenses were £8.1bn, up 5% year-on-year. Cost: income ratio of 60%, consistent with full
year guidance of low 60s in 2023
• Credit impairment charges were £0.9bn, reflecting the anticipated normalising of charges, with an LLR of 44bps;
maintaining expectation of 50-60bps LLR for 2023
• On a statutory basis:
– Group income was £13.5bn, up 2% year-on-year
– Group total operating expenses were £8.1bn, down 12% year-on-year
1 Includes dividend for H123 of 2.7p per share and share buyback announced in relation to H123 of £750m.
2 Denotes the Over-issuance of Securities under Barclays Bank PLC's US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019. See
page 5 for reconciliation of ex. Over-issuance of Securities performance.
3 The Gap portfolio refers to the Gap Inc. US credit card portfolio.
4 H122 impacts from the Over-Issuance of Securities: £0.8bn income gain and £1.5bn litigation and conduct charges.
Performance Highlights
Barclays PLC 2
-- 4 of 98 --
Group Targets and Outlook:
• Returns: targeting RoTE of greater than 10% in 2023, consistent with our medium-term target
• Income: diversified income streams continue to position the Group well for the current economic and market
environment including higher interest rates. In 2023, Barclays UK Net Interest Margin (NIM) is now expected to be less
than 3.20%, with a current view of around 3.15%. Guidance remains sensitive to product dynamics including the
trajectory of deposit balances and further macroeconomic developments
• Costs: targeting a cost: income ratio percentage in the low 60s in 2023, investing for growth whilst progressing towards
the Group’s medium-term target of below 60%
• Impairment: expect an LLR of 50-60bps in 2023, based on the current macroeconomic outlook
• Capital: expect to operate within the CET1 ratio medium-term target range of 13-14%
• Capital returns: capital distribution policy incorporates a progressive ordinary dividend, supplemented with share
buybacks as appropriate
Performance Highlights
Barclays PLC 3
-- 5 of 98 --
Barclays Group results Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
£m £m % Change £m £m % Change
Barclays UK 3,922 3,373 16 1,961 1,724 14
Corporate and Investment Bank 7,138 7,971 (10) 3,162 4,033 (22)
Consumer, Cards and Payments 2,584 1,969 31 1,278 1,083 18
Barclays International 9,722 9,940 (2) 4,440 5,116 (13)
Head Office (122) (109) (12) (116) (132) 12
Total income 13,522 13,204 2 6,285 6,708 (6)
Operating costs (8,030) (7,270) (10) (3,919) (3,682) (6)
Litigation and conduct (32) (1,857) 98 (33) (1,334) 98
Total operating expenses (8,062) (9,127) 12 (3,952) (5,016) 21
Other net (expenses)/income (2) (3) 33 3 7 (57)
Profit before impairment 5,458 4,074 34 2,336 1,699 37
Credit impairment charges (896) (341) (372) (200) (86)
Profit before tax 4,562 3,733 22 1,964 1,499 31
Tax charge (914) (823) (11) (353) (209) (69)
Profit after tax 3,648 2,910 25 1,611 1,290 25
Non-controlling interests (30) (21) (43) (22) (20) (10)
Other equity instrument holders (507) (414) (22) (261) (199) (31)
Attributable profit 3,111 2,475 26 1,328 1,071 24
Performance measures
Return on average tangible shareholders' equity 13.2% 10.1% 11.4% 8.7%
Average tangible shareholders' equity (£bn) 47.2 48.9 46.7 49.0
Cost: income ratio 60% 69% 63% 75%
Loan loss rate (bps) 44 17 37 20
Basic earnings per share 19.9p 14.8p 8.6p 6.4p
Dividend per share 2.7p 2.25p
Share buyback announced (£m) 750 500
Total payout equivalent per share c.7.5p c.5.25p
Basic weighted average number of shares (m) 15,645 16,684 (6) 15,523 16,684 (7)
Period end number of shares (m) 15,556 16,531 (6) 15,556 16,531 (6)
As at
30.06.23
As at
31.12.22
As at
30.06.22
Balance sheet and capital management1 £bn £bn £bn
Loans and advances at amortised cost 401.4 398.8 395.8
Loans and advances at amortised cost impairment
coverage ratio 1.4% 1.4% 1.4%
Total assets 1,549.7 1,513.7 1,589.2
Deposits at amortised cost 554.7 545.8 568.7
Tangible net asset value per share 291p 295p 297p
Common equity tier 1 ratio 13.8% 13.9% 13.6%
Common equity tier 1 capital 46.6 46.9 46.7
Risk weighted assets 336.9 336.5 344.5
UK leverage ratio 5.1% 5.3% 5.1%
UK leverage exposure 1,183.7 1,130.0 1,151.2
Funding and liquidity
Group liquidity pool (£bn) 330.7 318.0 342.5
Liquidity coverage ratio 158% 165% 156%
Net stable funding ratio2 139% 137%
Loan: deposit ratio 72% 73% 70%
1 Refer to pages 54 to 58 for further information on how capital, RWAs and leverage are calculated.
2 Represents average of the last four spot quarter end positions.
Performance Highlights
Barclays PLC 4
-- 6 of 98 --
Reconciliation of financial results excluding the impact of the Over-issuance of Securities in the prior year
Three months ended 30.06.23 30.06.22
Statutory Statutory Impact of the
Over-issuance of
Securities
Excluding impact of
the Over-issuance of
Securities
£m £m £m £m % Change
Barclays UK 1,961 1,724 — 1,724 14
Corporate and Investment Bank 3,162 4,033 758 3,275 (3)
Consumer, Cards and Payments 1,278 1,083 — 1,083 18
Barclays International 4,440 5,116 758 4,358 2
Head Office (116) (132) — (132) 12
Total income 6,285 6,708 758 5,950 6
Operating costs (3,919) (3,682) — (3,682) (6)
Litigation and conduct (33) (1,334) (1,149) (185) 82
Total operating expenses (3,952) (5,016) (1,149) (3,867) (2)
Other net income 3 7 — 7 (57)
Profit before impairment 2,336 1,699 (391) 2,090 12
Credit impairment charges (372) (200) — (200) (86)
Profit before tax 1,964 1,499 (391) 1,890 4
Attributable profit 1,328 1,071 (341) 1,412 (6)
Average tangible shareholders'
equity (£bn) 46.7 49.0 49.0
Return on average tangible
shareholders' equity 11.4% 8.7% 11.5%
Half year ended 30.06.23 30.06.22
Statutory Statutory Impact of the
Over-issuance of
Securities
Excluding impact of
the Over-issuance of
Securities
£m £m £m £m % Change
Barclays UK 3,922 3,373 — 3,373 16
Corporate and Investment Bank 7,138 7,971 758 7,213 (1)
Consumer, Cards and Payments 2,584 1,969 — 1,969 31
Barclays International 9,722 9,940 758 9,182 6
Head Office (122) (109) — (109) (12)
Total income 13,522 13,204 758 12,446 9
Operating costs (8,030) (7,270) — (7,270) (10)
Litigation and conduct (32) (1,857) (1,469) (388) 92
Total operating expenses (8,062) (9,127) (1,469) (7,658) (5)
Other net expenses (2) (3) — (3) 33
Profit before impairment 5,458 4,074 (711) 4,785 14
Credit impairment charges (896) (341) — (341)
Profit before tax 4,562 3,733 (711) 4,444 3
Attributable profit 3,111 2,475 (581) 3,056 2
Average tangible shareholders'
equity (£bn) 47.2 48.9 48.9
Return on average tangible
shareholders' equity 13.2% 10.1% 12.5%
Performance Highlights
Barclays PLC 5
-- 7 of 98 --
H123 Group performance
• Barclays delivered a profit before tax of £4,562m (H122: £3,733m), RoTE of 13.2% (H122: 10.1%) and earnings per
share (EPS) of 19.9p (H122: 14.8p)
• The Group has a diverse income profile across businesses and geographies including a significant presence in the US.
The appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit
impairment charges and total operating expenses
• Group income increased 2% to £13,522m primarily from the higher interest rate environment, including continued
structural hedge income, and the benefit of higher balances in US cards, partially offset by the prior year benefit from
hedging arrangements related to the Over-issuance of Securities and lower client activity in Global Markets and
Investment Banking fees
• Group total operating expenses decreased to £8,062m (H122: £9,127m)
– Group operating expenses excluding litigation and conduct charges increased to £8,030m (H122: £7,270m)
reflecting the impact of business growth, including the Gap portfolio acquisition in US cards and the Kensington
Mortgage Company (KMC) acquisition in Barclays UK, with the impact of inflation broadly offset by efficiency savings
– Litigation and conduct charges decreased to £32m (H122: £1,857m). The prior year charges included £1,469m of
costs related to the Over-issuance of Securities
• Credit impairment charges were £896m (H122: £341m), reflecting higher US cards balances and normalising
delinquencies. Total coverage ratio remains strong at 1.4% (December 2022: 1.4%)
• The effective tax rate (ETR) was 20.0% (H122: 22.0%). The prior year included the tax charge recognised for the re-
measurement of the Group’s UK deferred tax assets as a result of the UK banking surcharge rate being reduced from 8%
to 3%
• Attributable profit was £3,111m (H122: £2,475m)
• Total assets increased to £1,549.7bn (December 2022: £1,513.7bn) driven by increased trading and client activity
within Global Markets, partially offset by the strengthening of GBP against USD since December 2022. The Group
liquidity pool was further strengthened by growth in deposits
• TNAV per share was 291p (December 2022: 295p) as EPS of 19.9p was more than offset by the 2022 full year dividend
paid on 31 March 2023 and net negative reserve movements driven by currency movements and the interest rate
environment
Capital distributions
• Announced a half year dividend of 2.7p per share and intention to initiate a further share buyback of up to £750m
• Barclays is committed to maintaining a balance between a strong capital position, delivering total cash returns to
shareholders and investment in the business. Barclays pays a progressive ordinary dividend, taking into account these
objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividend as
appropriate, including with share buybacks
Group capital and leverage
• The CET1 ratio decreased by c.10bps to 13.8% (December 2022: 13.9%) as CET1 capital decreased to £46.6bn
(December 2022: £46.9bn) whilst RWAs remained broadly stable at £336.9bn:
– c.90bps increase from attributable profit generated in the period
– c.40bps aggregate decrease from expected capital impacts in Q123, including the £0.5bn share buyback announced
at FY22 results, the impact of regulatory change on 1 January 2023 relating to IFRS 9 transitional relief, and the
impact of the KMC acquisition
– c.30bps decrease as a result of a £8.6bn increase in RWAs primarily driven by increased trading and credit risk RWAs
within CIB
– c.30bps decrease primarily due to increased regulatory capital deductions largely driven by an accrual for the FY23
dividend
– An £8.8bn decrease in RWAs as a result of foreign exchange movements was broadly offset by a £1.2bn decrease in
CET1 capital due to a decrease in the currency translation reserve
• The UK leverage ratio decreased to 5.1% (December 2022: 5.3%) primarily due to a £53.7bn increase in leverage
exposure to £1,183.7bn (December 2022: £1,130.0bn). This is largely driven by increased trading and client activity
within Global Markets
Group Finance Director's Review
Barclays PLC 6
-- 8 of 98 --
Group funding and liquidity
• The liquidity and funding position remains robust and stable in H123. The liquidity pool increased to £330.7bn
(December 2022: £318.0bn) driven by deposit growth. The composition of the liquidity pool is conservative, with 80%
held in cash and deposits with central banks and the remainder primarily held in high quality government bonds,
materially held at fair value or hedged
• The strength of the funding and liquidity position is supported by a diverse and stable deposit franchise. Total deposits
increased to £554.7bn (December 2022: £545.8bn)
• The LCR remained significantly above the 100% regulatory requirement at 158% (December 2022: 165%), equivalent to
a surplus of £115.3bn (December 2022: £116.4bn)
• Net Stable Funding Ratio (average of last four quarter ends) was 139% (December 2022: 137%), which represents a
£166.6bn (December 2022: £155.6bn) surplus above the 100% regulatory requirement
• Wholesale funding outstanding, excluding repurchase agreements, was £183.3bn (December 2022: £184.0bn)
• The Group issued £7.1bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments
from Barclays PLC (the Parent company) in H123. The Group has a strong MREL position with a ratio of 32.9%, which is
in excess of the regulatory requirement of 29.2% plus a confidential, institution specific, Prudential Regulation Authority
(PRA) buffer
Other matters
• KMC acquisition: on 1 March 2023 Barclays completed the acquisition of UK specialist mortgage lender KMC, including a
portfolio of mortgages totalling £2.2bn with an RWA impact of £0.8bn
• Combination of the Private Bank and Barclays UK Wealth business: on 1 May 2023, Wealth Management & Investments
(WM&I) was transferred from Barclays UK to CC&P, creating a combined Private Bank and Wealth Management business.
The combination seeks to improve customer and client experience and create business synergies:
– The business transferred includes c.£28bn of invested assets, generating annualised income of c.£0.2bn
– Excluding the transfer, Q223 Barclays UK income would have been c.£35m higher, NIM c.2bps higher and
operating costs c.£35m higher, with corresponding impacts to income and operating costs for CC&P
Anna Cross, Group Finance Director
Group Finance Director's Review
Barclays PLC 7
-- 9 of 98 --
Barclays UK Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Income statement information £m £m % Change £m £m % Change
Net interest income 3,278 2,732 20 1,660 1,393 19
Net fee, commission and other income 644 641 — 301 331 (9)
Total income 3,922 3,373 16 1,961 1,724 14
Operating costs (2,182) (2,083) (5) (1,090) (1,085) —
Litigation and conduct 3 (25) 5 (16)
Total operating expenses (2,179) (2,108) (3) (1,085) (1,101) 1
Other net income — — — — #DIV/0!
Profit before impairment 1,743 1,265 38 876 623 41
Credit impairment charges (208) (48) (95) —
Profit before tax 1,535 1,217 26 781 623 25
Attributable profit 1,049 854 23 534 458 17
Performance measures
Return on average allocated tangible equity 20.4% 17.0% 20.9% 18.4%
Average allocated tangible equity (£bn) 10.3 10.0 10.2 10.0
Cost: income ratio 56% 62% 55% 64%
Loan loss rate (bps) 18 4 17 —
Net interest margin 3.20% 2.67% 3.22% 2.71%
Key facts
UK mortgage balances (£bn) 163.6 159.6
Mortgage gross lending flow (£bn) 12.2 13.9
Average loan to value of mortgage portfolio1 53% 51%
Average loan to value of new mortgage lending1 63% 69%
Number of branches 414 593
Mobile banking active customers (m) 10.8 10.1
30 day arrears rate - Barclaycard Consumer UK 0.9% 1.0%
As at
30.06.23 As at
31.12.22 As at
30.06.22
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 206.8 205.1 205.9
Total assets 304.8 313.2 318.8
Customer deposits at amortised cost 249.8 258.0 261.5
Loan: deposit ratio 90% 87% 85%
Risk weighted assets 73.0 73.1 72.2
Period end allocated tangible equity 10.1 10.1 9.9
1 Average loan to value of mortgages is balance weighted and reflects both residential and buy-to-let mortgage portfolios within the Home Loans portfolio.
Results by Business
Barclays PLC 8
-- 10 of 98 --
Analysis of Barclays UK Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Analysis of total income £m £m % Change £m £m % Change
Personal Banking 2,497 2,099 19 1,244 1,077 16
Barclaycard Consumer UK 484 541 (11) 237 265 (11)
Business Banking 941 733 28 480 382 26
Total income 3,922 3,373 16 1,961 1,724 14
Analysis of credit impairment (charges)/releases
Personal Banking (120) (21) (92) (42)
Barclaycard Consumer UK (118) 40 (35) 84
Business Banking 30 (67) 32 (42)
Total credit impairment charges (208) (48) (95) —
As at
30.06.23 As at
31.12.22 As at
30.06.22
Analysis of loans and advances to customers at
amortised cost £bn £bn £bn
Personal Banking 173.3 169.7 167.1
Barclaycard Consumer UK 9.3 9.2 8.8
Business Banking 24.2 26.2 30.0
Total loans and advances to customers at amortised cost 206.8 205.1 205.9
Analysis of customer deposits at amortised cost
Personal Banking 191.1 195.6 197.0
Barclaycard Consumer UK — — —
Business Banking 58.7 62.4 64.5
Total customer deposits at amortised cost 249.8 258.0 261.5
Results by Business
Barclays PLC 9
-- 11 of 98 --
Barclays UK delivered a RoTE of 20.4% supported by the higher interest rate environment and the continued investment in
our transformation into a next-generation, digitised consumer bank. The challenging environment has persisted with
customer behaviour driving a reduction in the NIM outlook.
Income statement - H123 compared to H122
• Profit before tax increased 26% to £1,535m with a RoTE of 20.4% (H122: 17.0%)
• Total income increased 16% to £3,922m. Net interest income increased 20% to £3,278m with a NIM of 3.20% (H122:
2.67%), as higher interest rates and associated structural hedge benefit outweighed mortgage margin pressure and
lower deposit volumes. Net fee, commission and other income was stable at £644m, including the impact of the transfer
of WM&I to CC&P
– Personal Banking income increased 19% to £2,497m, driven by higher interest rates, partially offset by mortgage
margin compression and lower current accounts deposit volumes in line with wider market trends and cost of living
pressures
– Barclaycard Consumer UK income decreased 11% to £484m as higher customer spend volumes were more than
offset by lower interest earning lending balances following repayments and ongoing prudent risk management
– Business Banking income increased 28% to £941m driven by higher interest rates, partially offset by lower
government scheme lending as repayments continue and lower deposit volumes in line with wider market trends
• Total operating expenses increased 3% to £2,179m from the impact of inflation, partially offset by the transfer of WM&I
to CC&P. Ongoing efficiency savings continue to be reinvested in digitisation to support further improvements to the
cost: income ratio over time
• Credit impairment charges increased to £208m (H122: £48m), driven by UK cards and Mortgages. The updated
macroeconomic scenarios reflect improvement in GDP and unemployment outlook against a backdrop of higher interest
rates and a weaker House Price Index (HPI). UK cards 30 and 90 day arrears remained low at 0.9% (H122: 1.0%) and
0.2% (H122: 0.2%) respectively. The UK cards total coverage ratio was 7.1% (December 2022: 7.6%)
Balance sheet - 30 June 2023 compared to 31 December 2022
• Loans and advances to customers at amortised cost increased 1% to £206.8bn primarily reflecting the acquisition of
KMC and continued mortgage lending, which more than offset repayment of government scheme lending in Business
Banking
• Customer deposits at amortised cost decreased 3% to £249.8bn. Increases in savings product balances were more
than offset by reduced current account and Business Banking deposits, reflecting broader market trends. The loan:
deposit ratio increased to 90% (December 2022: 87%)
• RWAs were broadly stable at £73.0bn (December 2022: £73.1bn) including a capital Loss Given Default (LGD) model
update for the mortgages portfolio, partially offset by the acquisition of KMC
Results by Business
Barclays PLC 10
-- 12 of 98 --
Barclays International Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Income statement information £m £m % Change £m £m % Change
Net interest income 3,084 1,965 57 1,730 1,029 68
Net trading income 3,697 5,212 (29) 1,278 2,766 (54)
Net fee, commission and other income 2,941 2,763 6 1,432 1,321 8
Total income 9,722 9,940 (2) 4,440 5,116 (13)
Operating costs (5,703) (5,042) (13) (2,747) (2,537) (8)
Litigation and conduct (30) (1,832) 98 (33) (1,319) 97
Total operating expenses (5,733) (6,874) 17 (2,780) (3,856) 28
Other net income 9 13 (31) 6 5 20
Profit before impairment 3,998 3,079 30 1,666 1,265 32
Credit impairment charges (679) (310) (275) (209) (32)
Profit before tax 3,319 2,769 20 1,391 1,056 32
Attributable profit 2,301 2,083 10 953 783 22
Performance measures
Return on average allocated tangible equity 12.4% 11.5% 10.3% 8.4%
Average allocated tangible equity (£bn) 37.1 36.2 37.1 37.3
Cost: income ratio 59% 69% 63% 75%
Loan loss rate (bps) 78 37 63 49
Net interest margin1 5.86% 4.29 % 5.85% 4.41 %
As at
30.06.23 As at
31.12.22 As at
30.06.22
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 126.6 133.7 126.7
Loans and advances to banks at amortised cost 9.7 8.7 11.3
Debt securities at amortised cost 35.2 27.2 29.3
Loans and advances at amortised cost 171.5 169.6 167.3
Trading portfolio assets 165.1 133.8 126.9
Derivative financial instrument assets 264.9 301.7 343.5
Financial assets at fair value through the income statement 232.2 210.5 209.3
Cash collateral and settlement balances 123.9 107.7 128.5
Other assets 268.8 258.0 275.1
Total assets 1,226.4 1,181.3 1,250.6
Deposits at amortised cost 305.0 287.6 307.4
Derivative financial instrument liabilities 254.5 288.9 321.2
Loan: deposit ratio 56% 59 % 54 %
Risk weighted assets 254.6 254.8 263.8
Period end allocated tangible equity 36.7 36.8 38.0
1 CIB and Barclays International margins include the lending related investment bank business.
Results by Business
Barclays PLC 11
-- 13 of 98 --
Analysis of Barclays International
Corporate and Investment Bank Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Income statement information £m £m % Change £m £m % Change
Net interest income 1,321 795 66 856 410
Net trading income 3,790 5,188 (27) 1,353 2,738 (51)
Net fee, commission and other income 2,027 1,988 2 953 885 8
Total income 7,138 7,971 (10) 3,162 4,033 (22)
Operating costs (4,186) (3,791) (10) (1,984) (1,870) (6)
Litigation and conduct 2 (1,632) (1) (1,314) 100
Total operating expenses (4,184) (5,423) 23 (1,985) (3,184) 38
Other net income 1 — 1 —
Profit before impairment 2,955 2,548 16 1,178 849 39
Credit impairment (charges)/releases (20) (32) 38 13 (65)
Profit before tax 2,935 2,516 17 1,191 784 52
Attributable profit 2,007 1,895 6 798 579 38
Performance measures
Return on average allocated tangible equity 12.6% 11.9% 10.0% 7.1%
Average allocated tangible equity (£bn) 31.8 31.8 31.8 32.7
Cost: income ratio 59% 68% 63% 79%
Loan loss rate (bps) 3 5 (4) 20
As at
30.06.23 As at
31.12.22 As at
30.06.22
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 84.8 90.5 86.5
Loans and advances to banks at amortised cost 9.0 8.1 10.0
Debt securities at amortised cost 35.1 27.2 29.3
Loans and advances at amortised cost 128.9 125.8 125.8
Trading portfolio assets 165.0 133.7 126.7
Derivative financial instrument assets 264.8 301.6 343.4
Financial assets at fair value through the income statement 232.1 210.5 209.2
Cash collateral and settlement balances 122.5 106.9 127.7
Other assets 224.6 222.6 237.2
Total assets 1,137.9 1,101.1 1,170.0
Deposits at amortised cost 225.5 205.8 229.5
Derivative financial instrument liabilities 254.5 288.9 321.2
Risk weighted assets 216.5 215.9 227.6
Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Analysis of total income £m £m % Change £m £m % Change
FICC 2,974 3,173 (6) 1,186 1,529 (22)
Equities 1,267 2,463 (49) 563 1,411 (60)
Global Markets 4,241 5,636 (25) 1,749 2,940 (41)
Advisory 342 421 (19) 130 236 (45)
Equity capital markets 119 84 42 69 37 86
Debt capital markets 614 697 (12) 273 281 (3)
Investment Banking fees 1,075 1,202 (11) 472 554 (15)
Corporate lending 263 78 168 (47)
Transaction banking 1,559 1,055 48 773 586 32
Corporate 1,822 1,133 61 941 539 75
Total income 7,138 7,971 (10) 3,162 4,033 (22)
Results by Business
Barclays PLC 12
-- 14 of 98 --
Analysis of Barclays International
Consumer, Cards and Payments Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Income statement information £m £m % Change £m £m % Change
Net interest income 1,763 1,170 51 874 619 41
Net fee, commission, trading and other income 821 799 3 404 464 (13)
Total income 2,584 1,969 31 1,278 1,083 18
Operating costs (1,517) (1,251) (21) (763) (667) (14)
Litigation and conduct (32) (200) 84 (32) (5)
Total operating expenses (1,549) (1,451) (7) (795) (672) (18)
Other net income 8 13 (38) 5 5 —
Profit before impairment 1,043 531 96 488 416 17
Credit impairment charges (659) (278) (288) (144)
Profit before tax 384 253 52 200 272 (26)
Attributable profit 294 188 56 155 204 (24)
Performance measures
Return on average allocated tangible equity 11.1% 8.5% 11.8% 17.8%
Average allocated tangible equity (£bn) 5.3 4.4 5.3 4.6
Cost: income ratio 60% 74% 62% 62%
Loan loss rate (bps) 293 128 255 132
Key facts
US cards 30 day arrears rate 2.4% 1.4%
US cards customer FICO score distribution
<660 11% 10%
>660 89% 90%
Total number of payments clients 401k 391k
Value of payments processed (£bn)1,2 161 150
As at
30.06.23 As at
31.12.22 As at
30.06.22
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 41.7 43.2 40.2
Total assets 88.5 80.2 80.6
Deposits at amortised cost 79.5 81.8 77.9
Risk weighted assets 38.1 38.9 36.2
Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Analysis of total income £m £m % Change £m £m % Change
International Cards and Consumer Bank 1,734 1,229 41 835 691 21
Private Bank 554 459 21 295 245 20
Payments 296 281 5 148 147 1
Total income 2,584 1,969 31 1,278 1,083 18
1 Includes £155bn (H122: £145bn) of merchant acquiring payments.
2 The H122 comparative has been restated to reflect only the turnover of the Payments business to be consistent with H123.
Results by Business
Barclays PLC 13
-- 15 of 98 --
Barclays International delivered a RoTE of 12.4%. Despite the reduced banking industry fee pool and lower client activity in
Global Markets, CIB delivered a RoTE of 12.6% reflecting the benefits of income diversification and investment in sustainable
growth. CC&P RoTE of 11.1% reflected continued investment in the business resulting in balance growth and increased
income, partially offset by higher impairment charges.
Income statement - H123 compared to H122
• Profit before tax increased 20% to £3,319m with a RoTE of 12.4% (H122: 11.5%), reflecting a RoTE of 12.6% (H122:
11.9%) in CIB and 11.1% (H122: 8.5%) in CC&P
• Barclays International has a diverse income profile across businesses and geographies including a significant
presence in the US. The appreciation of average USD against GBP positively impacted income and profits, and adversely
impacted credit impairment charges and total operating expenses
• Total income decreased to £9,722m (H122: £9,940m)
– CIB income decreased 10% to £7,138m. Excluding the impact from prior year hedging arrangements related to the
Over-issuance of Securities1, CIB income decreased 1%
– Global Markets income of £4,241m decreased 25%, and 13% excluding the impact from prior year hedging
arrangements related to the Over-issuance of Securities. FICC income decreased 6% to £2,974m, driven by macro
reflecting lower market volatility and client activity, partially offset by a strong performance in credit. Equities
income of £1,267m decreased 49%, and 26% excluding the impact from the Over-issuance of Securities driven
by a decline in derivatives income reflecting less volatile equity market conditions
– Investment Banking fees decreased 11% to £1,075m due to the reduced fee pool across Advisory and Debt
capital markets2, partially offset by an improvement in Equity capital markets
– Within Corporate, Transaction banking income increased 48% to £1,559m driven by improved deposit margins in
the higher rate environment. Corporate lending income increased to £263m (H122: £78m) mainly driven by lower
costs of hedging and the non-repeat of fair value losses on leverage finance lending net of mark to market gains
on related hedges in H122
– CC&P income increased 31% to £2,584m
– International Cards and Consumer Bank income increased 41% to £1,734m reflecting higher cards balances and
improved margins, including the Gap portfolio acquisition in Q222
– Private Bank income increased 21% to £554m, reflecting client balance growth and improved margins, including
the transfer of WM&I from Barclays UK
– Payments income increased 5% to £296m driven by merchant acquiring turnover growth
• Total operating expenses decreased 17% to £5,733m and increased 13% to £5,703m excluding litigation and
conduct, reflecting investment in the business
– CIB total operating expenses decreased 23% to £4,184m. Operating expenses excluding litigation and conduct
charges increased 10% to £4,186m reflecting investment in talent and technology, and the impact of inflation
– CC&P total operating expenses increased 7% to £1,549m. Operating expenses excluding litigation and conduct
charges increased 21% to £1,517m, driven by higher investment spend to support growth, mainly in marketing and
partnership costs, including the Gap portfolio acquisition, the transfer of WM&I from Barclays UK and the impact of
inflation
• Credit impairment charges were £679m (H122: £310m)
– CIB credit impairment charges of £20m (H122: £32m) were driven by single name charges partially offset by the
benefit of credit protection and the updated macroeconomic scenarios
– CC&P credit impairment charges increased to £659m (H122: £278m), reflecting higher US cards balances, including
the Gap portfolio, and normalising delinquencies. US cards 30 and 90 day arrears were 2.4% (H122: 1.4%) and 1.2%
(H122: 0.7%) respectively. The US cards total coverage ratio was 9.0% (December 2022: 8.1%)
1 H122 included a £758m of income related to hedging arrangements to manage the risks of the rescission offer in relation to the Over-issuance of
Securities.
2 Data source: Dealogic for the period covering 1 January to 30 June 2023.
Results by Business
Barclays PLC 14
-- 16 of 98 --
Balance sheet - 30 June 2023 compared to 31 December 2022
• Loans and advances at amortised cost increased £1.9bn to £171.5bn driven by increased investment in debt securities
in Treasury, offset by net loan repayments in CIB and the strengthening of GBP against USD
• Trading portfolio assets increased £31.3bn to £165.1bn driven by increased trading activity at the end of the period
within Global Markets
• Derivative assets and liabilities decreased £36.8bn and £34.4bn respectively to £264.9bn and £254.5bn reflecting
lower market volatility and the strengthening of GBP against USD
• Financial assets at fair value through the income statement increased £21.7bn to £232.2bn driven by increased
secured lending
• Deposits at amortised costs increased £17.4bn to £305.0bn driven by increased deposits in Treasury
• RWAs decreased to £254.6bn (December 2022: £254.8bn), as a reduction from the strengthening of GBP against USD
was partially offset by increased trading and credit risk RWAs within CIB
Results by Business
Barclays PLC 15
-- 17 of 98 --
Head Office Half year ended Three months ended
30.06.23 30.06.22 30.06.23 30.06.22
Income statement information £m £m % Change £m £m % Change
Net interest income (39) 66 (120) —
Net fee, commission and other income (83) (175) 53 4 (132)
Total income (122) (109) (12) (116) (132) 12
Operating costs (145) (145) — (82) (60) (37)
Litigation and conduct (5) — #DIV/0! (5) 1
Total operating expenses (150) (145) (3) (87) (59) (47)
Other net (expenses)/income (11) (16) 31 (3) 2
Loss before impairment (283) (270) (5) (206) (189) (9)
Credit impairment (charges)/releases (9) 17 (2) 9
Loss before tax (292) (253) (15) (208) (180) (16)
Attributable loss (239) (462) 48 (159) (170) 6
Performance measures
Average allocated tangible equity (£bn) (0.2) 2.7 (0.6) 1.7
As at
30.06.23 As at
31.12.22 As at
30.06.22
Balance sheet information £bn £bn £bn
Total assets 18.5 19.2 19.8
Risk weighted assets 9.3 8.6 8.6
Period end allocated tangible equity (1.5) (0.2) 1.1
Income statement - H123 compared to H122
• Loss before tax was £292m (H122: £253m)
• Total income was an expense of £122m (H122: £109m expense) primarily reflecting hedge accounting and treasury
items. The prior year included a one-off gain of £86m from the sale and leaseback of UK data centres
• Total operating expenses were £150m (H122: £145m)
Balance sheet - 30 June 2023 compared to 31 December 2022
• RWAs were £9.3bn (December 2022: £8.6bn)
Results by Business
Barclays PLC 16
-- 18 of 98 --
Barclays Group
Q223 Q123 Q422 Q322 Q222 Q122 Q4211 Q3211
Income statement information £m £m £m £m £m £m £m £m
Net interest income 3,270 3,053 2,741 3,068 2,422 2,341 2,230 1,940
Net fee, commission and other income 3,015 4,184 3,060 2,883 4,286 4,155 2,930 3,525
Total income 6,285 7,237 5,801 5,951 6,708 6,496 5,160 5,465
Operating costs (3,919) (4,111) (3,748) (3,939) (3,682) (3,588) (3,514) (3,446)
UK bank levy — — (176) — — — (170) —
Litigation and conduct (33) 1 (79) 339 (1,334) (523) (92) (129)
Total operating expenses (3,952) (4,110) (4,003) (3,600) (5,016) (4,111) (3,776) (3,575)
Other net income/(expenses) 3 (5) 10 (1) 7 (10) 13 94
Profit before impairment 2,336 3,122 1,808 2,350 1,699 2,375 1,397 1,984
Credit impairment (charges)/releases (372) (524) (498) (381) (200) (141) 31 (120)
Profit before tax 1,964 2,598 1,310 1,969 1,499 2,234 1,428 1,864
Tax (charge)/credit (353) (561) 33 (249) (209) (614) (104) (292)
Profit after tax 1,611 2,037 1,343 1,720 1,290 1,620 1,324 1,572
Non-controlling interests (22) (8) (22) (2) (20) (1) (27) (1)
Other equity instrument holders (261) (246) (285) (206) (199) (215) (218) (197)
Attributable profit 1,328 1,783 1,036 1,512 1,071 1,404 1,079 1,374
Performance measures
Return on average tangible shareholders' equity 11.4% 15.0% 8.9% 12.5% 8.7% 11.5% 9.0% 11.4%
Average tangible shareholders' equity (£bn) 46.7 47.6 46.7 48.6 49.0 48.8 48.0 48.3
Cost: income ratio 63% 57% 69% 60% 75% 63% 73% 65%
Loan loss rate (bps) 37 52 49 36 20 15 (3) 13
Basic earnings per share 8.6p 11.3p 6.5p 9.4p 6.4p 8.4p 6.4p 8.0p
Basic weighted average number of shares (m) 15,523 15,770 15,828 16,148 16,684 16,682 16,985 17,062
Period end number of shares (m) 15,556 15,701 15,871 15,888 16,531 16,762 16,752 16,851
Balance sheet and capital management2 £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 337.4 343.6 343.3 346.3 337.2 325.8 319.9 313.5
Loans and advances to banks at amortised cost 10.9 11.0 10.0 12.5 12.5 11.4 9.7 10.6
Debt securities at amortised cost 53.1 48.9 45.5 54.8 46.1 34.5 31.8 28.9
Loans and advances at amortised cost 401.4 403.5 398.8 413.7 395.8 371.7 361.5 353.0
Loans and advances at amortised cost impairment
coverage ratio 1.4% 1.4% 1.4% 1.4% 1.4% 1.5% 1.6% 1.7%
Total assets 1,549.7 1,539.1 1,513.7 1,726.9 1,589.2 1,496.1 1,384.3 1,406.5
Deposits at amortised cost 554.7 555.7 545.8 574.4 568.7 546.5 519.4 510.2
Tangible net asset value per share 291p 301p 295p 286p 297p 294p 291p 286p
Common equity tier 1 ratio 13.8% 13.6% 13.9% 13.8% 13.6% 13.8% 15.1% 15.3%
Common equity tier 1 capital 46.6 46.0 46.9 48.6 46.7 45.3 47.3 47.2
Risk weighted assets 336.9 338.4 336.5 350.8 344.5 328.8 314.1 307.7
UK leverage ratio 5.1% 5.1% 5.3% 5.0% 5.1% 5.0% 5.2% 5.1%
UK leverage exposure 1,183.7 1,168.9 1,130.0 1,232.1 1,151.2 1,123.5 1,137.9 1,162.7
Funding and liquidity
Group liquidity pool (£bn) 330.7 333.0 318.0 325.8 342.5 319.8 291.0 292.8
Liquidity coverage ratio 158% 163% 165% 151% 156% 159% 168% 161%
Net stable funding ratio3 139% 139% 137%
Loan: deposit ratio 72% 73% 73% 72% 70% 68% 70% 69%
1 The comparative capital and financial metrics relating to Q321 and Q421 have been restated to reflect the impact of the Over-issuance of Securities.
2 Refer to pages 54 to 58 for further information on how capital, RWAs and leverage are calculated.
3 Represents average of the last four spot quarter end positions.
Quarterly Results Summary
Barclays PLC 17
-- 19 of 98 --
Barclays UK
Q223 Q123 Q422 Q322 Q222 Q122 Q421 Q321
Income statement information £m £m £m £m £m £m £m £m
Net interest income 1,660 1,618 1,600 1,561 1,393 1,339 1,313 1,303
Net fee, commission and other income 301 343 370 355 331 310 386 335
Total income 1,961 1,961 1,970 1,916 1,724 1,649 1,699 1,638
Operating costs (1,090) (1,092) (1,108) (1,069) (1,085) (998) (1,202) (1,041)
UK bank levy — — (26) — — — (36) —
Litigation and conduct 5 (2) (13) (3) (16) (9) (5) (10)
Total operating expenses (1,085) (1,094) (1,147) (1,072) (1,101) (1,007) (1,243) (1,051)
Other net income/(expenses) — — 1 (1) — — (1) 1
Profit before impairment 876 867 824 843 623 642 455 588
Credit impairment (charges)/releases (95) (113) (157) (81) — (48) 59 (137)
Profit before tax 781 754 667 762 623 594 514 451
Attributable profit 534 515 474 549 458 396 420 317
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 206.8 208.2 205.1 205.1 205.9 207.3 208.8 208.6
Total assets 304.8 308.6 313.2 316.8 318.8 317.2 321.2 312.1
Customer deposits at amortised cost 249.8 254.3 258.0 261.0 261.5 260.3 260.6 256.8
Loan: deposit ratio 90% 90 % 87 % 86% 85% 85% 85 % 86 %
Risk weighted assets 73.0 74.6 73.1 73.2 72.2 72.7 72.3 73.2
Period end allocated tangible equity 10.1 10.3 10.1 10.1 9.9 10.1 10.0 10.0
Performance measures
Return on average allocated tangible equity 20.9% 20.0 % 18.7 % 22.1% 18.4% 15.6% 16.8 % 12.7 %
Average allocated tangible equity (£bn) 10.2 10.3 10.2 9.9 10.0 10.1 10.0 10.0
Cost: income ratio 55% 56 % 58 % 56% 64% 61% 73 % 64 %
Loan loss rate (bps) 17 20 27 14 — 9 (10) 24
Net interest margin 3.22% 3.18 % 3.10 % 3.01 % 2.71% 2.62% 2.49 % 2.49 %
Quarterly Results by Business
Barclays PLC 18
-- 20 of 98 --
Analysis of Barclays UK Q223 Q123 Q422 Q322 Q222 Q122 Q421 Q321
Analysis of total income £m £m £m £m £m £m £m £m
Personal Banking 1,244 1,253 1,229 1,212 1,077 1,022 983 990
Barclaycard Consumer UK 237 247 269 283 265 276 352 293
Business Banking 480 461 472 421 382 351 364 355
Total income 1,961 1,961 1,970 1,916 1,724 1,649 1,699 1,638
Analysis of credit impairment (charges)/releases
Personal Banking (92) (28) (120) (26) (42) 21 8 (30)
Barclaycard Consumer UK (35) (83) (12) 2 84 (44) 114 (108)
Business Banking 32 (2) (25) (57) (42) (25) (63) 1
Total credit impairment (charges)/releases (95) (113) (157) (81) — (48) 59 (137)
Analysis of loans and advances to customers at
amortised cost £bn £bn £bn £bn £bn £bn £bn £bn
Personal Banking 173.3 173.6 169.7 168.7 167.1 166.5 165.4 164.6
Barclaycard Consumer UK 9.3 9.0 9.2 9.0 8.8 8.4 8.7 8.6
Business Banking 24.2 25.6 26.2 27.4 30.0 32.4 34.7 35.4
Total loans and advances to customers at amortised
cost 206.8 208.2 205.1 205.1 205.9 207.3 208.8 208.6
Analysis of customer deposits at amortised cost
Personal Banking 191.1 194.3 195.6 197.3 197.0 196.6 196.4 193.3
Barclaycard Consumer UK — — — — — — — —
Business Banking 58.7 60.0 62.4 63.7 64.5 63.7 64.2 63.5
Total customer deposits at amortised cost 249.8 254.3 258.0 261.0 261.5 260.3 260.6 256.8
Quarterly Results by Business
Barclays PLC 19
-- 21 of 98 --
Barclays International
Q223 Q123 Q422 Q322 Q222 Q122 Q4211 Q3211
Income statement information £m £m £m £m £m £m £m £m
Net interest income 1,730 1,354 1,465 1,497 1,029 936 955 749
Net trading income 1,278 2,419 1,169 1,328 2,766 2,446 789 1,515
Net fee, commission and other income 1,432 1,509 1,228 1,240 1,321 1,442 1,766 1,673
Total income 4,440 5,282 3,862 4,065 5,116 4,824 3,510 3,937
Operating costs (2,747) (2,956) (2,543) (2,776) (2,537) (2,505) (2,160) (2,310)
UK bank levy — — (133) — — — (134) —
Litigation and conduct (33) 3 (67) 396 (1,319) (513) (84) (100)
Total operating expenses (2,780) (2,953) (2,743) (2,380) (3,856) (3,018) (2,378) (2,410)
Other net income 6 3 5 10 5 8 3 15
Profit before impairment 1,666 2,332 1,124 1,695 1,265 1,814 1,135 1,542
Credit impairment (charges)/releases (275) (404) (328) (295) (209) (101) (23) 18
Profit before tax 1,391 1,928 796 1,400 1,056 1,713 1,112 1,560
Attributable profit 953 1,348 625 1,136 783 1,300 818 1,191
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 126.6 131.0 133.7 137.0 126.7 113.9 106.4 99.9
Loans and advances to banks at amortised cost 9.7 9.8 8.7 11.0 11.3 10.2 8.4 9.4
Debt securities at amortised cost 35.2 30.8 27.2 36.2 29.3 20.7 19.0 16.6
Loans and advances at amortised cost 171.5 171.6 169.6 184.2 167.3 144.8 133.8 125.9
Trading portfolio assets 165.1 137.7 133.8 126.3 126.9 134.1 146.9 144.8
Derivative financial instrument assets 264.9 256.6 301.7 415.7 343.5 288.8 261.5 257.0
Financial assets at fair value through the income
statement 232.2 245.0 210.5 244.7 209.3 203.8 188.2 200.5
Cash collateral and settlement balances 123.9 125.5 107.7 163.3 128.5 132.0 88.1 115.9
Other assets 268.8 275.0 258.0 257.2 275.1 255.5 225.6 231.8
Total assets 1,226.4 1,211.4 1,181.3 1,391.4 1,250.6 1,159.0 1,044.1 1,075.9
Deposits at amortised cost 305.0 301.6 287.6 313.2 307.4 286.1 258.8 253.3
Derivative financial instrument liabilities 254.5 246.7 288.9 394.2 321.2 277.2 256.4 252.3
Loan: deposit ratio 56% 57% 59% 59% 54% 51% 52% 50%
Risk weighted assets 254.6 255.1 254.8 269.3 263.8 245.1 230.9 222.7
Period end allocated tangible equity 36.7 36.8 36.8 38.8 38.0 35.6 33.2 31.8
Performance measures
Return on average allocated tangible equity 10.3% 14.5% 6.4% 11.6% 8.4% 14.8% 9.9% 14.9%
Average allocated tangible equity (£bn) 37.1 37.1 38.9 39.1 37.3 35.1 32.9 31.8
Cost: income ratio 63% 56% 71% 59% 75% 63% 68% 61%
Loan loss rate (bps) 63 94 75 62 49 28 7 (6)
Net interest margin2 5.85% 5.87% 5.71% 5.58% 4.41% 4.15% 4.14% 4.02%
1 The comparative capital and financial metrics relating to Q321 and Q421 have been restated to reflect the impact of the Over-issuance of Securities.
2 CIB and Barclays International margins include the lending related investment bank business.
Quarterly Results by Business
Barclays PLC 20
-- 22 of 98 --
Analysis of Barclays International
Corporate and Investment Bank Q223 Q123 Q422 Q322 Q222 Q122 Q4211 Q3211
Income statement information £m £m £m £m £m £m £m £m
Net interest income 856 465 548 606 410 385 432 279
Net trading income 1,353 2,437 1,201 1,344 2,738 2,450 774 1,467
Net fee, commission and other income 953 1,074 827 871 885 1,103 1,426 1,383
Total income 3,162 3,976 2,576 2,821 4,033 3,938 2,632 3,129
Operating costs (1,984) (2,202) (1,796) (2,043) (1,870) (1,921) (1,562) (1,747)
UK bank levy — — (126) — — — (128) —
Litigation and conduct (1) 3 (55) 498 (1,314) (318) (59) (99)
Total operating expenses (1,985) (2,199) (1,977) (1,545) (3,184) (2,239) (1,749) (1,846)
Other net income 1 — 2 — — — 1 —
Profit before impairment 1,178 1,777 601 1,276 849 1,699 884 1,283
Credit impairment releases/(charges) 13 (33) (41) (46) (65) 33 73 128
Profit before tax 1,191 1,744 560 1,230 784 1,732 957 1,411
Attributable profit 798 1,209 454 1,015 579 1,316 695 1,085
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 84.8 89.2 90.5 93.6 86.5 79.5 73.4 68.3
Loans and advances to banks at amortised cost 9.0 9.2 8.1 10.2 10.0 9.4 7.6 8.9
Debt securities at amortised cost 35.1 30.7 27.2 36.2 29.3 20.7 19.0 16.6
Loans and advances at amortised cost 128.9 129.1 125.8 140.0 125.8 109.6 100.0 93.8
Trading portfolio assets 165.0 137.6 133.7 126.1 126.7 134.0 146.7 144.7
Derivative financial instruments assets 264.8 256.5 301.6 415.5 343.4 288.7 261.5 256.9
Financial assets at fair value through the income
statement 232.1 244.9 210.5 244.6 209.2 203.8 188.1 200.4
Cash collateral and settlement balances 122.5 124.7 106.9 162.6 127.7 131.2 87.2 115.1
Other assets 224.6 230.3 222.6 220.6 237.2 222.5 195.8 200.4
Total assets 1,137.9 1,123.1 1,101.1 1,309.4 1,170.0 1,089.8 979.3 1,011.3
Deposits at amortised cost 225.5 221.0 205.8 229.5 229.5 214.7 189.4 185.8
Derivative financial instrument liabilities 254.5 246.7 288.9 394.2 321.2 277.1 256.4 252.2
Risk weighted assets 216.5 216.8 215.9 230.6 227.6 213.5 200.7 192.5
Performance measures
Return on average allocated tangible equity 10.0% 15.2% 5.4% 11.9% 7.1% 17.1% 9.7% 15.6%
Average allocated tangible equity (£bn) 31.8 31.8 33.7 34.0 32.7 30.8 28.7 27.8
Cost: income ratio 63% 55% 77% 55% 79% 57% 66% 59%
Loan loss rate (bps) (4) 10 13 13 20 (12) (29) (54)
Net interest margin2 3.98% 3.95% 3.73% 3.56% 2.88% 2.52% 2.67%
Analysis of total income £m £m £m £m £m £m £m £m
FICC 1,186 1,788 976 1,546 1,529 1,644 546 803
Equities 563 704 440 246 1,411 1,052 501 757
Global Markets 1,749 2,492 1,416 1,792 2,940 2,696 1,047 1,560
Advisory 130 212 197 150 236 185 287 253
Equity capital markets 69 50 40 42 37 47 158 186
Debt capital markets 273 341 243 341 281 416 511 532
Investment Banking fees 472 603 480 533 554 648 956 971
Corporate lending 168 95 (128) (181) (47) 125 176 168
Transaction banking 773 786 808 677 586 469 453 430
Corporate 941 881 680 496 539 594 629 598
Total income 3,162 3,976 2,576 2,821 4,033 3,938 2,632 3,129
1 The comparative capital and financial metrics relating to Q321 and Q421 have been restated to reflect the impact of the Over-issuance of Securities.
2 CIB and Barclays International margins include the lending related investment bank business.
Quarterly Results by Business
Barclays PLC 21
-- 23 of 98 --
Analysis of Barclays International
Consumer, Cards and Payments Q223 Q123 Q422 Q322 Q222 Q122 Q421 Q321
Income statement information £m £m £m £m £m £m £m £m
Net interest income 874 889 918 891 619 551 522 471
Net fee, commission, trading and other income 404 417 368 353 464 335 356 337
Total income 1,278 1,306 1,286 1,244 1,083 886 878 808
Operating costs (763) (754) (747) (733) (667) (584) (598) (563)
UK bank levy — — (7) — — — (6) —
Litigation and conduct (32) — (12) (102) (5) (195) (25) (1)
Total operating expenses (795) (754) (766) (835) (672) (779) (629) (564)
Other net income 5 3 3 10 5 8 2 15
Profit before impairment 488 555 523 419 416 115 251 259
Credit impairment charges (288) (371) (287) (249) (144) (134) (96) (110)
Profit/(loss) before tax 200 184 236 170 272 (19) 155 149
Attributable profit/(loss) 155 139 171 121 204 (16) 123 106
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 41.7 41.8 43.2 43.4 40.2 34.4 33.0 31.6
Total assets 88.5 88.3 80.2 82.0 80.6 69.2 64.8 64.6
Deposits at amortised cost 79.5 80.6 81.8 83.7 77.9 71.4 69.4 67.5
Risk weighted assets 38.1 38.2 38.9 38.7 36.2 31.6 30.2 30.2
Performance measures
Return on average allocated tangible equity 11.8% 10.5% 13.0% 9.5% 17.8% (1.5)% 11.7% 10.5%
Average allocated tangible equity (£bn) 5.3 5.3 5.2 5.1 4.6 4.3 4.2 4.0
Cost: income ratio 62% 58% 60% 67% 62% 88% 72% 70%
Loan loss rate (bps) 255 332 245 211 132 145 105 127
Net interest margin 8.25% 8.42% 8.40% 8.41% 6.68% 6.56% 6.29%
Analysis of total income £m £m £m £m £m £m £m £m
International Cards and Consumer Bank 835 900 860 824 691 538 552 490
Private Bank 295 258 285 270 245 214 200 188
Payments 148 148 141 150 147 134 126 130
Total income 1,278 1,306 1,286 1,244 1,083 886 878 808
Quarterly Results by Business
Barclays PLC 22
-- 24 of 98 --
Head Office
Q223 Q123 Q422 Q322 Q222 Q122 Q421 Q321
Income statement information £m £m £m £m £m £m £m £m
Net interest income (120) 81 (324) 10 — 66 (38) (112)
Net fee, commission and other income 4 (87) 293 (40) (132) (43) (11) 2
Total income (116) (6) (31) (30) (132) 23 (49) (110)
Operating costs (82) (63) (97) (94) (60) (85) (152) (95)
UK bank levy — — (17) — — — — —
Litigation and conduct (5) — 1 (54) 1 (1) (3) (19)
Total operating expenses (87) (63) (113) (148) (59) (86) (155) (114)
Other net (expenses)/income (3) (8) 4 (10) 2 (18) 11 78
Loss before impairment (206) (77) (140) (188) (189) (81) (193) (146)
Credit impairment (charges)/releases (2) (7) (13) (5) 9 8 (5) (1)
Loss before tax (208) (84) (153) (193) (180) (73) (198) (147)
Attributable loss (159) (80) (63) (173) (170) (292) (159) (134)
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Total assets 18.5 19.1 19.2 18.7 19.8 19.9 19.0 18.5
Risk weighted assets1 9.3 8.8 8.6 8.2 8.6 11.0 11.0 11.8
Period end allocated tangible equity1 (1.5) 0.2 (0.2) (3.5) 1.1 3.6 5.5 6.3
Performance measures1
Average allocated tangible equity (£bn) (0.6) 0.2 (2.4) (0.4) 1.7 3.6 5.1 6.5
1 The comparative capital and financial metrics relating to Q321 and Q421 have been restated to reflect the impact of the Over-issuance of Securities.
Quarterly Results by Business
Barclays PLC 23
-- 25 of 98 --
Margins and balances
Half year ended 30.06.23 Half year ended 30.06.22
Net interest
income
Average
customer
assets
Net interest
margin
Net interest
income
Average
customer
assets
Net interest
margin
£m £m % £m £m %
Barclays UK 3,278 206,653 3.20 2,732 206,524 2.67
Corporate and Investment Bank1 1,091 55,504 3.96 713 52,991 2.71
Consumer, Cards and Payments 1,763 42,673 8.33 1,170 35,616 6.63
Barclays International1 2,854 98,177 5.86 1,883 88,607 4.29
Total Barclays UK and Barclays International 6,132 304,830 4.06 4,615 295,131 3.15
Other2 191 148
Total Barclays Group 6,323 4,763
1 CIB and Barclays International margins include the lending related investment bank business.
2 Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins.
The Barclays UK and Barclays International NIM has increased 91bps from 3.15% in H122 to 4.06% in H123, driven by the
higher interest rate environment and continued structural hedge income momentum across the Group as well as higher
balances in CC&P including the Gap portfolio acquisition, partially offset by product dynamics in deposits and mortgages.
The Group’s combined product and equity structural hedge notional amount at June 2023 was £256bn (December 2022:
£263bn), with an average duration of close to 2.5 years (2022: average duration close to 3 years). Gross structural hedge
contributions of £1,639m (H122: £879m) and net structural hedge contributions of £(3,701)m (H122: £83m) are included in
Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the
fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest
earned on the difference between the structural hedge rate and prevailing floating rates.
Quarterly analysis for Barclays UK and Barclays International
Q223 Q123 Q422 Q322 Q222
Net interest income £m £m £m £m £m
Barclays UK 1,660 1,618 1,600 1,561 1,393
Corporate and Investment Bank1 540 551 556 529 397
Consumer, Cards and Payments 874 889 918 891 619
Barclays International1 1,414 1,440 1,474 1,420 1,016
Total Barclays UK and Barclays International 3,074 3,058 3,074 2,981 2,409
Average customer assets £m £m £m £m £m
Barclays UK 207,073 206,241 204,941 205,881 205,834
Corporate and Investment Bank1 54,417 56,612 59,146 58,891 55,181
Consumer, Cards and Payments 42,503 42,840 43,319 42,019 37,190
Barclays International1 96,920 99,452 102,465 100,910 92,371
Total Barclays UK and Barclays International 303,993 305,693 307,406 306,791 298,205
Net interest margin % % % % %
Barclays UK 3.22 3.18 3.10 3.01 2.71
Corporate and Investment Bank1 3.98 3.95 3.73 3.56 2.88
Consumer, Cards and Payments 8.25 8.42 8.40 8.41 6.68
Barclays International1 5.85 5.87 5.71 5.58 4.41
Total Barclays UK and Barclays International 4.06 4.06 3.97 3.85 3.24
1 CIB and Barclays International margins include the lending related investment bank business.
Performance Management
Barclays PLC 24
-- 26 of 98 --
Risk management and principal risks
The roles and responsibilities of the business groups, Risk and Compliance in the management of risk in the Group are
defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the
Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent limits
which it places on related risk taking.
The framework identifies nine principal risks: credit risk, market risk, treasury and capital risk, climate risk, operational risk,
model risk, compliance risk, reputation risk and legal risk. Further detail on the Group’s principal risks and previously
identified material existing and emerging risks and how such risks are managed is available in the Barclays PLC Annual
Report 2022 (pages 266 to 295), which can be accessed at home.barclays/annualreport. Other than the changes set out in
the paragraph below, there have been no significant changes to these principal risks or previously identified material existing
and emerging risks in the period.
In Q223, the 'conduct risk' principal risk was expanded to include “Laws, Rules and Regulations (LRR) Risk” and
consequently renamed 'compliance risk’. Reflecting this, the definition of compliance risk is: 'The risk of poor outcomes for,
or harm to, customers, clients and markets, arising from the delivery of the firm’s products and services (also known as
'Conduct Risk') and the risk to Barclays, its clients, customers or markets from a failure to comply with the laws, rules and
regulations applicable to the firm (also known as Laws, Rules and Regulations Risk 'LRR Risk').' The definition of the 'legal
risk' principal risk was updated to: 'The risk of loss or imposition of penalties, damages or fines from the failure of the firm to
meet applicable laws, rules and regulations or contractual requirements or to assert or defend its intellectual property rights.'
The revised framework has been in force from June 2023.
The following section gives an overview of credit risk, market risk, and treasury and capital risk for the period.
Risk Management
Barclays PLC 25
-- 27 of 98 --
Loans and advances at amortised cost by stage
Total loans and advances at amortised cost in the credit risk performance section includes Loans and advances at amortised
cost to banks, Loans and advances at amortised cost to customers and Debt securities at amortised cost.
The table below presents a stage allocation and business segment analysis of loans and advances at amortised cost by gross
exposure, impairment allowance, impairment charge and coverage ratio as at 30 June 2023. Also included are stage
allocation of off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment
allowance and coverage as at 30 June 2023.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios,
the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn
exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios,
impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.
Gross exposure Impairment allowance Net
exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.23 £m £m £m £m £m £m £m £m £m
Barclays UK 164,741 23,408 2,390 190,539 324 669 507 1,500 189,039
Barclays International 32,431 4,645 1,954 39,030 365 1,211 1,144 2,720 36,310
Head Office 3,181 281 558 4,020 3 23 315 341 3,679
Total Barclays Group retail 200,353 28,334 4,902 233,589 692 1,903 1,966 4,561 229,028
Barclays UK 33,997 2,383 761 37,141 72 74 94 240 36,901
Barclays International 121,655 13,259 1,007 135,921 190 270 292 752 135,169
Head Office 307 — 17 324 — — 17 17 307
Total Barclays Group wholesale 155,959 15,642 1,785 173,386 262 344 403 1,009 172,377
Total loans and advances at
amortised cost 356,312 43,976 6,687 406,975 954 2,247 2,369 5,570 401,405
Off-balance sheet loan commitments
and financial guarantee contracts1 364,839 28,637 1,262 394,738 200 308 41 549 394,189
Total2 721,151 72,613 7,949 801,713 1,154 2,555 2,410 6,119 795,594
As at 30.06.23 Half year ended 30.06.23
Coverage ratio
Loan impairment charge/(release) and
loan loss rate
Stage 1 Stage 2 Stage 3 Total
Loan impairment
charge/(release) Loan loss rate
% % % % £m bps
Barclays UK 0.2 2.9 21.2 0.8 225 24
Barclays International 1.1 26.1 58.5 7.0 665 344
Head Office 0.1 8.2 56.5 8.5 9 45
Total Barclays Group retail 0.3 6.7 40.1 2.0 899 78
Barclays UK 0.2 3.1 12.4 0.6 (47)
Barclays International 0.2 2.0 29.0 0.6 58 9
Head Office — — 100.0 5.2 —
Total Barclays Group wholesale 0.2 2.2 22.6 0.6 11 1
Total loans and advances at
amortised cost 0.3 5.1 35.4 1.4 910 45
Off-balance sheet loan commitments
and financial guarantee contracts1 0.1 1.1 3.2 0.1 (25)
Other financial assets subject to
impairment2 11
Total3 0.2 3.5 30.3 0.8 896
1 Excludes loan commitments and financial guarantees of £12.3bn carried at fair value.
2 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value
through other comprehensive income and other assets. These have a total gross exposure of £198.2bn and impairment allowance of £165m. This comprises
£18m ECL on £196.8bn Stage 1 assets, £12m on £1.3bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement
balances and £135m on £145m Stage 3 other assets.
3 The annualised loan loss rate is 44bps after applying the total impairment charge of £896m.
Credit Risk
Barclays PLC 26
-- 28 of 98 --
Gross exposure Impairment allowance Net
exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.22 £m £m £m £m £m £m £m £m £m
Barclays UK 160,424 24,837 2,711 187,972 232 718 485 1,435 186,537
Barclays International 33,735 4,399 1,793 39,927 392 1,200 949 2,541 37,386
Head Office 3,644 252 661 4,557 3 24 359 386 4,171
Total Barclays Group retail 197,803 29,488 5,165 232,456 627 1,942 1,793 4,362 228,094
Barclays UK 34,858 2,954 805 38,617 129 109 96 334 38,283
Barclays International 117,692 14,298 1,098 133,088 301 265 312 878 132,210
Head Office 192 — 18 210 — — 18 18 192
Total Barclays Group wholesale 152,742 17,252 1,921 171,915 430 374 426 1,230 170,685
Total loans and advances at
amortised cost 350,545 46,740 7,086 404,371 1,057 2,316 2,219 5,592 398,779
Off-balance sheet loan commitments
and financial guarantee contracts1 372,945 30,694 1,180 404,819 245 315 23 583 404,236
Total2 723,490 77,434 8,266 809,190 1,302 2,631 2,242 6,175 803,015
As at 31.12.22 Year ended 31.12.22
Coverage ratio
Loan impairment charge/(release) and
loan loss rate
Stage 1 Stage 2 Stage 3 Total
Loan impairment
charge/(release) Loan loss rate
% % % % £m bps
Barclays UK 0.1 2.9 17.9 0.8 169 9
Barclays International 1.2 27.3 52.9 6.4 763 191
Head Office 0.1 9.5 54.3 8.5 —
Total Barclays Group retail 0.3 6.6 34.7 1.9 932 40
Barclays UK 0.4 3.7 11.9 0.9 106 27
Barclays International 0.3 1.9 28.4 0.7 127 10
Head Office — — 100.0 8.6 —
Total Barclays Group wholesale 0.3 2.2 22.2 0.7 233 14
Total loans and advances at
amortised cost 0.3 5.0 31.3 1.4 1,165 29
Off-balance sheet loan commitments
and financial guarantee contracts1 0.1 1.0 1.9 0.1 18
Other financial assets subject to
impairment2 37
Total3 0.2 3.4 27.1 0.8 1,220
1 Excludes loan commitments and financial guarantees of £14.9bn carried at fair value.
2 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value
through other comprehensive income and other assets. These have a total gross exposure of £180.1bn and impairment allowance of £163m. This comprises
£10m ECL on £178.4bn Stage 1 assets, £9m on £1.5bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement
balances and £144m on £149m Stage 3 other assets.
3 The annualised loan loss rate is 30bps after applying the total impairment charge of £1,220m.
Credit Risk
Barclays PLC 27
-- 29 of 98 --
Taskforce on Disclosures about Expected Credit Losses (DECL)
The latest DECL III Taskforce recommendation for the minimum product groupings has been adopted in the credit risk
performance section for this period and the prior period comparatives have been aligned accordingly. The Group intends to
adopt further enhancements such as geographical breakdown and other recommendations in future periods.
Loans and advances at amortised cost by product
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage
allocation by asset classification.
Stage 2
As at 30.06.23 Stage 1
Not past
due
<=30
days past
due
>30 days
past due Total Stage 3 Total
Gross exposure £m £m £m £m £m £m £m
Retail mortgages 155,521 15,114 1,841 848 17,803 2,108 175,432
Retail credit cards 29,351 5,676 356 266 6,298 1,455 37,104
Retail other 10,677 1,252 92 286 1,630 520 12,827
Corporate loans 106,387 14,074 133 209 14,416 2,602 123,405
Debt securities and other1 54,376 3,829 — — 3,829 2 58,207
Total 356,312 39,945 2,422 1,609 43,976 6,687 406,975
Impairment allowance
Retail mortgages 41 67 21 16 104 409 554
Retail credit cards 474 1,235 164 152 1,551 1,125 3,150
Retail other 81 122 22 27 171 246 498
Corporate loans 335 367 12 8 387 589 1,311
Debt securities and other1 23 34 — — 34 — 57
Total 954 1,825 219 203 2,247 2,369 5,570
Net exposure
Retail mortgages 155,480 15,047 1,820 832 17,699 1,699 174,878
Retail credit cards 28,877 4,441 192 114 4,747 330 33,954
Retail other 10,596 1,130 70 259 1,459 274 12,329
Corporate loans 106,052 13,707 121 201 14,029 2,013 122,094
Debt securities and other1 54,353 3,795 — — 3,795 2 58,150
Total 355,358 38,120 2,203 1,406 41,729 4,318 401,405
Coverage ratio % % % % % % %
Retail mortgages — 0.4 1.1 1.9 0.6 19.4 0.3
Retail credit cards 1.6 21.8 46.1 57.1 24.6 77.3 8.5
Retail other 0.8 9.7 23.9 9.4 10.5 47.3 3.9
Corporate loans 0.3 2.6 9.0 3.8 2.7 22.6 1.1
Debt securities and other1 — 0.9 — — 0.9 — 0.1
Total 0.3 4.6 9.0 12.6 5.1 35.4 1.4
1 Predominantly includes debt securities within Treasury and CIB, these have a total gross exposure of £53.2bn and an impairment allowance of £57m. Also
includes loans and advances of £4.5bn within Treasury and £0.5bn within Head Office, which have an impairment allowance of £nil.
Credit Risk
Barclays PLC 28
-- 30 of 98 --
Stage 2
As at 31.12.22 Stage 1
Not past
due
<=30
days past
due
>30 days
past due Total Stage 3 Total
Gross exposure £m £m £m £m £m £m £m
Retail mortgages 153,672 15,990 1,684 526 18,200 2,414 174,286
Retail credit cards 29,788 5,731 284 434 6,449 1,380 37,617
Retail other 13,470 1,232 104 132 1,468 720 15,658
Corporate loans 107,309 16,560 159 107 16,826 2,567 126,702
Debt securities and other1 46,306 3,797 — — 3,797 5 50,108
Total 350,545 43,310 2,231 1,199 46,740 7,086 404,371
Impairment allowance
Retail mortgages 29 53 11 9 73 414 516
Retail credit cards 458 1,334 100 186 1,620 955 3,033
Retail other 100 118 22 26 166 308 574
Corporate loans 461 401 13 10 424 542 1,427
Debt securities and other1 9 33 — — 33 — 42
Total 1,057 1,939 146 231 2,316 2,219 5,592
Net exposure
Retail mortgages 153,643 15,937 1,673 517 18,127 2,000 173,770
Retail credit cards 29,330 4,397 184 248 4,829 425 34,584
Retail other 13,370 1,114 82 106 1,302 412 15,084
Corporate loans 106,848 16,159 146 97 16,402 2,025 125,275
Debt securities and other1 46,297 3,764 — — 3,764 5 50,066
Total 349,488 41,371 2,085 968 44,424 4,867 398,779
Coverage ratio % % % % % % %
Retail mortgages — 0.3 0.7 1.7 0.4 17.1 0.3
Retail credit cards 1.5 23.3 35.2 42.9 25.1 69.2 8.1
Retail other 0.7 9.6 21.2 19.7 11.3 42.8 3.7
Corporate loans 0.4 2.4 8.2 9.3 2.5 21.1 1.1
Debt securities and other1 — 0.9 — — 0.9 — 0.1
Total 0.3 4.5 6.5 19.3 5.0 31.3 1.4
1 Predominantly includes debt securities within Treasury and CIB, these have a total gross exposure of £45.5bn and an impairment allowance of £42m. Also
includes loans and advances of £4.1bn within Treasury and £0.5bn within Head Office, which have an impairment allowance of £nil.
Credit Risk
Barclays PLC 29
-- 31 of 98 --
Loans and advances at amortised cost by selected sectors
The table below presents a breakdown of drawn exposure and impairment allowance for loans and advances at amortised
cost with stage allocation for selected industry sectors within the corporate loan portfolio. As the nature of macroeconomic
uncertainties have evolved, including to higher interest rates and continuing inflationary stress, so has the appraisal of
selected sectors under management focus.
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.23 £m £m £m £m £m £m £m £m
Autos 911 182 41 1,134 3 4 7 14
Consumer manufacture 4,046 1,351 231 5,628 20 37 49 106
Discretionary retail and wholesale 4,432 1,394 174 6,000 29 30 37 96
Hospitality and leisure 3,654 1,349 324 5,327 23 24 59 106
Passenger travel 733 194 39 966 6 7 13 26
Real estate 13,637 2,423 495 16,555 53 46 116 215
Steel and aluminium manufacturers 453 154 28 635 4 2 19 25
Total 27,866 7,047 1,332 36,245 138 150 300 588
Total of corporate exposures (%) 26% 49% 51% 29% 41% 39% 51% 45%
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.22 £m £m £m £m £m £m £m £m
Autos 881 194 31 1,106 6 5 6 17
Consumer manufacture 3,845 1,729 199 5,773 45 41 46 132
Discretionary retail and wholesale 5,143 1,711 249 7,103 41 37 51 129
Hospitality and leisure 3,902 1,316 429 5,647 40 31 70 141
Passenger travel 744 267 51 1,062 9 7 13 29
Real estate 13,042 3,049 499 16,590 91 66 123 280
Steel and aluminium manufacturers 486 85 18 589 7 1 8 16
Total 28,043 8,351 1,476 37,870 239 188 317 744
Total of corporate exposures (%) 26% 50% 57% 30% 52% 44% 58% 52%
Gross loans and advances to selected sectors have decreased through the year, as has the coverage ratio at June 2023: 1.6%
(December 2022: 2.0%) primarily driven by non-default coverage reducing from 1.2% at December 2022 to 0.8% at June
2023. The lower impairment provisioning is primarily driven by the retirement of the customer uncertainty PMA following
rebuild of certain CIB models, which better capture the macroeconomic outlook; and a granular assessment of the portfolio,
which is subject to increased monitoring under Barclays Risk Management framework. The portfolio also benefits from an
external hedge protection program that enables effective risk management against credit losses.
An additional £72m (December 2022: £115m) impairment allowance has been provisioned against undrawn commitments
not included in the table above.
Credit Risk
Barclays PLC 30
-- 32 of 98 --
Movement in gross exposures and impairment allowance including provisions for loan commitments and
financial guarantees
The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment
allowance. An explanation of the methodology used to determine credit impairment provisions is included in the Barclays
PLC Annual Report 2022.
Transfers between stages in the tables have been reflected as if they had taken place at the beginning of the year. 'Net
drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes' includes
additional drawdowns and partial repayments from existing facilities. Additionally, the below tables do not include other
financial assets subject to impairment such as cash collateral and settlement balances, financial assets at fair value through
other comprehensive income and other assets.
The movements are measured over a 6-month period.
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Retail mortgages £m £m £m £m £m £m £m £m
As at 1 January 2023 153,672 29 18,200 73 2,414 414 174,286 516
Transfers from Stage 1 to Stage 2 (5,762) (1) 5,762 1 — — — —
Transfers from Stage 2 to Stage 1 5,086 15 (5,086) (15) — — — —
Transfers to Stage 3 (145) — (141) (9) 286 9 — —
Transfers from Stage 3 18 1 80 1 (98) (2) — —
Business activity in the period1 14,681 9 361 3 6 5 15,048 17
Refinements to models used for calculation — — — — — — — —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(6,695) (11) (589) 53 (300) (2) (7,584) 40
Final repayments (5,334) (1) (784) (3) (190) (5) (6,308) (9)
Disposals — — — — — — — —
Write-offs — — — — (10) (10) (10) (10)
As at 30 June 2023 155,521 41 17,803 104 2,108 409 175,432 554
Retail credit cards
As at 1 January 2023 29,788 458 6,449 1,620 1,380 955 37,617 3,033
Transfers from Stage 1 to Stage 2 (2,037) (57) 2,037 57 — — — —
Transfers from Stage 2 to Stage 1 1,789 429 (1,789) (429) — — — —
Transfers to Stage 3 (239) (13) (531) (255) 770 268 — —
Transfers from Stage 3 12 7 6 3 (18) (10) — —
Business activity in the period 1,290 25 97 25 2 1 1,389 51
Refinements to models used for calculation2 — — — — — (20) — (20)
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(1,128) (360) 67 571 (152) 424 (1,213) 635
Final repayments (124) (15) (38) (41) (12) (13) (174) (69)
Disposals3 — — — — (91) (56) (91) (56)
Write-offs — — — — (424) (424) (424) (424)
As at 30 June 2023 29,351 474 6,298 1,551 1,455 1,125 37,104 3,150
.
1 Business activity in the period reported within Retail mortgages includes an acquisition of Kensington Mortgage Company in UK Mortgages of £2.4bn.
2 Refinements to models used for calculation reported within Retail credit cards include a £20m movement in US cards. These reflect model enhancements
made during the year. Barclays continually reviews the output of models to determine accuracy of the ECL calculation including review of model monitoring,
external benchmarking and experience of model operation over an extended period of time. This helps to ensure that the models used continue to reflect the
risks inherent across the businesses.
3 The £91m disposals reported within Retail credit cards relates to debt sales undertaken during the year.
Credit Risk
Barclays PLC 31
-- 33 of 98 --
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Retail other £m £m £m £m £m £m £m £m
As at 1 January 2023 13,470 100 1,468 166 720 308 15,658 574
Transfers from Stage 1 to Stage 2 (890) (12) 890 12 — — — —
Transfers from Stage 2 to Stage 1 392 30 (392) (30) — — — —
Transfers to Stage 3 (86) (3) (107) (35) 193 38 — —
Transfers from Stage 3 10 2 11 4 (21) (6) — —
Business activity in the period 2,481 16 53 8 9 5 2,543 29
Refinements to models used for calculation — — — — — — — —
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes
(3,350) (47) (187) 50 (151) 27 (3,688) 30
Final repayments (1,350) (5) (106) (4) (75) (17) (1,531) (26)
Disposals1 — — — — (98) (52) (98) (52)
Write-offs — — — — (57) (57) (57) (57)
As at 30 June 2023 10,677 81 1,630 171 520 246 12,827 498
Corporate loans
As at 1 January 2023 107,309 461 16,826 424 2,567 542 126,702 1,427
Transfers from Stage 1 to Stage 2 (5,875) (31) 5,875 31 — — — —
Transfers from Stage 2 to Stage 1 6,102 99 (6,102) (99) — — — —
Transfers to Stage 3 (370) (3) (584) (22) 954 25 — —
Transfers from Stage 3 109 8 195 12 (304) (20) — —
Business activity in the period 11,281 24 355 14 123 17 11,759 55
Refinements to models used for calculation2 — (49) — 142 — — — 93
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes3
1,521 (105) (1,422) (93) (379) 225 (280) 27
Final repayments (13,690) (69) (727) (22) (157) (13) (14,574) (104)
Disposals1 — — — — (110) (95) (110) (95)
Write-offs — — — — (92) (92) (92) (92)
As at 30 June 2023 106,387 335 14,416 387 2,602 589 123,405 1,311
1 The £98m disposals reported within Retail other includes £64m part sale of Wealth portfolio in Italy and £34m relates to debt sales undertaken during the
year. The £110m disposals reported within Corporate loans relates to debt sales undertaken during the year.
2 Refinements to models used for calculation reported within Corporate loans include a £93m movement in Corporate and Investment Bank. These reflect
model enhancements made during the year. Barclays continually reviews the output of models to determine accuracy of the ECL calculation including review
of model monitoring, external benchmarking and experience of model operation over an extended period of time. This helps to ensure that the models used
continue to reflect the risks inherent across the businesses.
3 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes' reported within Corporate loans also
include assets of £0.5bn de-recognised due to payment received on defaulted loans from government guarantees issued under government’s Bounce Back
Loan Scheme.
Credit Risk
Barclays PLC 32
-- 34 of 98 --
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Debt securities and other £m £m £m £m £m £m £m £m
As at 1 January 2023 46,306 9 3,797 33 5 — 50,108 42
Transfers from Stage 1 to Stage 2 (260) — 260 — — — — —
Transfers from Stage 2 to Stage 1 118 2 (118) (2) — — — —
Transfers to Stage 3 — — — — — — — —
Transfers from Stage 3 — — — — — — — —
Business activity in the period 15,435 3 140 2 2 — 15,577 5
Refinements to models used for calculation — — — — — — — —
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes
(2,087) 9 (82) 3 — — (2,169) 12
Final repayments (5,136) — (168) (2) (5) — (5,309) (2)
Disposals — — — — — — — —
Write-offs — — — — — — — —
As at 30 June 2023 54,376 23 3,829 34 2 — 58,207 57
Reconciliation of ECL movement to impairment charge/(release) for the period
Stage 1 Stage 2 Stage 3 Total
£m £m £m £m
Retail mortgages 12 31 5 48
Retail credit cards 16 (69) 650 597
Retail other (19) 5 47 33
Corporate loans (126) (37) 234 71
Debt securities and other 14 1 — 15
ECL movement excluding assets derecognised due to disposals and write-offs1 (103) (69) 936 764
ECL movement on loan commitments and other financial guarantees (45) (7) 18 (34)
ECL movement on other financial assets 8 3 (9) 2
Recoveries and reimbursements2 62 (29) (51) (18)
Total exchange and other adjustments 182
Total income statement charge for the period 896
1 In H123, gross write-offs amounted to £583m (H122: £768m). Post write-off recoveries amounted to £21m (H122: £36m). Net write-offs represent gross
write-offs less post write-off recoveries and amounted to £562m (H122: £732m).
2 Recoveries and reimbursements includes a net reduction of £3m (H122 gain: £11m) in amounts expected to be received under the arrangement where
Group has entered into financial guarantee contracts which provide credit protection over certain loan assets with third parties; cash recoveries of previously
written off amounts is £21m (H122: £36m).
Credit Risk
Barclays PLC 33
-- 35 of 98 --
Loan commitments and financial guarantees
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Retail mortgages £m £m £m £m £m £m £m £m
As at 1 January 2023 11,714 — 450 — 6 — 12,170 —
Net transfers between stages (22) — 20 — 2 — — —
Business activity in the period 6,019 — — — — — 6,019 —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(7,423) — 18 — (4) — (7,409) —
Limit management and final repayments (190) — (21) — — — (211) —
As at 30 June 2023 10,098 — 467 — 4 — 10,569 —
Retail credit cards
As at 1 January 2023 144,957 50 5,435 83 228 — 150,620 133
Net transfers between stages (358) 36 293 (36) 65 — — —
Business activity in the period 10,136 7 107 6 1 — 10,244 13
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(6,446) (34) (646) 76 (36) — (7,128) 42
Limit management and final repayments (7,696) (5) (331) (20) (37) — (8,064) (25)
As at 30 June 2023 140,593 54 4,858 109 221 — 145,672 163
Retail other
As at 1 January 2023 10,427 5 520 — 80 — 11,027 5
Net transfers between stages (92) — 67 — 25 — — —
Business activity in the period 655 — 2 — 2 — 659 —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(1,209) 3 (44) — (48) — (1,301) 3
Limit management and final repayments (420) — (10) — — — (430) —
As at 30 June 2023 9,361 8 535 — 59 — 9,955 8
Corporate loans
As at 1 January 2023 205,684 190 24,289 232 866 23 230,839 445
Net transfers between stages 747 18 (898) (19) 151 1 — —
Business activity in the period 22,771 7 544 8 1 — 23,316 15
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
1,977 (26) 594 (3) 184 19 2,755 (10)
Limit management and final repayments (26,568) (51) (1,752) (19) (224) (2) (28,544) (72)
As at 30 June 2023 204,611 138 22,777 199 978 41 228,366 378
Debt securities and other
As at 1 January 2023 163 — — — — — 163 —
Net transfers between stages — — — — — — — —
Business activity in the period 14 — — — — — 14 —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(1) — — — — — (1) —
Limit management and final repayments — — — — — — — —
As at 30 June 2023 176 — — — — — 176 —
Credit Risk
Barclays PLC 34
-- 36 of 98 --
Management adjustments to models for impairment
Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy
that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period
end. Management adjustments are reviewed and incorporated into future model development where applicable.
Management adjustments are captured through “Economic uncertainty” and “Other” adjustments, and are presented by
product below:
Management adjustments to models for impairment allowance presented by product1
Impairment
allowance pre
management
adjustments2
Economic
uncertainty
adjustments
Other
adjustments
Management
adjustments
Total
impairment
allowance3
Proportion of
Management
adjustments
to total
impairment
allowance
(a) (b) (a+b)
As at 30 June 2023 £m £m £m £m £m %
Retail mortgages 416 22 116 138 554 24.9
Retail credit cards 3,122 143 48 191 3,313 5.8
Retail other 453 8 45 53 506 10.5
Corporate loans 1,441 98 150 248 1,689 14.7
Debt securities and other 57 — — — 57 —
Total 5,489 271 359 630 6,119 10.3
As at 31 December 2022 £m £m £m £m £m %
Retail mortgages 427 4 85 89 516 17.2
Retail credit cards 2,986 93 87 180 3,166 5.7
Retail other 455 25 99 124 579 21.4
Corporate loans 1,740 195 (63) 132 1,872 7.1
Debt securities and other 42 — — — 42 —
Total 5,650 317 208 525 6,175 8.5
Economic uncertainty adjustments presented by stage
Stage 1 Stage 2 Stage 3 Total
As at 30 June 2023 £m £m £m £m
Retail mortgages 5 14 3 22
Retail credit cards 27 116 — 143
Retail other 3 5 — 8
Corporate loans 77 14 7 98
Debt securities and other — — — —
Total 112 149 10 271
As at 31 December 2022 £m £m £m £m
Retail mortgages 1 3 — 4
Retail credit cards 17 76 — 93
Retail other 7 17 1 25
Corporate loans 181 14 — 195
Debt securities and other — — — —
Total 206 110 1 317
1 Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance.
2 Includes £4.7bn (FY22: £4.8bn) of modelled ECL, £0.4bn (FY22: £0.4bn) of individually assessed impairments and £0.4bn (FY22: £0.5bn) ECL from non-
modelled exposures.
3 Total impairment allowance consists of ECL stock on drawn and undrawn exposure.
Credit Risk
Barclays PLC 35
-- 37 of 98 --
Economic uncertainty adjustments
Models have been developed with data from non-inflationary periods establishing a relationship between input variables
and customer delinquency based on past behaviour. Additionally, models are trying to interpret significant rates of change
in macroeconomic variables and applying these to stable probability of default (PD) levels. As such there is a risk that the
modelled output fails to capture the appropriate response to changes in macroeconomic variables including higher interest
rates and continuing inflationary stress with modelled impairment provisions impacted by uncertainty.
This uncertainty continues to be captured in two ways. Firstly, customer uncertainty: the identification of customers and
clients who may be more vulnerable to economic instability; and secondly, model uncertainty: to capture the impact from
model limitations and sensitivities to specific macroeconomic parameters which are applied at a portfolio level.
Economic uncertainty adjustments have decreased from last year, informed by retirement of all legacy Corporate and
Investment Bank (CIB) adjustments following the rebuild of certain CIB models in order to better capture the
macroeconomic outlook. Furthermore, adjustments have been re-sized to capture affordability headwinds in UK retail
lending considered not adequately captured in modelled outcomes.
The balance as at H123 is £271m (FY22: £317m) and includes:
Customer and client uncertainty provisions of £221m (FY22: £423m) includes:
• Retail mortgages: £22m (FY22: £4m) includes an adjustment applied to customers considered most vulnerable to
affordability pressures. The increase is primarily driven by an adjustment introduced to reflect the risk of borrowers
refinancing onto higher rates in the medium term.
• Retail credit cards: £93m (FY22: £93m) and Retail other: £8m (FY22: £25m) includes an adjustment applied to
customers considered most vulnerable to affordability pressures. This adjustment is predominantly held in Stage 2 in line
with customer risk profiles. Reduction within Retail other is primarily driven by re-scoping for customers remaining
resilient to affordability headwinds.
• Corporate loans: £98m (FY22: £301m) includes an adjustment of £86m to reflect possible cross default risk on Barclays’
lending in respect of clients who have taken bounce back loans and £12m for SME exposures considered most at risk
from inflationary concerns, supply chain constraints and consumer demand headwinds.
The reduction of £(203)m is primarily informed by retirement of adjustment for high risk sectors following a granular
credit risk assessment for qualifying exposures, and re-build of certain CIB models which more appropriately capture
downside risk.
Model uncertainty provisions of £50m (FY22: £(106)m) includes:
• Retail credit cards: £50m (FY22: £nil) includes an adjustment to reflect recent changes to certain macroeconomic
variables to more appropriately capture the provision impact.
• Previously held adjustment of £(106)m within Corporate loans to correct for model oversensitivity has been retired
following the re-build of certain CIB models which more appropriately capture the macroeconomic outlook.
Other adjustments
Other adjustments are operational in nature and are expected to remain in place until they can be reflected in the underlying
models. These adjustments result from data limitations and model performance related issues identified through model
monitoring and other established governance processes.
Other adjustments of £359m (FY22: £208m) includes:
• Retail mortgages: £116m (FY22: £85m) primarily include adjustments informed by model monitoring and an
adjustment for the definition of default under the Capital Requirements Regulation. The increase is predominantly driven
by resizing of model monitoring adjustments.
• Retail credit cards: £48m (FY22: £87m) primarily includes an adjustment in the UK for the definition of default under the
Capital Requirements Regulation, and an adjustment in the US to the qualitative measures for high-risk account
management (HRAM) accounts; partially offset by model monitoring adjustments.
The reduction is primarily driven by an adjustment made during the year in the US to limit ECL sensitivity to certain
macroeconomic variables partially offset by an adjustment in the UK for recalibration of Loss Given Default (LGD) to
reflect revised recovery expectations.
• Retail other: £45m (FY22: £99m) primarily includes an adjustment for the definition of default under the Capital
Requirements Regulation and adjustments informed by model monitoring. The reduction is primarily driven by
operational model adjustments made during the year within Private Banking and Wealth Management.
• Corporate loans: £150m (FY22: £(63)m) primarily include adjustments within SME informed by model monitoring and
definition of default under the Capital Requirements Regulation.
Movement of £213m within Corporate loans is primarily driven by the retirement of all CIB legacy adjustments.
Management adjustments held in 2022 primarily comprised of an adjustment to limit ECL sensitivity to the
macroeconomic variable for Federal Tax Receipts and model monitoring adjustments, which is no longer needed
following the re-build of certain CIB models.
Credit Risk
Barclays PLC 36
-- 38 of 98 --
Measurement uncertainty
Scenarios used to calculate the Group’s ECL charge were refreshed in Q223 with the Baseline scenario reflecting the latest
consensus macroeconomic forecasts available at the time of the scenario refresh. In the Baseline scenario, although the
outlook in major economies has improved somewhat (since Q422), the full effect of the inflation shock and rising rates is
lagged and so contributes to a further squeeze of household finances over the coming quarters, posing downside risks to
GDP. UK and US unemployment rates increase only gradually in the coming quarters, peaking at 4.5% in Q424 and 4.7% in
Q224 respectively. Central banks continue raising interest rates, with both the UK bank rate and the US federal funds rate
peaking at 5.25% during 2023.
The Downside 2 scenario is broadly aligned to the previous scenario refresh. Inflation rates rise again as energy prices
suddenly surge again amid renewed geopolitical risks. Inflation becomes entrenched and inflation expectations go up,
contributing to higher pressure on wage growth. Central banks are forced to raise interest rates sharply with the UK bank
rate reaching 8% and the US federal funds rate peaking at 7%. Weakened businesses lay off workers and consumers stop
spending exacerbating the downward stress. Unemployment peaks at 8.5% in the UK and 9.8% in the US. Given already
stretched valuations, the sharp increase in borrowing costs sees house prices decrease significantly. In the Upside scenarios,
lower energy prices add downward pressure on prices globally, while recovering labour force participation limits wage
growth. As a result of easing inflation, central banks lower interest rates to support the economic recovery.
The methodology for estimating scenario probability weights involves simulating a range of future paths for UK and US GDP
using historical data with the five scenarios mapped against the distribution of these future paths. The median is centred
around the Baseline with scenarios further from the Baseline attracting a lower weighting before the five weights are
normalised to total 100%. The decrease in the Downside weightings and the increase in the Upside weightings reflected the
improving economic outlook which moved the Baseline UK/US GDP paths closer to the Upside scenarios. For further details
see page 39.
The economic uncertainty adjustments of £0.3bn (2022: £0.3bn) have been applied as overlays to the modelled ECL output.
These adjustments consist of a customer and client uncertainty provision of £0.2bn (2022: £0.4bn) which has been applied
to customers and clients considered most vulnerable to affordability pressures, and a model uncertainty adjustment of
£0.1bn (2022: £(0.1)bn). For further details see page 36.
The following tables show the key macroeconomic variables used in the five scenarios (5 year annual paths) and the
probability weights applied to each scenario.
Credit Risk
Barclays PLC 37
-- 39 of 98 --
Macroeconomic variables used in the calculation of ECL
As at 30.06.23 2023 2024 2025 2026 2027
Baseline % % % % %
UK GDP1 0.3 0.9 1.6 1.8 1.9
UK unemployment2 4.1 4.4 4.2 4.2 4.2
UK HPI3 (6.1) (1.3) 2.0 4.3 5.7
UK bank rate 4.8 4.6 3.9 3.8 3.5
US GDP1 1.1 0.7 2.0 2.0 2.0
US unemployment4 3.8 4.6 4.6 4.6 4.6
US HPI5 (0.7) 3.6 2.4 2.7 2.7
US federal funds rate 5.0 3.7 3.0 2.8 3.0
Downside 2
UK GDP1 (0.5) (5.0) (0.4) 2.5 1.9
UK unemployment2 4.4 7.8 8.3 7.7 7.1
UK HPI3 (10.2) (20.5) (17.7) 5.6 8.2
UK bank rate 5.5 8.0 7.3 6.1 4.8
US GDP1 0.5 (4.8) (0.3) 2.8 2.1
US unemployment4 4.5 8.7 9.6 8.5 7.0
US HPI5 (1.8) (3.7) (4.2) 2.6 4.8
US federal funds rate 5.7 7.0 6.5 5.1 4.2
Downside 1
UK GDP1 (0.1) (2.1) 0.6 2.2 1.9
UK unemployment2 4.2 6.1 6.2 5.9 5.6
UK HPI3 (8.1) (11.3) (8.2) 5.0 7.0
UK bank rate 5.2 6.1 5.6 4.8 4.1
US GDP1 0.8 (2.0) 0.8 2.4 2.0
US unemployment4 4.1 6.7 7.1 6.5 5.8
US HPI5 (1.2) (0.1) (0.9) 2.7 3.8
US federal funds rate 5.2 4.9 4.5 4.3 3.8
Upside 2
UK GDP1 1.2 4.1 3.2 2.6 2.3
UK unemployment2 3.9 3.6 3.5 3.6 3.6
UK HPI3 0.4 10.6 4.8 4.2 3.8
UK bank rate 4.4 3.3 2.5 2.5 2.5
US GDP1 2.2 3.9 3.0 2.8 2.8
US unemployment4 3.4 3.5 3.6 3.6 3.6
US HPI5 2.5 5.5 4.6 4.5 4.5
US federal funds rate 4.7 3.2 2.2 2.0 2.0
Upside 1
UK GDP1 0.8 2.5 2.4 2.2 2.1
UK unemployment2 4.0 4.0 3.9 3.9 3.9
UK HPI3 (2.9) 4.5 3.4 4.3 4.7
UK bank rate 4.6 4.0 3.1 3.0 3.0
US GDP1 1.6 2.3 2.5 2.4 2.4
US unemployment4 3.6 4.1 4.1 4.1 4.1
US HPI5 0.9 4.6 3.5 3.6 3.6
US federal funds rate 4.8 3.4 2.6 2.5 2.5
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year end US HPI = FHFA House Price Index, relative to prior year end.
Credit Risk
Barclays PLC 38
-- 40 of 98 --
Macroeconomic variables used in the calculation of ECL
As at 31.12.22 2022 2023 2024 2025 2026
Baseline % % % % %
UK GDP1 3.3 (0.8) 0.9 1.8 1.9
UK unemployment2 3.7 4.5 4.4 4.1 4.2
UK HPI3 8.4 (4.7) (1.7) 2.2 2.2
UK bank rate 1.8 4.4 4.1 3.8 3.4
US GDP1 1.8 0.5 1.2 1.5 1.5
US unemployment4 3.7 4.3 4.7 4.7 4.7
US HPI5 11.2 1.8 1.5 2.3 2.4
US federal funds rate 2.1 4.8 3.6 3.1 3.0
Downside 2
UK GDP1 3.3 (3.4) (3.8) 2.0 2.3
UK unemployment2 3.7 6.0 8.4 8.0 7.4
UK HPI3 8.4 (18.3) (18.8) (7.7) 8.2
UK bank rate 1.8 7.3 7.9 6.6 5.5
US GDP1 1.8 (2.7) (3.4) 2.0 2.6
US unemployment4 3.7 6.0 8.5 8.1 7.1
US HPI5 11.2 (3.1) (4.0) (1.9) 4.8
US federal funds rate 2.1 6.6 6.9 5.8 4.6
Downside 1
UK GDP1 3.3 (2.1) (1.5) 1.9 2.1
UK unemployment2 3.7 5.2 6.4 6.0 5.8
UK HPI3 8.4 (11.7) (10.6) (2.8) 5.2
UK bank rate 1.8 5.9 6.1 5.3 4.6
US GDP1 1.8 (1.1) (1.1) 1.7 2.1
US unemployment4 3.7 5.1 6.6 6.4 5.9
US HPI5 11.2 (0.7) (1.3) 0.2 3.6
US federal funds rate 2.1 5.8 5.4 4.4 3.9
Upside 2
UK GDP1 3.3 2.8 3.7 2.9 2.4
UK unemployment2 3.7 3.5 3.4 3.4 3.4
UK HPI3 8.4 8.7 7.5 4.4 4.2
UK bank rate 1.8 3.1 2.6 2.5 2.5
US GDP1 1.8 3.3 3.5 2.8 2.8
US unemployment4 3.7 3.3 3.3 3.3 3.3
US HPI5 11.2 5.8 5.1 4.5 4.5
US federal funds rate 2.1 3.6 2.9 2.8 2.8
Upside 1
UK GDP1 3.3 1.0 2.3 2.4 2.1
UK unemployment2 3.7 4.0 3.9 3.8 3.8
UK HPI3 8.4 1.8 2.9 3.3 3.2
UK bank rate 1.8 3.5 3.3 3.0 2.8
US GDP1 1.8 1.9 2.3 2.2 2.2
US unemployment4 3.7 3.8 4.0 4.0 4.0
US HPI5 11.2 3.8 3.3 3.4 3.4
US federal funds rate 2.1 3.9 3.4 3.0 3.0
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year end US HPI = FHFA House Price Index, relative to prior year end.
Scenario probability weighting
Upside 2 Upside 1 Baseline Downside 1 Downside 2
% % % % %
As at 30.06.23
Scenario probability weighting 13.0 24.7 40.2 15.2 6.9
As at 31.12.22
Scenario probability weighting 10.9 23.1 39.4 17.6 9.0
Credit Risk
Barclays PLC 39
-- 41 of 98 --
Specific bases show the most extreme position of each variable in the context of the downside/upside scenarios, for
example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest
unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest
cumulative position relative to the start point, in the 20 quarter period.
Macroeconomic variables (specific bases)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.23 % % % % %
UK GDP2 15.1 11.2 1.3 (2.7) (6.9)
UK unemployment3 3.5 3.9 4.2 6.5 8.5
UK HPI4 25.8 14.6 0.8 (25.2) (41.5)
UK bank rate 2.5 3.0 4.1 6.3 8.0
US GDP2 15.9 11.9 1.6 (2.3) (6.2)
US unemployment3 3.3 3.5 4.4 7.2 9.8
US HPI4 23.6 17.2 2.1 (2.3) (10.1)
US federal funds rate 2.0 2.5 3.5 5.3 7.0
As at 31.12.22 % % % % %
UK GDP2 13.9 9.4 1.4 (3.2) (6.8)
UK unemployment3 3.4 3.6 4.2 6.6 8.5
UK HPI4 37.8 21.0 1.2 (17.9) (35.0)
UK bank rate 0.5 0.5 3.5 6.3 8.0
US GDP2 14.1 9.6 1.3 (2.5) (6.3)
US unemployment3 3.3 3.6 4.4 6.7 8.6
US HPI4 35.0 27.5 3.8 3.7 0.2
US federal funds rate 0.1 0.1 3.3 6.0 7.0
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP
= Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period
starts from Q123 (2022: Q122).
2 Maximum growth relative to Q422 (2022: Q421), based on 20 quarter period in Upside scenarios; 5-year yearly average CAGR in Baseline; minimum growth
relative to Q422 (2022: Q421), based on 20 quarter period in Downside scenarios.
3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.
4 Maximum growth relative to Q422 (2022: Q421), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth
relative to Q422 (2022: Q421), based on 20 quarter period in Downside scenarios.
Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly
average and quarterly CAGRs respectively.
Macroeconomic variables (5-year averages)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.23 % % % % %
UK GDP2 2.7 2.0 1.3 0.5 (0.3)
UK unemployment3 3.6 3.9 4.2 5.6 7.0
UK HPI4 4.7 2.8 0.8 (3.4) (7.6)
UK bank rate 3.0 3.6 4.1 5.2 6.4
US GDP2 2.9 2.3 1.6 0.8 —
US unemployment3 3.5 4.0 4.4 6.0 7.6
US HPI4 4.3 3.2 2.1 0.8 (0.5)
US federal funds rate 2.8 3.2 3.5 4.5 5.7
As at 31.12.22 % % % % %
UK GDP2 3.0 2.2 1.4 0.7 —
UK unemployment3 3.5 3.8 4.2 5.4 6.7
UK HPI4 6.6 3.9 1.2 (2.6) (6.4)
UK bank rate 2.5 2.9 3.5 4.7 5.8
US GDP2 2.9 2.1 1.3 0.7 —
US unemployment3 3.4 3.9 4.4 5.5 6.7
US HPI4 6.2 5.0 3.8 2.5 1.2
US federal funds rate 2.8 3.1 3.3 4.3 5.2
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP
= Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index.
2 5-year yearly average CAGR, starting 2022 (2022: 2021).
3 5-year average. Period based on 20 quarters from Q123 (2022: Q122).
4 5-year quarter end CAGR, starting Q422 (2022: Q421).
Credit Risk
Barclays PLC 40
-- 42 of 98 --
ECL under 100% weighted scenarios for modelled portfolios
The table below shows the modelled ECL assuming each of the five modelled scenarios are 100% weighted with the
dispersion of results around the Baseline, highlighting the impact on exposure and ECL across the scenarios. Model exposure
uses exposure at default (EAD) values and is not directly comparable to gross exposure used in prior disclosures.
Scenarios
As at 30 June 2023 Weighted1 Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Retail mortgages 149,626 151,300 150,889 150,274 147,210 141,860
Retail credit cards2 66,280 66,587 66,408 66,240 66,101 65,834
Retail other2 11,479 11,654 11,573 11,482 11,307 11,146
Corporate loans2 146,763 152,688 150,797 147,814 142,071 127,549
Debt securities and other3 28,515 28,693 28,673 28,515 28,503 28,226
Stage 1 Model ECL (£m)
Retail mortgages 10 3 4 5 18 49
Retail credit cards 495 483 489 495 505 515
Retail other 52 47 50 51 55 60
Corporate loans 278 234 257 275 300 303
Debt securities and other 21 18 19 21 23 26
Stage 1 Coverage (%)
Retail mortgages — — — — — —
Retail credit cards 0.7 0.7 0.7 0.7 0.8 0.8
Retail other 0.5 0.4 0.4 0.4 0.5 0.5
Corporate loans 0.2 0.2 0.2 0.2 0.2 0.2
Debt securities and other 0.1 0.1 0.1 0.1 0.1 0.1
Stage 2 Model Exposure (£m)
Retail mortgages 18,147 16,473 16,884 17,499 20,563 25,913
Retail credit cards2 7,471 6,748 7,090 7,424 8,170 9,066
Retail other2 1,699 1,512 1,597 1,690 1,891 2,078
Corporate loans2 26,584 20,495 22,449 25,555 31,422 46,128
Debt securities and other3 2,629 2,451 2,471 2,629 2,641 2,918
Stage 2 Model ECL (£m)
Retail mortgages 40 18 21 24 62 300
Retail credit cards 1,559 1,376 1,456 1,541 1,757 2,023
Retail other 137 115 126 135 162 185
Corporate loans 558 368 427 521 805 1,401
Debt securities and other 35 28 31 34 41 56
Stage 2 Coverage (%)
Retail mortgages 0.2 0.1 0.1 0.1 0.3 1.2
Retail credit cards 20.9 20.4 20.5 20.8 21.5 22.3
Retail other 8.1 7.6 7.9 8.0 8.6 8.9
Corporate loans 2.1 1.8 1.9 2.0 2.6 3.0
Debt securities and other 1.3 1.1 1.3 1.3 1.6 1.9
Stage 3 Model Exposure (£m)4
Retail mortgages 1,580 1,580 1,580 1,580 1,580 1,580
Retail credit cards 1,497 1,497 1,497 1,497 1,497 1,497
Retail other 219 219 219 219 219 219
Corporate loans 3,193 3,193 3,193 3,193 3,193 3,193
Debt securities and other3 — — — — — —
Stage 3 Model ECL (£m)
Retail mortgages 329 303 309 316 360 455
Retail credit cards 983 966 975 983 996 1,007
Retail other 138 136 137 138 140 143
Corporate loans5 81 76 78 80 88 97
Debt securities and other — — — — — —
Stage 3 Coverage (%)
Retail mortgages 20.8 19.2 19.6 20.0 22.8 28.8
Retail credit cards 65.7 64.5 65.1 65.7 66.5 67.3
Retail other 63.0 62.1 62.6 63.0 63.9 65.3
Corporate loans5 2.5 2.4 2.4 2.5 2.8 3.0
Debt securities and other — — — — — —
Total Model ECL (£m)
Retail mortgages 379 324 334 345 440 804
Retail credit cards 3,037 2,825 2,920 3,019 3,258 3,545
Retail other 327 298 313 324 357 388
Corporate loans5 917 678 762 876 1,193 1,801
Debt securities and other 56 46 50 55 64 82
Total Model ECL 4,716 4,171 4,379 4,619 5,312 6,620
Credit Risk
Barclays PLC 41
-- 43 of 98 --
Reconciliation to total ECL £m
Total weighted model ECL 4,716
ECL from individually assessed impairments5 420
ECL from non-modelled exposures and others 353
ECL from post model management adjustments 630
Of which: ECL from economic uncertainty adjustments 271
Total ECL 6,119
1 Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach as required for Barclays reported
impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given balances may be assigned
to a different stage dependent on the scenario.
2 For Retail credit cards, Retail other and Corporate loans, the model exposure movement between stages 1 and 2 across scenarios differs due to additional
impacts from the undrawn exposure.
3 Debt securities and other excludes Treasury exposures since these are non-modelled.
4 Model exposures allocated to Stage 3 does not change in any of the scenarios as the transition criteria relies only on an observable evidence of default as at
30 June 2023 and not on macroeconomic scenario.
5 Material corporate loan defaults are individually assessed across different recovery strategies. As a result, ECL of £420m is reported as an individually
assessed impairment in the reconciliation table.
The use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 2.1%.
Retail mortgages: Total weighted ECL of £379m represents a 9.9% increase over the Baseline ECL (£345m) with coverage
ratios remaining steady across the Upside scenarios, Baseline and Downside 1 scenario. Under the Downside 2 scenario,
total ECL increases to £804m driven by a significant fall in UK HPI.
Retail credit cards: Total weighted ECL of £3,037m is broadly aligned to the Baseline ECL (£3,019m). Total ECL increases to
£3,545m under the Downside 2 scenario, driven by an increase in UK unemployment rate.
Retail other: Total weighted ECL of £327m is aligned to the Baseline ECL (£324m). Total ECL increases to £388m under the
Downside 2 scenario, largely driven by increase in UK unemployment rate.
Corporate loans: Total weighted ECL of £917m represents a 4.7% increase over the Baseline ECL (£876m). Total ECL
increases to £1,801m under Downside 2 scenario, driven by decrease in UK GDP and US GDP.
Debt securities and other: Total weighted ECL of £56m is broadly aligned to the Baseline ECL (£55m). Total ECL increases to
£82m under the Downside 2 scenario.
Credit Risk
Barclays PLC 42
-- 44 of 98 --
Scenarios
As at 31 December 2022 Weighted1 Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Retail mortgages 144,701 147,754 146,873 145,322 142,599 138,619
Retail credit cards2 67,204 67,622 67,352 67,080 66,908 66,636
Retail other2 12,282 12,428 12,341 12,235 12,111 11,986
Corporate loans2 156,302 164,207 161,578 158,218 150,827 138,618
Debt securities and other3 32,380 32,484 32,403 32,385 32,321 31,137
Stage 1 Model ECL (£m)
Retail mortgages 7 3 3 4 9 30
Retail credit cards 509 493 503 512 517 521
Retail other 52 45 49 52 54 55
Corporate loans 341 259 290 325 397 443
Debt securities and other 14 10 11 13 17 21
Stage 1 Coverage (%)
Retail mortgages — — — — — —
Retail credit cards 0.8 0.7 0.7 0.8 0.8 0.8
Retail other 0.4 0.4 0.4 0.4 0.4 0.5
Corporate loans 0.2 0.2 0.2 0.2 0.3 0.3
Debt securities and other — — — — 0.1 0.1
Stage 2 Model Exposure (£m)
Retail mortgages 18,723 15,670 16,551 18,102 20,825 24,805
Retail credit cards2 7,611 6,551 7,118 7,691 8,313 9,062
Retail other2 1,559 1,386 1,485 1,601 1,741 1,881
Corporate loans2 24,935 16,858 19,550 23,031 30,548 42,952
Debt securities and other3 943 839 919 938 1,002 2,186
Stage 2 Model ECL (£m)
Retail mortgages 33 15 18 23 45 151
Retail credit cards 1,624 1,361 1,487 1,624 1,811 2,032
Retail other 124 96 109 124 144 160
Corporate loans 610 399 470 569 817 1,304
Debt securities and other 32 23 26 31 42 66
Stage 2 Coverage (%)
Retail mortgages 0.2 0.1 0.1 0.1 0.2 0.6
Retail credit cards 21.3 20.8 20.9 21.1 21.8 22.4
Retail other 8.0 6.9 7.3 7.7 8.3 8.5
Corporate loans 2.4 2.4 2.4 2.5 2.7 3.0
Debt securities and other 3.4 2.7 2.8 3.3 4.2 3.0
Stage 3 Model Exposure (£m)4
Retail mortgages 1,553 1,553 1,553 1,553 1,553 1,553
Retail credit cards 1,354 1,354 1,354 1,354 1,354 1,354
Retail other 216 216 216 216 216 216
Corporate loans 2,892 2,892 2,892 2,892 2,892 2,892
Debt securities and other3 — — — — — —
Stage 3 Model ECL (£m)
Retail mortgages 332 311 317 323 347 405
Retail credit cards 880 861 871 880 893 903
Retail other 132 129 131 132 134 136
Corporate loans5 70 66 68 70 78 85
Debt securities and other — — — — — —
Stage 3 Coverage (%)
Retail mortgages 21.4 20.0 20.4 20.8 22.3 26.1
Retail credit cards 65.0 63.6 64.3 65.0 66.0 66.7
Retail other 61.1 59.7 60.6 61.1 62.0 63.0
Corporate loans5 2.4 2.3 2.4 2.4 2.7 2.9
Debt securities and other — — — — — —
Total Model ECL (£m)
Retail mortgages 372 329 338 350 401 586
Retail credit cards 3,013 2,715 2,861 3,016 3,221 3,456
Retail other 308 270 289 308 332 351
Corporate loans5 1,021 724 828 964 1,292 1,832
Debt securities and other 46 33 37 44 59 87
Total Model ECL 4,760 4,071 4,353 4,682 5,305 6,312
Credit Risk
Barclays PLC 43
-- 45 of 98 --
Reconciliation to total ECL £m
Total weighted model ECL 4,760
ECL from individually assessed impairments5 434
ECL from non-modelled exposures and others 456
ECL from post model management adjustments 525
Of which: ECL from economic uncertainty adjustments 317
Total ECL 6,175
1 Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach, as required for Barclays reported
impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given balances may be assigned
to a different stage dependent on the scenario.
2 For Retail credit cards, Retail other and Corporate loans, the model exposure movement between stages 1 and 2 across scenarios differs due to additional
impacts from the undrawn exposure.
3 Debt securities and other excludes Treasury exposures since these are non-modelled.
4 Model exposures allocated to Stage 3 does not change in any of the scenarios as the transition criteria relies only on an observable evidence of default as at
31 December 2022 and not on macroeconomic scenario.
5 Material corporate loan defaults are individually assessed across different recovery strategies. As a result, ECL of £434m is reported as an individually
assessed impairment in the reconciliation table.
Credit Risk
Barclays PLC 44
-- 46 of 98 --
Analysis of specific portfolios and asset types
Secured home loans
The UK home loan portfolio primarily comprises first lien mortgages and accounts for 95% (December 2022: 93%) of the
Group’s total home loans balance.
Barclays UK
Home loans principal portfolios As at
30.06.23 As at
31.12.22
Gross loans and advances (£m) 166,374 162,380
90 day arrears rate, excluding recovery book (%) 0.2 0.1
Annualised gross charge-off rates - 180 days past due (%) 0.5 0.5
Recovery book proportion of outstanding balances (%) 0.6 0.5
Recovery book impairment coverage ratio (%)1 6.4 5.2
Average marked to market LTV
Balance weighted % 52.8 50.4
Valuation weighted % 39.2 37.3
New lending
Half year
ended
30.06.23
Half year
ended
30.06.22
New home loan bookings (£m) 12,531 14,117
New home loan proportion > 90% LTV (%) 0.7 2.6
Average LTV on new home loans: balance weighted (%) 62.5 68.6
Average LTV on new home loans: valuation weighted (%) 53.7 60.4
1 Recovery Book Impairment Coverage Ratio excludes KMC and Settle portfolios.
Home loans principal portfolios – distribution of balances by LTV1
Distribution of balances Distribution of impairment
allowance Coverage ratio
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
Barclays UK % % % % % % % % % % % %
As at 30.06.23
<=75% 75.8 9.5 0.7 86.0 10.3 27.4 27.4 65.1 — 0.3 4.3 0.1
>75% and <=90% 11.4 0.9 0.1 12.4 5.7 13.5 8.2 27.4 0.1 1.8 30.4 0.3
>90% and <=100% 1.5 0.1 — 1.6 0.9 1.5 1.9 4.3 0.1 1.8 69.9 0.3
>100% — — — — 0.1 0.5 2.6 3.2 0.3 12.9 70.5 11.2
As at 31.12.22
<=75% 78.8 10.5 0.8 90.1 10.2 30.8 33.2 74.2 — 0.2 2.9 0.1
>75% and <=90% 8.8 0.5 — 9.3 3.9 9.7 5.2 18.8 — 1.4 30.8 0.1
>90% and <=100% 0.6 — — 0.6 0.3 0.3 2.4 3.0 — 1.5 85.0 0.4
>100% — — — — 0.1 0.6 3.3 4.0 0.4 21.4 64.9 13.1
1 Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest
HPI available as at 30 June 2023.
New lending reduced 11% to £12.5bn (H122: £14.1bn), mainly driven by economic conditions that resulted in general
mortgage market suppression, including higher mortgage payments as rates continued to rise and increased cost of living
factors in line with inflation. The reduction in new home loan proportion of >90% LTV was driven by credit tightening
actions taken in the period and the impact from the withdrawal of the Government Help to Buy scheme.
Head Office: Italian home loans and advances at amortised cost reduced to £4.0bn (2022: £4.5bn) and continue to run off
since new bookings ceased in 2016. The portfolio is secured on residential property with an average balance weighted mark
to market LTV of 56.6% (2022: 58.8%). 90 day arrears increased to 1.6% (2022: 1.2%) due to deterioration caused by
affordability stress related to rising inflation and interest rates. The gross charge-off rate was stable at 0.6% (2022: 0.6%).
Credit Risk
Barclays PLC 45
-- 47 of 98 --
Retail credit cards and Retail other
The principal portfolios listed below accounted for 91% (December 2022: 85%) of the Group’s total credit cards, unsecured
loans and other retail lending.
Principal portfolios
Gross
exposure
30 day
arrears rate,
excluding
recovery
book
90 day
arrears rate,
excluding
recovery
book
Annualised
gross write-
off rate
Annualised
net write-off
rate
As at 30.06.23 £m % % % %
Barclays UK
UK cards 10,011 0.9 0.2 2.0 1.9
UK personal loans 3,717 1.5 0.6 1.3 1.1
Barclays Partner Finance 2,557 0.5 0.2 0.6 0.6
Barclays International
US cards 24,908 2.4 1.2 2.5 2.4
Germany consumer lending 4,098 1.7 0.8 0.8 0.8
As at 31.12.22
Barclays UK
UK cards 9,939 0.9 0.2 3.7 3.6
UK personal loans 4,023 1.4 0.6 4.1 3.8
Barclays Partner Finance 2,612 0.5 0.2 0.7 0.7
Barclays International
US cards 25,554 2.2 1.2 2.4 2.3
Germany consumer lending 4,269 1.7 0.7 0.7 0.6
UK cards: 30 day and 90 days arrears rate remain stable at 0.9% (Q422: 0.9%) and 0.2% (Q422: 0.2%) respectively, whilst
total exposure increased to £10bn. Both the gross and net write off rates decreased by 1.7% due to the impact of lower
historical delinquency flows.
UK personal loans: 30 days arrears rates have marginally increased to 1.5% (Q422: 1.4%) whilst 90 days arrears rate
remained stable at 0.6% (Q422: 0.6%). Total exposure decreased to £3.7bn due to lower demand and prudent lending
strategies. The annualised gross and net write off rates decreased by 2.8% and 2.7% respectively, due to the impact of
lower historical delinquency flows.
Barclays Partner Finance: 30 day and 90 days arrears rate remain stable at 0.5% (Q422: 0.5%) and 0.2% (Q422: 0.2%)
respectively, with total exposure stable at £2.6bn. Both the annualised gross and net write off rates decreased by 0.1%
US cards: Balances increased 2% in USD as consumer spending remained strong, however movement in the USD/GBP
exchange rate resulted in a decrease in reported balances. 30 day arrears rates increased to 2.4% (Q422: 2.2%) due to the
continued normalisation of customer behaviour, though rates remain below pre-pandemic levels. Write-off rates increased
due to normalisation and as the impact of Gap portfolio write-offs lagging the portfolio acquisition and building to steady
state levels.
Germany consumer lending: 30 day arrears rate remain at 1.7% (Q422: 1.7%) despite increase of macroeconomic
uncertainty in Germany.
Credit Risk
Barclays PLC 46
-- 48 of 98 --
Government supported loans
Since the COVID-19 pandemic Barclays has supported its customers and clients by participating in the UK government's
Bounce Back Loan Scheme (BBLS), Coronavirus Business Interruption Loan Scheme (CBILS), Coronavirus Large Business
Interruption Loan Scheme (CLBILS) and the Recovery Loan Scheme (RLS).
Gross exposure Impairment allowance
Government
guaranteed
exposure
Stage 1 Stage 2 Stage 3 Total
Modelled
impairment
Management
adjustment
Impairment
post-
management
adjustment
Impairment
Coverage Total
As at 30.06.23 £m £m £m £m £m £m £m % £m
Barclays UK
BBLS 2,747 2,244 444 5,435 8 26 34 0.6 5,400
CBILS 233 288 76 597 17 (4) 13 2.2 478
RLS 13 2 2 17 — — — — 13
Barclays International
CBILS 235 163 15 413 7 — 7 1.7 330
CLBILS 40 23 10 73 2 — 2 3.2 59
RLS 18 3 1 22 — — — 1.9 16
Total 3,286 2,723 548 6,557 34 22 56 0.9 6,296
As at 31.12.22
Barclays UK
BBLS 3,066 2,903 618 6,587 6 27 33 0.5 6,554
CBILS 286 396 66 748 22 (9) 13 1.7 598
RLS 13 4 1 18 — — — — 14
Barclays International
CBILS 306 154 8 468 5 — 5 1.1 375
CLBILS 67 32 13 112 2 — 2 2.1 89
RLS 17 3 1 21 — — — 1.5 16
Total 3,755 3,492 707 7,954 35 18 53 0.7 7,646
The BBLS and CBILS schemes were launched to provide financial support to smaller and medium-sized businesses and
CLBILS for larger businesses in the UK who may experience financial difficulties as a result of the COVID-19 outbreak. The
RLS aims to help UK businesses access finance as they recover and grow following the COVID-19 pandemic. These loans are
guaranteed by the government at 100% for BBLS and 80% for CBILS, CLBILS and RLS (70% for RLS issued post January 1,
2022) as at the balance sheet date.
In instances where Barclays has assessed the BBLS exposure to have not met strict assessment criteria, no claim has been
made against the government guarantee resulting in an impairment allowance against these loans of £34m (December
2022: £33m) as at the balance sheet date. The remaining balance represents impairment allowance against the CBILS &
CLBILS which are 80% guaranteed by government.
Additionally, while the government supported loans are covered by guarantees, many BBLS customers have other financing
arrangements with Barclays which are not covered by the government guarantee. Noting the elevated levels of delinquency
across the BBLS population, Barclays has continued to apply an adjustment of £0.1bn to BBLS customers outside the
scheme.
Credit Risk
Barclays PLC 47
-- 49 of 98 --
Analysis of management value at risk (VaR)
The table below shows the total management VaR on a diversified basis by asset class. Total management VaR includes all
trading positions in Barclays Bank Group and it is calculated with a one-day holding period. VaR limits are applied to total
management VaR and by asset class. Additionally, the market risk management function applies VaR sub-limits to material
businesses and trading desks.
Management VaR (95%) by asset class
Half year ended 30.06.23 Half year ended 31.12.22 Half year ended 30.06.22
Average High Low Average High Low Average High Low
£m £m £m £m £m £m £m £m £m
Credit risk 48 57 38 35 71 17 16 24 8
Interest rate risk 16 25 9 16 23 10 10 19 4
Equity risk 6 10 3 10 16 4 10 29 4
Basis risk 16 25 11 15 20 11 9 24 4
Spread risk 10 14 7 8 11 5 5 10 3
Foreign exchange risk 3 6 1 5 17 3 10 25 2
Commodity risk — 1 — — 1 — — 1 —
Inflation risk 9 11 6 7 11 5 6 17 3
Diversification effect1 (63) n/a n/a (52) n/a n/a (39) n/a n/a
Total management VaR 45 60 34 44 73 27 27 43 13
1 Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate
loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these
assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a
whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above
table.
Average Management VaR was stable at £45m (H222: £44m) and the range narrowed. Management VaR decreased in H123
from a high of £73m in November 2022, driven by a reduction in funded, fair value leverage loan exposure in Investment
Banking and lower volatility. Market volatility and credit spread levels declined in H123 as geopolitical tensions eased,
inflation decreased and the pace of interest rate rises moderated.
Market Risk
Barclays PLC 48
-- 50 of 98 --
The Group has established a comprehensive set of policies, standards and controls for managing its liquidity risk; together
these set out the requirements for Barclays’ liquidity risk framework. The liquidity risk framework meets the PRA standards
and enables Barclays to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is
appropriate to meet the Group’s Liquidity Risk Appetite. The liquidity risk framework is delivered via a combination of policy
formation, review and challenge, governance, analysis, stress testing, limit setting and monitoring.
Liquidity risk stress testing
The Internal Liquidity Stress Tests (ILST) measure the potential contractual and contingent stress outflows under a range of
scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated
outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide
stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group
also runs a liquidity stress test which measures the anticipated outflows over a 12 month market-wide scenario.
The LCR requirement takes into account the relative stability of different sources of funding and potential incremental
funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank’s liquidity risk profile by
holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days.
As at 30 June 2023 the spot LCR was 158% (December 2022: £165%), and the average LCR (trailing average of last twelve
month ends) was 157%. The Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and
external regulatory requirements.
Liquidity coverage ratio As at
30.06.23
As at
31.12.22
£bn £bn
LCR Eligible High Quality Liquid Assets (HQLA) 313 295
Net stress outflows (198) (178)
Surplus 115 117
Liquidity coverage ratio 158% 165%
Net Stable Funding Ratio
The external NSFR metric requires banks to maintain a stable funding profile taking into account both on and certain off
balance sheet exposures over a medium to long term period. The ratio is defined as the Available Stable Funding (capital and
certain liabilities which are treated as stable sources of funding) relative to the Required Stable Funding (assets on balance
sheet and certain off balance sheet exposures). The NSFR (average of last four quarter ends) as at 30 June 2023 was 139%,
which was a surplus above requirements of £166bn.
Net Stable Funding Ratio1 As at
30.06.23
As at
31.12.22
£bn £bn
Total Available Stable Funding 596 576
Total Required Stable Funding 430 421
Surplus 166 155
Net Stable Funding Ratio 139% 137%
1 Represents average of the last four spot quarter end positions.
As part of the liquidity risk appetite, Barclays establishes minimum LCR, NSFR and internal liquidity stress test limits. The
Group plans to maintain its surplus to the internal and regulatory requirements at an efficient level. Risks to market funding
conditions, the Group’s liquidity position and funding profile are assessed continuously, and actions are taken to manage the
size of the liquidity pool and the funding profile as appropriate.
Treasury and Capital Risk
Barclays PLC 49
-- 51 of 98 --
Composition of the Group liquidity pool
LCR eligible1 High Quality Liquid Assets (HQLA) Liquidity pool
Cash Level 1 Level 2A Level 2B Total 2023 2022
£bn £bn £bn £bn £bn £bn £bn
Cash and deposits with central banks2 249 — — — 249 264 263
Government bonds3
AAA to AA- — 37 8 — 45 49 39
A+ to A- — 3 1 — 4 4 3
BBB+ to BBB- — 1 — — 1 1 —
Total government bonds — 41 9 — 50 54 42
Other
Government Guaranteed Issuers, PSEs and GSEs — 4 1 — 5 5 6
International Organisations and MDBs — 2 — — 2 2 2
Covered bonds — 2 3 — 5 6 5
Other — — — 2 2 — —
Total other — 8 4 2 14 13 13
Total as at 30 June 2023 249 49 13 2 313 331
Total as at 31 December 2022 248 31 15 1 295 318
1 The LCR eligible HQLA is adjusted for operational restrictions upon consolidation under Article 8 of the Liquidity Coverage Ratio section of the PRA rulebook
(CRR) such as trapped liquidity within Barclays subsidiaries. It also reflects differences in eligibility of assets between the LCR and Barclays’ Liquidity Pool.
2 Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 98% (December 2022: over 99%) was placed with
the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.
3 Of which over 78% (December 2022: over 79%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.
The Group liquidity pool increased to £331bn as at June 2023 (December 2022: £318bn) driven by deposit growth. During
2023, the month-end liquidity pool ranged from £321bn to £342bn (2022: £309bn to £359bn), and the month-end average
balance was £331bn (2022: £331bn). The liquidity pool is held unencumbered and is not used to support payment or
clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool represents
readily accessible funds to meet potential cash outflows during stress periods.
As at 30 June 2023, 65% (December 2022: 60%) of the liquidity pool was located in Barclays Bank PLC, 21% (December
2022: 25%) in Barclays Bank UK PLC and 9% (December 2022: 9%) in Barclays Bank Ireland PLC. The residual portion of the
liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and
local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local
regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR.
The composition of the pool is subject to limits set by the Board and the independent liquidity risk, credit risk and market risk
functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type.
Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.
Treasury and Capital Risk
Barclays PLC 50
-- 52 of 98 --
Deposit funding
As at 30.06.23 As at
31.12.22
Loans and
advances at
amortised
cost
Deposits at
amortised
cost
Loan: deposit
ratio1
Loan: deposit
ratio1
Funding of loans and advances £bn £bn % %
Barclays UK 226 250 90 87
Barclays International 171 305 56 59
Head Office 4 —
Barclays Group 401 555 72 73
1 The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.
Funding structure and funding relationships
The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an
inability to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified funding
base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to
provide protection against unexpected fluctuations, while minimising the cost of funding.
Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are
largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of
reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched.
A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are
largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual
assets.
These funding relationships as at 30 June 2023 are summarised below:
As at
30.06.23
As at
31.12.22
As at
30.06.23
As at
31.12.22
Assets £bn £bn Liabilities and equity £bn £bn
Loans and advances at amortised cost1 377 385 Deposits at amortised cost 555 546
Group liquidity pool 331 318 <1 Year wholesale funding 73 73
>1 Year wholesale funding 110 111
Reverse repurchase agreements, trading
portfolio assets, cash collateral and
settlement balances 479 412
Repurchase agreements, trading portfolio
liabilities, cash collateral and settlement
balances 428 370
Derivative financial instruments 266 302 Derivative financial instruments 255 290
Other assets2 97 97 Other liabilities 60 55
Equity 69 69
Total assets 1,550 1,514 Total liabilities and equity 1,550 1,514
1 Adjusted for liquidity pool debt securities reported at amortised cost of £24bn (December 2022: £14bn).
2 Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.
Treasury and Capital Risk
Barclays PLC 51
-- 53 of 98 --
Composition of wholesale funding
Wholesale funding outstanding (excluding repurchase agreements) was £183.3bn (December 2022: £184.0bn). In 2023, the
Group issued £7.1bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and
currencies.
Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases.
Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank UK
PLC continued to issue in the shorter-term markets and maintains active secured funding programmes.
Wholesale funding of £73.1bn (December 2022: £72.5bn) matures in less than one year, representing 40% (December 2022:
39%) of total wholesale funding outstanding. This includes £17.9bn (December 2022: £15.0bn) related to term funding1.
Maturity profile of wholesale funding1,2
<1 1-3 3-6 6-12 <1 1-2 2-3 3-4 4-5 >5
month months months months year years years years years years Total
£bn £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn
Barclays PLC (the Parent
company)
Senior unsecured (public
benchmark) 0.2 0.6 0.9 1.5 3.2 7.2 6.8 5.7 3.3 17.7 43.9
Senior unsecured (privately
placed) — — 0.1 — 0.1 — — — — 0.9 1.0
Subordinated liabilities — — — — — 0.9 1.5 — 1.6 5.8 9.8
Barclays Bank PLC (including
subsidiaries)
Certificates of deposit and
commercial paper 7.3 11.2 14.0 7.3 39.8 1.6 0.2 — — — 41.6
Asset backed commercial paper 3.0 6.7 1.0 — 10.7 — — — — — 10.7
Senior unsecured (public
benchmark) — — — 1.0 1.0 — — — — — 1.0
Senior unsecured (privately
placed)3 1.3 1.9 2.8 6.0 12.0 12.3 8.4 4.1 6.6 18.8 62.2
Asset backed securities — — 0.6 0.4 1.0 1.7 0.4 0.4 0.1 1.9 5.5
Subordinated liabilities 0.1 0.1 0.2 0.2 0.6 0.1 — 0.3 — 0.4 1.4
Barclays Bank UK PLC
(including subsidiaries)
Certificates of deposit and
commercial paper 4.7 — — — 4.7 — — — — — 4.7
Senior unsecured (public
benchmark) — — — — — — — — — 0.1 0.1
Covered bonds — — — — — — — — 0.5 0.9 1.4
Total as at 30 June 2023 16.6 20.5 19.6 16.4 73.1 23.8 17.3 10.5 12.1 46.5 183.3
Of which secured 3.0 6.7 1.6 0.4 11.7 1.7 0.4 0.4 0.6 2.8 17.6
Of which unsecured 13.6 13.8 18.0 16.0 61.4 22.1 16.9 10.1 11.5 43.7 165.7
Total as at 31 December 2022 11.1 26.5 16.4 18.5 72.5 22.4 16.9 14.5 9.7 48.0 184.0
Of which secured 4.9 6.7 1.3 0.2 13.1 1.8 0.7 0.5 1.0 2.1 19.2
Of which unsecured 6.2 19.8 15.1 18.3 59.4 20.6 16.2 14.0 8.7 45.9 164.8
1 The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated
liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.
2 Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt
where the original maturity of the instrument is more than 1 year.
3 Includes structured notes of £50.5bn, of which £10.5bn matures within one year.
Treasury and Capital Risk
Barclays PLC 52
-- 54 of 98 --
Credit ratings
In addition to monitoring and managing key metrics related to the financial strength of the Group, Barclays also solicits
independent credit ratings from Standard & Poor’s Global (S&P), Moody’s, Fitch, and Rating and Investment Information
(R&I). These ratings assess the creditworthiness of the Group, its subsidiaries and its branches, and are based on reviews of a
broad range of business and financial attributes including capital strength, profitability, funding, liquidity, asset quality,
strategy and governance.
Barclays Bank PLC
Standard &
Poor's Moody's Fitch
Long-term A+ / Stable A1 / Stable A+ / Stable
Short-term A-1 P-1 F1
Barclays Bank UK PLC
Long-term A+ / Stable A1 / Stable A+ / Stable
Short-term A-1 P-1 F1
Barclays PLC
Long-term BBB+ / Stable Baa1 / Stable A / Stable
Short-term A-2 P-2 F1
In March 2023, Moody’s upgraded Barclays PLC’s long-term rating by one notch to Baa1 and reverted the outlook to stable,
reflecting Moody's expectation that the Group’s earnings will be higher, more diversified and more sustainable than before,
while asset risk will remain broadly stable and capital and liquidity will remain strong. This followed the review for upgrade
that had been placed on Barclays PLC in December 2022. Moody’s also revised Barclays Bank PLC’s outlook to stable from
negative, reflecting Moody’s expectation that the Bank’s capital and liquidity will remain strong and whilst profitability will
reduce from the exceptional levels of the last couple of years for capital markets and investment banking, it will remain
sound due to improving income from other businesses and lower litigation and conduct costs.
In May 2023, S&P upgraded all Barclays rated entities by one notch and reverted the outlooks to stable, reflecting S&P’s view
that Barclays PLC's diversified international banking franchise has performed well against a difficult economic and financial
backdrop and S&Ps expectation that Barclays PLC will generate solid earnings over the next 12-24 months, even as interest
rates approach their peak. This action upgraded Barclays PLC’s long-term rating to BBB+ and Barclays Bank PLC and Barclays
Bank UK PLC’s long-term ratings to A+.
In September 2022, Fitch affirmed all ratings for Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC.
Barclays also solicits issuer ratings from R&I and the ratings of A for Barclays PLC and A+ for Barclays Bank PLC were
affirmed in November 2022 with stable outlooks.
A credit rating downgrade could result in outflows to meet collateral requirements on existing contracts. Outflows related to
credit rating downgrades are included in the ILST scenarios and a portion of the liquidity pool is held against this risk. Credit
ratings downgrades could also result in reduced funding capacity and increased funding costs.
The contractual collateral requirement following one- and two-notch long-term and associated short-term downgrades
across all credit rating agencies, would result in outflows of £1bn and £3bn respectively on derivative contracts and other off
balance sheet products, and are provided for in determining an appropriate liquidity pool size given the Group’s liquidity risk
appetite. These numbers do not assume any management or restructuring actions that could be taken to reduce posting
requirements.
Treasury and Capital Risk
Barclays PLC 53
-- 55 of 98 --
Regulatory minimum requirements
Capital
The Group’s Overall Capital Requirement for CET1 is 11.4% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital
Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and
a 0.5% Countercyclical Capital Buffer (CCyB).
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 13
December 2021, the Financial Policy Committee (FPC) announced the re-introduction of a CCyB rate of 1% for UK exposures
with effect from 13 December 2022. The buffer rates set by other national authorities for non-UK exposures are not
currently material. Overall, this results in a 0.5% CCyB for the Group. On 5 July 2022, the FPC announced that the UK CCyB
rate will be increased from 1% to 2% with effect from 5 July 2023.
The Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement is 4.3% of which at least 56.25% needs to
be met with CET1 capital, equating to 2.4% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has
been set as a proportion of RWAs and is subject to at least annual review.
The Group’s CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential
institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA
buffer.
Leverage
The Group is subject to a UK leverage ratio requirement of 4.0%. This comprises the 3.25% minimum requirement, a G-SII
additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.2%. Although
the leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4%, needs to
be met with CET1 capital. In addition, the G-SII ALRB and CCLB must be covered solely with CET1 capital. The CET1 capital
held against the 0.53% G-SII ALRB was £6.2bn and against the 0.2% CCLB was £2.4bn.
The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month
in the quarter and an exposure measure for each day in the quarter.
MREL
The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.3% Pillar 2A equating to 24.7% of
RWAs; and (ii) 6.75% of leverage exposures. In addition, the higher of regulatory capital and leverage buffers apply. CET1
capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including the above mentioned
confidential institution-specific PRA buffer, will effectively be applied above MREL requirements.
In the disclosures that follow, references to CRR, as amended by CRR II, mean the capital regulatory requirements, as they
form part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.
Treasury and Capital Risk
Barclays PLC 54
-- 56 of 98 --
Capital ratios1,2 As at
30.06.23
As at
31.03.23
As at
31.12.22
CET1 13.8% 13.6 % 13.9 %
T1 17.9% 17.6 % 17.9 %
Total regulatory capital 20.5% 20.2 % 20.8 %
MREL ratio as a percentage of total RWAs 32.9% 32.7 % 33.5 %
Own funds and eligible liabilities £m £m £m
Total equity excluding non-controlling interests per the balance sheet 67,669 69,699 68,292
Less: other equity instruments (recognised as AT1 capital) (13,759) (13,784) (13,284)
Adjustment to retained earnings for foreseeable ordinary share dividends (622) (338) (787)
Adjustment to retained earnings for foreseeable repurchase of shares — (224) —
Adjustment to retained earnings for foreseeable other equity coupons (39) (52) (37)
Other regulatory adjustments and deductions
Additional value adjustments (PVA) (1,800) (1,913) (1,726)
Goodwill and intangible assets (8,584) (8,642) (8,224)
Deferred tax assets that rely on future profitability excluding temporary differences (1,372) (1,435) (1,500)
Fair value reserves related to gains or losses on cash flow hedges 7,992 6,164 7,237
Excess of expected losses over impairment (228) (232) (119)
Gains or losses on liabilities at fair value resulting from own credit (116) (86) (620)
Defined benefit pension fund assets (2,995) (3,593) (3,430)
Direct and indirect holdings by an institution of own CET1 instruments (20) (20) (20)
Adjustment under IFRS 9 transitional arrangements 206 245 700
Other regulatory adjustments 308 196 396
CET1 capital 46,640 45,985 46,878
AT1 capital
Capital instruments and related share premium accounts 13,759 13,784 13,284
Other regulatory adjustments and deductions (60) (60) (60)
AT1 capital 13,699 13,724 13,224
T1 capital 60,339 59,709 60,102
T2 capital
Capital instruments and related share premium accounts 8,212 7,538 9,000
Qualifying T2 capital (including minority interests) issued by subsidiaries 769 1,061 1,095
Credit risk adjustments (excess of impairment over expected losses) 71 66 35
Other regulatory adjustments and deductions (160) (160) (160)
Total regulatory capital 69,231 68,214 70,072
Less : Ineligible T2 capital (including minority interests) issued by subsidiaries (769) (1,061) (1,095)
Eligible liabilities 42,559 43,489 43,851
Total own funds and eligible liabilities3 111,021 110,642 112,828
Total RWAs 336,946 338,448 336,518
1 CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9
transitional arrangements and the grandfathering of CRR II non-compliant capital instruments.
2 The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.8%, with £46.4bn of CET1
capital and £336.9bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.
3 As at 30 June 2023, the Group's MREL requirement, excluding the PRA buffer, was to hold £98.3bn of own funds and eligible liabilities equating to 29.2% of
RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer.
Treasury and Capital Risk
Barclays PLC 55
-- 57 of 98 --
Movement in CET1 capital Three months
ended
30.06.23
Six months
ended
30.06.23
£m £m
Opening CET1 capital 45,985 46,878
Profit for the period attributable to equity holders 1,588 3,618
Own credit relating to derivative liabilities 15 8
Ordinary share dividends paid and foreseen (284) (622)
Purchased and foreseeable share repurchase — (500)
Other equity coupons paid and foreseen (246) (507)
Increase in retained regulatory capital generated from earnings 1,073 1,997
Net impact of share schemes 134 (156)
Fair value through other comprehensive income reserve (74) 75
Currency translation reserve (642) (1,173)
Other reserves (16) (20)
Decrease in other qualifying reserves (598) (1,274)
Pension remeasurements within reserves (611) (476)
Defined benefit pension fund asset deduction 598 435
Net impact of pensions (13) (41)
Additional value adjustments (PVA) 113 (74)
Goodwill and intangible assets 58 (360)
Deferred tax assets that rely on future profitability excluding those arising from temporary differences 63 128
Excess of expected loss over impairment 4 (109)
Adjustment under IFRS 9 transitional arrangements (39) (494)
Other regulatory adjustments (6) (11)
Increase/(decrease) in regulatory capital due to adjustments and deductions 193 (920)
Closing CET1 capital 46,640 46,640
CET1 capital decreased £0.2bn to £46.6bn (December 2022: £46.9bn).
£3.6bn of capital generated from profit was partially offset by distributions of £1.6bn comprising:
• £0.6bn accrual towards a FY23 dividend
• £0.5bn of buybacks announced with FY22 results
• £0.5bn of equity coupons paid and foreseen
Other significant movements in the period were:
• £1.2bn decrease in the currency translation reserve driven by the strengthening of GBP against USD since December
2022
• £0.4bn increase in the goodwill and intangibles deduction primarily as a result of the acquisition of KMC
• £0.5bn decrease in IFRS 9 transitional relief primarily due to the relief applied to the pre-2020 impairment charge
reducing to 0% in 2023 from 25% in 2022 and the relief applied to the post-2022 impairment charge reducing to 50% in
2023 from 75% in 2022.
Treasury and Capital Risk
Barclays PLC 56
-- 58 of 98 --
RWAs by risk type and business
Credit risk Counterparty credit risk Market Risk
Operational
risk
Total
RWAs
STD IRB STD IRB
Settlement
Risk CVA STD IMA
As at 30.06.23 £m £m £m £m £m £m £m £m £m £m
Barclays UK 8,377 52,867 245 — — 124 374 — 11,054 73,041
Corporate and Investment Bank 33,567 75,880 17,551 20,687 454 2,841 16,179 22,251 27,093 216,503
Consumer, Cards and Payments 26,306 4,484 202 51 — 63 3 424 6,527 38,060
Barclays International 59,873 80,364 17,753 20,738 454 2,904 16,182 22,675 33,620 254,563
Head Office 2,584 7,567 — — — — — — (809) 9,342
Barclays Group 70,834 140,798 17,998 20,738 454 3,028 16,556 22,675 43,865 336,946
As at 31.03.23
Barclays UK 7,816 55,174 246 — — 115 196 — 11,054 74,601
Corporate and Investment Bank 33,904 75,225 17,014 21,692 237 2,811 15,734 23,136 27,093 216,846
Consumer, Cards and Payments 26,511 4,343 205 45 — 60 — 525 6,527 38,216
Barclays International 60,415 79,568 17,219 21,737 237 2,871 15,734 23,661 33,620 255,062
Head Office 2,578 7,016 — — — — — — (809) 8,785
Barclays Group 70,809 141,758 17,465 21,737 237 2,986 15,930 23,661 43,865 338,448
As at 31.12.22
Barclays UK 6,836 54,752 167 — — 72 233 — 11,023 73,083
Corporate and Investment Bank 35,738 75,413 16,814 21,449 80 3,093 13,716 22,497 27,064 215,864
Consumer, Cards and Payments 27,882 3,773 214 46 — 61 — 388 6,559 38,923
Barclays International 63,620 79,186 17,028 21,495 80 3,154 13,716 22,885 33,623 254,787
Head Office 2,636 6,843 — — — — — — (831) 8,648
Barclays Group 73,092 140,781 17,195 21,495 80 3,226 13,949 22,885 43,815 336,518
Movement analysis of RWAs Credit risk
Counterparty
credit risk Market risk
Operational
risk Total RWAs
£m £m £m £m £m
Opening RWAs (as at 31.12.22) 213,873 41,996 36,834 43,815 336,518
Book size 849 2,181 3,132 50 6,212
Acquisitions and disposals 688 — — — 688
Book quality 2,169 (247) — — 1,922
Model updates (2,600) — — — (2,600)
Methodology and policy 2,461 583 — — 3,044
Foreign exchange movements1 (5,808) (2,295) (735) — (8,838)
Total RWA movements (2,241) 222 2,397 50 428
Closing RWAs (as at 30.06.23) 211,632 42,218 39,231 43,865 336,946
1 Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.
Overall RWAs increased £0.4bn to £336.9bn (December 2022: £336.5bn)
Credit risk RWAs decreased £2.2bn:
• A £2.2bn increase in book quality RWAs primarily driven by changes in risk parameters and HPI refresh within Barclays
UK
• A £2.6bn decrease in model updates primarily driven by capital LGD model update for the mortgage portfolio to reflect
the significant decrease in repossession volume during and post the COVID pandemic
• A £2.5bn increase in methodology and policy primarily driven by the recalibration of the post model adjustment (PMA)
introduced to address the IRB roadmap changes
• A £5.8bn decrease in FX primarily due to the strengthening of GBP against USD since December 2022
Counterparty Credit risk RWAs increased £0.2bn:
• A £2.2bn increase in book size primarily due to an increase in trading activity within derivatives
• A £2.3bn decrease in FX primarily due to the strengthening of GBP against USD since December 2022
Market risk RWAs increased £2.4bn:
• A £3.1bn increase in book size primarily due to increased trading activity
Treasury and Capital Risk
Barclays PLC 57
-- 59 of 98 --
Leverage ratios1,2
As at
30.06.23
As at
31.03.23
As at
31.12.22
£m £m £m
UK leverage ratio 5.1% 5.1% 5.3%
T1 capital 60,339 59,709 60,102
UK leverage exposure 1,183,703 1,168,899 1,129,973
Average UK leverage ratio 4.8% 4.8% 4.8%
Average T1 capital 60,176 59,488 60,865
Average UK leverage exposure 1,261,094 1,251,286 1,280,972
1 Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.
2 Fully loaded UK leverage ratio was 5.1%, with £60.1bn of T1 capital and £1,183.5bn of leverage exposure. Fully loaded average UK leverage ratio was 4.8%
with £60.0bn of T1 capital and £1,260.9bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional
arrangements of the CRR as amended by CRR II.
The UK leverage ratio decreased to 5.1% (December 2022: 5.3%) primarily due to a £53.7bn increase in leverage exposure
to £1,183.7bn (December 2022: £1,130.0bn). This is largely driven by increased trading and client activity within Global
Markets.
Treasury and Capital Risk
Barclays PLC 58
-- 60 of 98 --
The Directors (the names of whom are set out below) are required to prepare the financial statements on a going concern
basis unless it is not appropriate to do so. In making this assessment, the directors have considered information relating to
present and future conditions. Each of the Directors confirm that to the best of their knowledge, the condensed consolidated
interim financial statements set out on pages 62 to 67 have been prepared in accordance with International Accounting
Standard 34, ‘Interim Financial Reporting’, as adopted by the UK, and that the interim management report herein includes a
fair review of the information required by Disclosure Guidance and Transparency Rules 4.2.7R and 4.2.8R namely:
• an indication of important events that have occurred during the six months ended 30 June 2023 and their impact on
the condensed consolidated interim financial statements, and a description of the principal risks and uncertainties for
the remaining six months of the financial year
• any related party transactions in the six months ended 30 June 2023 that have materially affected the financial position
or performance of Barclays during that period and any changes in the related party transactions described in the last
Annual Report that could have a material effect on the financial position or performance of Barclays in the six months
ended 30 June 2023
Signed on 26 July 2023 on behalf of the Board by
C.S. Venkatakrishnan Anna Cross
Group Chief Executive Group Finance Director
Barclays PLC Board of Directors
Chairman Executive Directors Non-Executive Directors
Nigel Higgins C.S. Venkatakrishnan Robert Berry
Anna Cross Tim Breedon CBE
Mohamed A. El-Erian
Dawn Fitzpatrick
Mary Francis CBE
Brian Gilvary
Sir John Kingman
Marc Moses
Diane Schueneman
Julia Wilson
Statement of Directors' Responsibilities
Barclays PLC 59
-- 61 of 98 --
Conclusion
We have been engaged by Barclays PLC (“the Company” or "the Group") to review the condensed set of financial statements
in the Interim Results Announcement for the six months ended 30 June 2023 which comprises:
• the condensed consolidated income statement and condensed consolidated statement of comprehensive income for the
period then ended;
• the condensed consolidated balance sheet as at 30 June 2023;
• the condensed consolidated statement of changes in equity for the period then ended;
• the condensed consolidated cash flow statement for the period then ended; and
• the related explanatory notes.
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial
statements in the Interim Results Announcement for the six months ended 30 June 2023 is not prepared, in all material
respects, in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK and the Disclosure Guidance
and Transparency Rules (“the DTR”) of the UK’s Financial Conduct Authority (“the UK FCA”).
Basis for conclusion
We conducted our review in accordance with International Standard on Review Engagements (UK) 2410 Review of Interim
Financial Information Performed by the Independent Auditor of the Entity (“ISRE (UK) 2410”) issued for use in the UK. A
review of interim financial information consists of making enquiries, primarily of persons responsible for financial and
accounting matters, and applying analytical and other review procedures. We read the other information contained in the
Interim Results Announcement and consider whether it contains any apparent misstatements or material inconsistencies
with the information in the condensed set of financial statements.
A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK)
and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might
be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusions relating to going concern
Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for
conclusion section of this report, nothing has come to our attention that causes us to believe that the directors have
inappropriately adopted the going concern basis of accounting, or that the directors have identified material uncertainties
relating to going concern that have not been appropriately disclosed.
This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410. However, future events or
conditions may cause the Group to cease to continue as a going concern, and the above conclusions are not a guarantee
that the Group will continue in operation.
Directors’ responsibilities
The Interim Results Announcement is the responsibility of, and has been approved by, the directors. The directors are
responsible for preparing the Interim Results Announcement in accordance with the DTR of the UK FCA.
As disclosed in Note 1, the annual financial statements of the Barclays PLC Group are prepared in accordance with UK-
adopted international accounting standards.
The directors are responsible for preparing the condensed set of financial statements included in the Interim Results
Announcement in accordance with IAS 34 as adopted for use in the UK.
In preparing the condensed set of financial statements, the directors are responsible for assessing the Group’s ability to
continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the Group or to cease operations, or have no realistic alternative
but to do so.
Our responsibility
Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the Interim
Results Announcement based on our review. Our conclusion, including our conclusions relating to going concern, are based
on procedures that are less extensive than audit procedures, as described in the Basis for conclusion section of this report.
Independent Review Report to Barclays PLC
Barclays PLC 60
-- 62 of 98 --
The purpose of our review work and to whom we owe our responsibilities
This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in
meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the
Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted
by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or
for the conclusions we have reached.
Stuart Crisp
for and on behalf of KPMG LLP
Chartered Accountants
15 Canada Square
London, E14 5GL
26 July 2023
Independent Review Report to Barclays PLC
Barclays PLC 61
-- 63 of 98 --
Condensed consolidated income statement (unaudited)
Half year
ended
30.06.23
Half year
ended
30.06.22
Notes1 £m £m
Interest and similar income 15,632 7,134
Interest and similar expense (9,309) (2,371)
Net interest income 6,323 4,763
Fee and commission income 3 5,257 4,726
Fee and commission expense 3 (1,898) (1,302)
Net fee and commission income 3 3,359 3,424
Net trading income 3,786 5,013
Net investment income 10 (116)
Other income 44 120
Total income 13,522 13,204
Staff costs 4 (4,985) (4,583)
Infrastructure, administration and general expenses 5 (3,045) (2,687)
Litigation and conduct (32) (1,857)
Operating expenses (8,062) (9,127)
Share of post-tax results of associates and joint ventures (2) (3)
Profit before impairment 5,458 4,074
Credit impairment charges (896) (341)
Profit before tax 4,562 3,733
Tax charge (914) (823)
Profit after tax 3,648 2,910
Attributable to:
Equity holders of the parent 3,111 2,475
Other equity instrument holders 507 414
Total equity holders of the parent 3,618 2,889
Non-controlling interests 30 21
Profit after tax 3,648 2,910
Earnings per share
Basic earnings per ordinary share 6 19.9p 14.8p
Diluted earnings per ordinary share 6 19.3p 14.5p
1 For Notes to the Financial Statements see pages 68 to 88.
Condensed Consolidated Financial Statements
Barclays PLC 62
-- 64 of 98 --
Condensed consolidated statement of comprehensive income (unaudited)
Half year
ended
30.06.23
Half year
ended
30.06.22
Notes1 £m £m
Profit after tax 3,648 2,910
Other comprehensive income/(loss) that may be recycled to profit or loss:2
Currency translation reserve 14 (1,173) 1,703
Fair value through other comprehensive income reserve 14 77 (913)
Cash flow hedging reserve 14 (755) (3,818)
Other comprehensive loss that may be recycled to profit (1,851) (3,028)
Other comprehensive income/(loss) not recycled to profit or loss:2
Retirement benefit remeasurements 13 (476) 1,090
Fair value through other comprehensive income reserve 14 (2) 154
Own credit 14 (494) 855
Other comprehensive income not recycled to profit (972) 2,099
Other comprehensive loss for the period (2,823) (929)
Total comprehensive income for the period 825 1,981
Attributable to:
Equity holders of the parent 795 1,960
Non-controlling interests 30 21
Total comprehensive income for the period 825 1,981
1 For Notes to the Financial Statements see pages 68 to 88.
2 Reported net of tax.
Condensed Consolidated Financial Statements
Barclays PLC 63
-- 65 of 98 --
Condensed consolidated balance sheet (unaudited)
As at
30.06.23
As at
31.12.22
Assets Notes1 £m £m
Cash and balances at central banks 252,830 256,351
Cash collateral and settlement balances 130,489 112,597
Debt securities at amortised cost2 53,147 45,487
Loans and advances at amortised cost to banks 10,895 10,015
Loans and advances at amortised cost to customers 337,363 343,277
Reverse repurchase agreements and other similar secured lending 2,600 776
Trading portfolio assets 165,834 133,813
Financial assets at fair value through the income statement 235,100 213,568
Derivative financial instruments 8 266,312 302,380
Financial assets at fair value through other comprehensive income 66,068 65,062
Investments in associates and joint ventures 900 922
Goodwill and intangible assets 10 8,607 8,239
Property, plant and equipment 3,478 3,616
Current tax assets 100 385
Deferred tax assets 7,371 6,991
Retirement benefit assets 13 4,140 4,743
Other assets 4,480 5,477
Total assets 1,549,714 1,513,699
Liabilities
Deposits at amortised cost from banks 26,827 19,979
Deposits at amortised cost from customers 527,839 525,803
Cash collateral and settlement balances 115,190 96,927
Repurchase agreements and other similar secured borrowing 41,213 27,052
Debt securities in issue 105,018 112,881
Subordinated liabilities 11 11,019 11,423
Trading portfolio liabilities 70,980 72,924
Financial liabilities designated at fair value 314,654 271,637
Derivative financial instruments 8 254,849 289,620
Current tax liabilities 675 580
Deferred tax liabilities 16 16
Retirement benefit liabilities 13 261 264
Other liabilities 11,204 13,789
Provisions 12 1,424 1,544
Total liabilities 1,481,169 1,444,439
Equity
Called up share capital and share premium 4,325 4,373
Other reserves 14 (4,457) (2,192)
Retained earnings 54,042 52,827
Shareholders' equity attributable to ordinary shareholders of the parent 53,910 55,008
Other equity instruments 13,759 13,284
Total equity excluding non-controlling interests 67,669 68,292
Non-controlling interests 876 968
Total equity 68,545 69,260
1 For Notes to the Financial Statements see pages 68 to 88.
2 For the fair value of debt securities at amortised cost see page 80 .
Condensed Consolidated Financial Statements
Barclays PLC 64
-- 66 of 98 --
Condensed consolidated statement of changes in equity (unaudited)
Called up
share capital
and share
premium1,2
Other equity
instruments3
Other
reserves2,4
Retained
earnings2 Total
Non-
controlling
interests5
Total
equity
Half year ended 30.06.2023 £m £m £m £m £m £m £m
Balance as at 1 January 2023 4,373 13,284 (2,192) 52,827 68,292 968 69,260
Profit after tax — 507 — 3,111 3,618 30 3,648
Currency translation movements — — (1,173) — (1,173) — (1,173)
Fair value through other
comprehensive income reserve — — 75 — 75 — 75
Cash flow hedges — — (755) — (755) — (755)
Retirement benefit remeasurements — — — (476) (476) — (476)
Own credit — — (494) — (494) — (494)
Total comprehensive income for the
period — 507 (2,347) 2,635 795 30 825
Employee share schemes and
hedging thereof 38 — — 371 409 — 409
Issue and redemption of other equity
instruments — 500 — (8) 492 (93) 399
Other equity instruments coupon paid — (507) — — (507) — (507)
Vesting of employee share schemes — — (4) (484) (488) — (488)
Dividends paid — — — (793) (793) (30) (823)
Repurchase of shares (86) — 86 (503) (503) — (503)
Other movements — (25) — (3) (28) 1 (27)
Balance as at 30 June 2023 4,325 13,759 (4,457) 54,042 67,669 876 68,545
Called up
share capital
and share
premium1,2
Other equity
instruments3
Other
reserves2,4
Retained
earnings2 Total
Non-
controlling
interests5
Total
equity
Half year ended 31.12.2022 £m £m £m £m £m £m £m
Balance as at 1 July 2022 4,508 12,357 (218) 52,980 69,627 969 70,596
Profit after tax — 491 — 2,548 3,039 24 3,063
Currency translation movements — — 329 — 329 — 329
Fair value through other
comprehensive income reserve — — (434) — (434) — (434)
Cash flow hedges — — (2,564) — (2,564) — (2,564)
Retirement benefit remeasurements — — — (1,371) (1,371) — (1,371)
Own credit — — 608 — 608 — 608
Total comprehensive income for the
period — 491 (2,061) 1,177 (393) 24 (369)
Employee share schemes and
hedging thereof 37 — — 59 96 — 96
Issue and redemption of other equity
instruments — 917 — 3 920 — 920
Other equity instruments coupon paid — (491) — — (491) — (491)
Disposal of Absa holding — — (45) 45 — — —
Vesting of employee share schemes — — (2) (21) (23) — (23)
Dividends paid — — — (364) (364) (24) (388)
Repurchase of shares (172) — 172 (1,076) (1,076) — (1,076)
Own credit realisation — — (36) 36 — — —
Other movements — 10 (2) (12) (4) (1) (5)
Balance as at 31 December 2022 4,373 13,284 (2,192) 52,827 68,292 968 69,260
Condensed Consolidated Financial Statements
Barclays PLC 65
-- 67 of 98 --
Condensed consolidated statement of changes in equity (unaudited)
Called up
share capital
and share
premium1,2
Other equity
instruments3
Other
reserves2,4
Retained
earnings2 Total
Non-
controlling
interests5
Total
equity
Half year ended 30.06.2022 £m £m £m £m £m £m £m
Balance as at 1 January 2022 4,536 12,259 1,770 50,487 69,052 989 70,041
Profit after tax — 414 — 2,475 2,889 21 2,910
Currency translation movements — — 1,703 — 1,703 — 1,703
Fair value through other
comprehensive income reserve — — (759) — (759) — (759)
Cash flow hedges — — (3,818) — (3,818) — (3,818)
Retirement benefit remeasurements — — — 1,090 1,090 — 1,090
Own credit — — 855 — 855 — 855
Total comprehensive income for the
period — 414 (2,019) 3,565 1,960 21 1,981
Employee share schemes and
hedging thereof 33 — — 417 450 — 450
Issue and redemption of other equity
instruments — 115 — 25 140 (20) 120
Other equity instruments coupon paid — (414) — — (414) — (414)
Disposal of Absa holding — — (39) 39 — — —
Vesting of employee share schemes — — 7 (464) (457) — (457)
Dividends paid — — — (664) (664) (21) (685)
Repurchase of shares (61) — 61 (432) (432) — (432)
Other movements — (17) 2 7 (8) — (8)
Balance as at 30 June 2022 4,508 12,357 (218) 52,980 69,627 969 70,596
1 As at 30 June 2023, Called up share capital comprises 15,556m (December 2022: 15,871m) ordinary shares of 25p each.
2 During the period ended 30 June 2023, Barclays PLC announced and executed a share buy-back of up to £500m. Accordingly, it repurchased and cancelled
343m shares. The nominal value of £86m has been transferred from Share capital to Capital redemption reserve within Other reserves. During the year
ended 31 December 2022, two share buybacks were executed, totalling £1500m. Accordingly, Barclays PLC repurchased and cancelled 931m shares. The
nominal value of £233m was transferred from Share capital to Capital redemption reserve within Other reserves.
3 Other equity instruments of £13,759m (December 2022: £13,284m) comprise AT1 securities issued by Barclays PLC. There were two issuances in the form
of Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities for £1,745m (net of £5m issuance costs) and one redemption of £1,245m
(net of £5m issuance costs, transferred to retained earnings on redemption) for the period ended 30 June 2023. During the period ended 31 December 2022,
there were three issuances in the form of Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities, for £3,158m, which includes
issuance costs of £9m and two redemptions totalling £2,126m.
4 See Note 14 Other reserves.
5 During the period ended 30 June 2023 a redemption notice was published related to the Undated Floating Rate Primary Capital Note Series 1, as a result of
which £93m was transferred from non-controlling interests to subordinated liabilities ahead of redemption on 26 July 2023 (year ended 31 December 2022:
one redemption of £20m, related to the Undated Floating Rate Primary Capital Notes Series 3).
Condensed Consolidated Financial Statements
Barclays PLC 66
-- 68 of 98 --
Condensed consolidated cash flow statement (unaudited)
Half year
ended
30.06.23
Half year
ended
30.06.22
£m £m
Profit before tax 4,562 3,733
Adjustment for non-cash items 10,085 (7,115)
Net decrease/(increase) in loans and advances at amortised cost 7,734 (17,667)
Net increase in deposits at amortised cost 8,919 49,237
Net (decrease)/increase in debt securities in issue (9,596) 19,748
Changes in other operating assets and liabilities 2,553 14,719
Corporate income tax paid (346) (401)
Net cash from operating activities 23,911 62,254
Net cash from investing activities (14,784) (14,939)
Net cash from financing activities1 (191) (5,500)
Effect of exchange rates on cash and cash equivalents (6,069) 7,047
Net increase in cash and cash equivalents 2,867 48,862
Cash and cash equivalents at beginning of the period 278,790 259,206
Cash and cash equivalents at end of the period 281,657 308,068
1 Issuance and redemption of debt securities included in financing activities relate to instruments that qualify as eligible liabilities and satisfy regulatory
requirements for MREL instruments which came into effect during 2019.
Condensed Consolidated Financial Statements
Barclays PLC 67
-- 69 of 98 --
1. Basis of preparation
These condensed consolidated interim financial statements ("the financial statements") for the six months ended 30 June
2023 have been prepared in accordance with the Disclosure Guidance and Transparency Rules (DTR) of the UK’s Financial
Conduct Authority (FCA), and IAS 34, Interim Financial Reporting, as published by the International Accounting Standards
Board (IASB) and adopted by the UK.
The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements
for the year ended 31 December 2022. The annual financial statements for the year ended 31 December 2022 were prepared
in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and
in accordance with International Financial Reporting Standards (IFRS) and interpretations (IFRICs) as issued by the IASB and
adopted by the UK.
The accounting policies and methods of computation used in these condensed consolidated interim financial statements are
the same as those used in the Barclays PLC Annual Report for the financial year ended 31 December 2022.
1. Going concern
The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent
company have the resources to continue in business for a period of at least 12 months from approval of the interim financial
statements. In making this assessment, the Directors have considered a wide range of information relating to present and
future conditions and includes a review of a working capital report (WCR). The WCR is used by the Directors to assess the
future performance of the business and that it has the resources in place that are required to meet its ongoing regulatory
requirements. The WCR also includes an assessment of the impact of internally generated stress testing scenarios on the
liquidity and capital requirement forecasts. The stress tests used were based upon an assessment of reasonably possible
downside economic scenarios that the Group could experience.
The WCR indicated that the Group had sufficient capital in place to support its future business requirements and remained
above its regulatory minimum requirements in the internal stress scenarios.
2. Other disclosures
The Credit risk disclosures on pages 26 to 47 form part of these interim financial statements.
Financial Statement Notes
Barclays PLC 68
-- 70 of 98 --
2. Segmental reporting
Analysis of results by business
Barclays UK
Barclays
International Head Office
Barclays
Group
Half year ended 30.06.23 £m £m £m £m
Total income 3,922 9,722 (122) 13,522
Operating costs (2,182) (5,703) (145) (8,030)
Litigation and conduct 3 (30) (5) (32)
Total operating expenses (2,179) (5,733) (150) (8,062)
Other net income/(expenses)1 — 9 (11) (2)
Profit/(loss) before impairment 1,743 3,998 (283) 5,458
Credit impairment charges (208) (679) (9) (896)
Profit/(loss) before tax 1,535 3,319 (292) 4,562
As at 30.06.23 £bn £bn £bn £bn
Total assets 304.8 1,226.4 18.5 1,549.7
Total liabilities 276.9 1,142.4 61.9 1,481.2
Barclays UK
Barclays
International Head Office
Barclays
Group
Half year ended 30.06.22 £m £m £m £m
Total income 3,373 9,940 (109) 13,204
Operating costs (2,083) (5,042) (145) (7,270)
Litigation and conduct (25) (1,832) — (1,857)
Total operating expenses (2,108) (6,874) (145) (9,127)
Other net income/(expenses)1 — 13 (16) (3)
Profit/(loss) before impairment 1,265 3,079 (270) 4,074
Credit impairment (charges)/releases (48) (310) 17 (341)
Profit/(loss) before tax 1,217 2,769 (253) 3,733
As at 31.12.22 £bn £bn £bn £bn
Total assets 313.2 1,181.3 19.2 1,513.7
Total liabilities 287.3 1,093.9 63.2 1,444.4
1 Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates
and joint ventures and gains on acquisitions.
Split of income by geographic region1
Half year
ended
30.06.23
Half year
ended
30.06.22
£m £m
United Kingdom 7,312 7,972
Europe 1,265 1,311
Americas 4,187 3,200
Africa and Middle East 42 31
Asia 716 690
Total 13,522 13,204
1 The geographical analysis is based on the location of the office where the transactions are recorded.
Financial Statement Notes
Barclays PLC 69
-- 71 of 98 --
3. Net fee and commission income
Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from
Contracts with Customers:
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.23 £m £m £m £m
Fee type
Transactional 560 1,827 — 2,387
Advisory 57 457 — 514
Brokerage and execution 122 1,042 — 1,164
Underwriting and syndication — 1,036 — 1,036
Other 27 53 2 82
Total revenue from contracts with customers 766 4,415 2 5,183
Other non-contract fee income — 74 — 74
Fee and commission income 766 4,489 2 5,257
Fee and commission expense (188) (1,707) (3) (1,898)
Net fee and commission income 578 2,782 (1) 3,359
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.22 £m £m £m £m
Fee type
Transactional 515 1,448 — 1,963
Advisory 83 511 — 594
Brokerage and execution 125 762 — 887
Underwriting and syndication — 1,102 — 1,102
Other 29 80 2 111
Total revenue from contracts with customers 752 3,903 2 4,657
Other non-contract fee income — 69 — 69
Fee and commission income 752 3,972 2 4,726
Fee and commission expense (147) (1,153) (2) (1,302)
Net fee and commission income 605 2,819 — 3,424
Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees.
These include interchange and merchant fee income generated from credit and bank card usage.
Advisory fees are generated from wealth management services and investment banking advisory services related to mergers,
acquisitions and financial restructurings.
Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter
markets and assisting clients in clearing transactions and facilitating foreign exchange transactions for spot/forward
contracts.
Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and
administration of a loan syndication. These include commitment fees to provide loan financing.
Financial Statement Notes
Barclays PLC 70
-- 72 of 98 --
4. Staff costs
Half year
ended
30.06.23
Half year
ended
30.06.22
Compensation costs £m £m
Upfront bonus charge 665 705
Deferred bonus charge 263 280
Other incentives 42 44
Performance costs 970 1,029
Salaries 2,540 2,278
Social security costs 399 377
Post-retirement benefits 268 282
Other compensation costs 281 241
Total compensation costs 4,458 4,207
Other resourcing costs
Outsourcing 340 268
Redundancy and restructuring 63 (15)
Temporary staff costs 53 53
Other 71 70
Total other resourcing costs 527 376
Total staff costs 4,985 4,583
Barclays Group compensation costs as a % of total income 33.0% 31.9%
5. Infrastructure, administration and general expenses
Half year
ended
30.06.23
Half year
ended
30.06.22
Infrastructure costs £m £m
Property and equipment 857 758
Depreciation and amortisation 902 863
Impairment of property, equipment and intangible assets 18 21
Total infrastructure costs 1,777 1,642
Administration and general expenses
Consultancy, legal and professional fees 336 288
Marketing and advertising 288 206
Other administration and general expenses 644 551
Total administration and general expenses 1,268 1,045
Total infrastructure, administration and general expenses 3,045 2,687
Financial Statement Notes
Barclays PLC 71
-- 73 of 98 --
6. Earnings per share
Half year
ended
30.06.23
Half year
ended
30.06.22
£m £m
Profit attributable to ordinary equity holders of the parent 3,111 2,475
m m
Basic weighted average number of shares in issue 15,645 16,684
Number of potential ordinary shares 470 428
Diluted weighted average number of shares 16,115 17,112
p p
Basic earnings per ordinary share 19.9 14.8
Diluted earnings per ordinary share 19.3 14.5
7. Dividends on ordinary shares
Half year ended 30.06.23 Half year ended 30.06.22
Per share Total Per share Total
Dividends paid during the period p £m p £m
Full year dividend paid during period 5.00 793 4.00 664
A half year dividend for 2023 of 2.7p (H122: 2.25p) per ordinary share will be paid on 15 September 2023 to shareholders on
the register on 11 August 2023.
For qualifying American Depositary Receipt (ADR) holders, the half year dividend of 2.7p per ordinary share becomes 10.8p
per American Depositary Share (representing 4 shares). The depositary bank will post the half year dividend on 15
September 2023 to ADR holders on the record at close of business on 11 August 2023.
The Directors have confirmed their intention to initiate a share buyback of up to £750m after the balance sheet date. The
share buyback is expected to commence in the third quarter of 2023. The financial statements for the six months ended 30
June 2023 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are
repurchased by the Company.
Financial Statement Notes
Barclays PLC 72
-- 74 of 98 --
8. Derivative financial instruments
Contract
notional
amount
Fair value
Assets Liabilities
As at 30.06.23 £m £m £m
Foreign exchange derivatives 6,411,178 89,839 (83,459)
Interest rate derivatives 53,452,259 119,533 (107,171)
Credit derivatives 1,482,669 5,280 (5,999)
Equity and stock index and commodity derivatives 2,835,137 49,986 (57,777)
Derivative assets/(liabilities) held for trading 64,181,243 264,638 (254,406)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 156,774 1,428 —
Derivatives designated as fair value hedges 125,205 201 (434)
Derivatives designated as hedges of net investments 3,864 45 (9)
Derivative assets/(liabilities) designated in hedge accounting relationships 285,843 1,674 (443)
Total recognised derivative assets/(liabilities) 64,467,086 266,312 (254,849)
As at 31.12.22
Foreign exchange derivatives 5,908,087 109,288 (103,918)
Interest rate derivatives 42,506,611 134,496 (121,290)
Credit derivatives 1,727,220 5,423 (6,052)
Equity and stock index and commodity derivatives 2,547,855 52,440 (57,313)
Derivative assets/(liabilities) held for trading 52,689,773 301,647 (288,573)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 155,483 549 (212)
Derivatives designated as fair value hedges 126,060 83 (815)
Derivatives designated as hedges of net investments 3,962 101 (20)
Derivative assets/(liabilities) designated in hedge accounting relationships 285,505 733 (1,047)
Total recognised derivative assets/(liabilities) 52,975,278 302,380 (289,620)
The IFRS netting posted against derivative assets was £74bn including £16bn of cash collateral netted (December 2022:
£76bn including £15bn cash collateral netted) and £74bn for liabilities including £16bn of cash collateral netted (December
2022: £77bn including £15bn of cash collateral netted). Derivative asset exposures would be £237bn (December 2022:
£273bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for
which the Group holds cash collateral of £34bn (December 2022: £35bn). Similarly, derivative liabilities would be £228bn
(December 2022: £264bn) lower reflecting counterparty netting and cash collateral placed of £24bn (December 2022:
£25bn). In addition, non-cash collateral of £11bn (December 2022: £11bn) was held in respect of derivative assets and £3bn
(December 2022: £1bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on balance sheet
exposure so as to not include over-collateralisation.
Financial Statement Notes
Barclays PLC 73
-- 75 of 98 --
9. Fair value of financial instruments
This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual
Report 2022 which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair
value and the valuation control framework which governs oversight of valuations. There have been no changes in the
accounting policies adopted or the valuation methodologies used.
Valuation
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique
(fair value hierarchy) and balance sheet classification:
Valuation technique using
Quoted
market prices
Observable
inputs
Significant
unobservable
inputs
(Level 1) (Level 2) (Level 3) Total
As at 30.06.23 £m £m £m £m
Trading portfolio assets 87,003 72,032 6,799 165,834
Financial assets at fair value through the income statement 6,144 219,938 9,018 235,100
Derivative financial instruments 3,484 258,295 4,533 266,312
Financial assets at fair value through other comprehensive income 24,477 41,477 114 66,068
Investment property — — 2 2
Total assets 121,108 591,742 20,466 733,316
Trading portfolio liabilities (37,451) (33,477) (52) (70,980)
Financial liabilities designated at fair value (115) (313,439) (1,100) (314,654)
Derivative financial instruments (4,064) (245,517) (5,268) (254,849)
Total liabilities (41,630) (592,433) (6,420) (640,483)
As at 31.12.22
Trading portfolio assets 62,478 64,855 6,480 133,813
Financial assets at fair value through the income statement 5,720 198,723 9,125 213,568
Derivative financial instruments 10,054 287,152 5,174 302,380
Financial assets at fair value through other comprehensive income 20,704 44,347 11 65,062
Investment property — — 5 5
Total assets 98,956 595,077 20,795 714,828
Trading portfolio liabilities (44,128) (28,740) (56) (72,924)
Financial liabilities designated at fair value (133) (270,454) (1,050) (271,637)
Derivative financial instruments (10,823) (272,434) (6,363) (289,620)
Total liabilities (55,084) (571,628) (7,469) (634,181)
Financial Statement Notes
Barclays PLC 74
-- 76 of 98 --
The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type:
As at 30.06.23 As at 31.12.22
Assets Liabilities Assets Liabilities
£m £m £m £m
Interest rate derivatives 2,523 (2,043) 2,362 (2,858)
Foreign exchange derivatives 182 (177) 1,513 (1,474)
Credit derivatives 342 (694) 290 (603)
Equity derivatives 1,488 (2,356) 1,009 (1,428)
Corporate debt 1,769 (35) 1,677 (49)
Reverse repurchase and repurchase agreements 44 (643) 37 (434)
Non-asset backed loans 9,631 — 9,949 —
Private equity investments 1,280 (8) 1,291 (8)
Other1 3,207 (464) 2,667 (615)
Total 20,466 (6,420) 20,795 (7,469)
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, asset backed securities, equity cash products, issued debt,
commercial paper, Government and government sponsored debt and investment property.
Assets and liabilities reclassified between Level 1 and Level 2
During the period, there were no material transfers between Level 1 and Level 2 (period ended 31 December 2022: no
material transfers between Level 1 and Level 2).
Level 3 movement analysis
The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table
shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to
and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period.
Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market
activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as
Level 3 if an unobservable input is deemed significant.
Financial Statement Notes
Barclays PLC 75
-- 77 of 98 --
Level 3 movement analysis
Total gains and (losses)
in the period recognised
in the income statement
Total gains
or (losses)
recognised
in OCI
Transfers
As at
01.01.23 Purchases Sales Issues
Settle-
ments
Trading
income
Other
income In Out
As at
30.06.23
£m £m £m £m £m £m £m £m £m £m £m
Corporate debt 597 336 (118) — (53) 5 — — 36 (29) 774
Non-asset backed loans 4,837 919 (1,152) — (311) 4 — — 556 (334) 4,519
Other 1,046 1,030 (606) — (38) (43) — — 430 (313) 1,506
Trading portfolio assets 6,480 2,285 (1,876) — (402) (34) — — 1,022 (676) 6,799
Corporate debt 1,079 — (120) — — (20) (3) — — — 936
Non-asset backed loans 5,112 1,051 (305) — (641) (46) (42) — 50 (114) 5,065
Private equity investments 1,284 50 (22) — (3) (50) 14 — 2 — 1,275
Reverse repurchase and
repurchase agreements 38 — — — — (11) — — 46 (29) 44
Other 1,612 796 (530) — (151) (26) (9) — 22 (16) 1,698
Financial assets at fair value
through the income statement 9,125 1,897 (977) — (795) (153) (40) — 120 (159) 9,018
Corporate debt — 13 — — — — — — 46 — 59
Non-asset backed loans — 47 — — — — — — — — 47
Private equity investments 7 — — — — — — (2) — — 5
Other 4 — — — (1) — — — — — 3
Assets at fair value through
other comprehensive income 11 60 — — (1) — — (2) 46 — 114
Investment property 5 — — — — — (3) — — — 2
Trading portfolio liabilities (56) (16) 4 — — 15 — — (8) 9 (52)
Financial liabilities designated
at fair value (1,050) — — (226) — 4 (1) — (290) 463 (1,100)
Interest rate derivatives (496) 2 — — 19 (35) — — 544 446 480
Foreign exchange derivatives 39 — — — — (31) — — 12 (15) 5
Credit derivatives (313) (191) 5 — 66 13 — — 52 16 (352)
Equity derivatives (419) (90) — — (132) (135) — — (104) 12 (868)
Net derivative financial
instruments1 (1,189) (279) 5 — (47) (188) — — 504 459 (735)
Total 13,326 3,947 (2,844) (226) (1,245) (356) (44) (2) 1,394 96 14,046
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £4,533m and derivative financial liabilities
were £5,268m.
Financial Statement Notes
Barclays PLC 76
-- 78 of 98 --
Level 3 movement analysis
As at
01.01.22 Purchases Sales Issues
Settle-
ments
Total gains and (losses)
in the period recognised
in the income statement
Total gains
or (losses)
recognised
in OCI
Transfers
As at
30.06.22
Trading
income
Other
income In Out
£m £m £m £m £m £m £m £m £m £m £m
Corporate debt 389 90 (144) — (17) 54 — — 43 (11) 404
Non-asset backed loans 758 2,448 (459) — — 11 — — 50 (113) 2,695
Other 1,134 419 (178) — (302) 60 — — 191 (167) 1,157
Trading portfolio assets 2,281 2,957 (781) — (319) 125 — — 284 (291) 4,256
Corporate debt 816 45 — — (148) 55 — — — — 768
Non-asset backed loans 5,647 1,847 (757) — (484) (334) — — 52 (9) 5,962
Private equity investments 1,095 99 (16) — (1) 84 (26) — 59 (4) 1,290
Reverse repurchase and
repurchase agreements 13 66 — — (12) 16 — — 95 — 178
Other 2,141 4,706 (5,579) — 4 (57) 184 — 4 (19) 1,384
Financial assets at fair value
through the income statement 9,712 6,763 (6,352) — (641) (236) 158 — 210 (32) 9,582
Non-asset backed loans — — — — — — — 1 6 — 7
Asset backed securities 38 — — — — — — (2) — — 36
Assets at fair value through
other comprehensive income 38 — — — — — — (1) 6 — 43
Investment property 7 — (1) — — — (1) — — — 5
Trading portfolio liabilities (27) (35) 3 — — (29) — — — 6 (82)
Financial liabilities designated at
fair value (410) (5) — (13) 47 (22) — — (81) 37 (447)
Interest rate derivatives (260) 25 — — (4) (305) (9) — 271 6 (276)
Foreign exchange derivatives 2 — — — (9) 273 — — (65) 25 226
Credit derivatives (386) (36) 5 — 60 (99) — — 20 55 (381)
Equity derivatives (1,405) (83) — — 171 980 (1) — (9) 272 (75)
Net derivative financial
instruments1 (2,049) (94) 5 — 218 849 (10) — 217 358 (506)
Total 9,552 9,586 (7,126) (13) (695) 687 147 (1) 636 78 12,851
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,873m and derivative financial liabilities
were £4,379m.
Financial Statement Notes
Barclays PLC 77
-- 79 of 98 --
Unrealised gains and losses on Level 3 financial assets and liabilities
The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and
liabilities held at the period end.
Half year ended 30.06.23 Half year ended 30.06.22
Income statement Other
compre
hensive
income Total
Income statement Other
compre
hensive
income Total
Trading
income
Other
income
Trading
income
Other
income
£m £m £m £m £m £m £m £m
Trading portfolio assets (35) — — (35) 121 — — 121
Financial assets at fair value
through the income statement (144) (40) — (184) (165) (22) — (187)
Financial assets at fair value
through other comprehensive
income — — (2) (2) — — (1) (1)
Investment properties — (3) — (3) — (1) — (1)
Trading portfolio liabilities 15 — — 15 (35) — — (35)
Financial liabilities designated at
fair value 2 (1) — 1 (14) — — (14)
Net derivative financial
instruments (186) — — (186) 862 (1) — 861
Total (348) (44) (2) (394) 769 (24) (1) 744
Valuation techniques and sensitivity analysis
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably
possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques
used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative
models.
Sensitivities are dynamically calculated on a monthly basis. The calculation is based on range or spread data of a reliable
reference source or a scenario based on relevant market analysis alongside the impact of using alternative models.
Sensitivities are calculated without reflecting the impact of any diversification in the portfolio.
Current year valuation and sensitivity methodologies are consistent with those described within Note 17, Fair value of
financial instruments in the Barclays PLC Annual Report 2022.
Sensitivity analysis of valuations using unobservable inputs
As at 30.06.23 As at 31.12.22
Favourable changes Unfavourable changes Favourable changes Unfavourable changes
Income
statement Equity
Income
statement Equity
Income
statement Equity
Income
statement Equity
£m £m £m £m £m £m £m £m
Interest rate derivatives 123 — (186) — 119 — (155) —
Foreign exchange derivatives 11 — (17) — 16 — (22) —
Credit derivatives 26 — (79) — 79 — (71) —
Equity derivatives 186 — (264) — 161 — (168) —
Corporate debt 23 — (22) — 45 — (27) —
Non-asset backed loans 360 1 (590) (1) 316 — (521) —
Private equity investments 240 1 (239) (1) 268 1 (281) (1)
Other1 126 — (124) — 71 — (82) —
Total 1,095 2 (1,521) (2) 1,075 1 (1,327) (1)
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, asset backed securities, equity cash products, issued debt,
commercial paper, Government and government sponsored debt and investment property.
Financial Statement Notes
Barclays PLC 78
-- 80 of 98 --
The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact
of using alternative models, would be to increase fair values by up to £1,097m (December 2022: £1,076m) or to decrease
fair values by up to £1,523m (December 2022: £1,328m) with substantially all the potential effect impacting profit and loss
rather than reserves.
Significant unobservable inputs
The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified
as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2022.
Fair value adjustments
Key balance sheet valuation adjustments are quantified below:
As at
30.06.23
As at
31.12.22
£m £m
Exit price adjustments derived from market bid-offer spreads (554) (577)
Uncollateralised derivative funding (24) (11)
Derivative credit valuation adjustments (241) (319)
Derivative debit valuation adjustments 196 208
• Exit price adjustments derived from market bid-offer spreads decreased by £23m to £554m
• Uncollateralised derivative funding increased by £13m to £24m
• Derivative credit valuation adjustments decreased by £78m to £241m as a result of tightening input counterparty credit
spreads
• Derivative debit valuation adjustments decreased by £12m to £196m
Portfolio exemption
The Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial
assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an
asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an
orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the
Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would
price the net risk exposure at the measurement date.
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair
value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been
used on initial recognition, less amounts subsequently recognised, is £197m (December 2022: £126m) for financial
instruments measured at fair value and £209m (December 2022: £216m) for financial instruments carried at amortised cost.
There are additions and FX gains of £107m (December 2022: £59m) and amortisation and releases of £36m (December
2022: £66m) for financial instruments measured at fair value and additions of £nil (December 2022: £nil) and amortisation
and releases of £7m (December 2022: £14m) for financial instruments carried at amortised cost.
Third party credit enhancements
Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal
Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks
pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the
IFRS 9 fair value option includes this third party credit enhancement. The on balance sheet value of these brokered
certificates of deposit amounted to £4,648m (December 2022: £5,197m).
Financial Statement Notes
Barclays PLC 79
-- 81 of 98 --
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost
are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report
2022.
The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s
balance sheet.
As at 30.06.23 As at 31.12.22
Carrying
amount Fair value
Carrying
amount Fair value
Financial assets £m £m £m £m
Debt securities at amortised cost 53,147 51,615 45,487 44,815
Loans and advances at amortised cost 348,258 341,484 353,292 346,846
Reverse repurchase agreements and other similar secured lending 2,600 2,600 776 776
Financial liabilities
Deposits at amortised cost (554,666) (554,536) (545,782) (545,738)
Repurchase agreements and other similar secured borrowing (41,213) (41,211) (27,052) (27,054)
Debt securities in issue (105,018) (105,546) (112,881) (113,276)
Subordinated liabilities (11,019) (11,001) (11,423) (11,474)
10. Goodwill and intangible assets
The Group performed an impairment review to assess the recoverability of its goodwill and intangible asset balances as at 31
December 2022. The outcome of this review is disclosed on pages 473-476 of the Barclays PLC Annual Report 2022. No
impairment was recognised as a result of the review as value in use exceeded carrying amount. The increased goodwill in the
period is primarily a result of the Kensington Mortgage Company acquisition in March 2023. A review of the Group's
goodwill and intangible assets as at 30 June 2023 did not identify any factors indicating impairment.
In May 2023, Barclays Bank UK PLC sold the entire issued share capital of Barclays Asset Management Limited and Barclays
Investment Solutions Limited along with certain other assets and liabilities, business guarantees and business contracts
(together with the transfer of associated employees of Barclays Bank UK PLC) to Barclays Bank PLC. As a result of this
transfer, Intangible assets of approximately £0.2bn held within Barclays Execution Services Limited has been allocated from
Personal Banking to Private Banking.
11. Subordinated liabilities
Half year
ended
30.06.23
Year ended
31.12.22
£m £m
Opening balance as at 1 January 11,423 12,759
Issuances 1,317 1,477
Redemptions (1,362) (2,679)
Other (359) (134)
Closing balance 11,019 11,423
Issuances of £1,317m comprise £1,180m USD 7.119% Fixed-to-Floating Rate Subordinated Callable Notes issued externally
by Barclays PLC and £137m USD Floating Rate Notes issued externally by a Barclays subsidiary.
Redemptions of £1,362m comprise £1,345m EUR 2% Fixed Rate Subordinated Notes issued externally by Barclays PLC and
£17m USD Floating Rate Notes issued externally by a Barclays subsidiary.
Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments. In addition, it
also includes a UT2 instrument (£99m) which was previously equity accounted and has now been reclassified to Dated
Subordinated Liabilities, on the basis of an irrevocable notice of redemption being issued in June 2023.
Financial Statement Notes
Barclays PLC 80
-- 82 of 98 --
12. Provisions
As at
30.06.23 As at
31.12.22
£m £m
Customer redress 349 378
Legal, competition and regulatory matters 105 159
Redundancy and restructuring 121 136
Undrawn contractually committed facilities and guarantees 549 583
Sundry provisions 300 288
Total 1,424 1,544
13. Retirement benefits
As at 30 June 2023, the Group’s IAS 19 net pension surplus across all schemes was £3.9bn (December 2022: £4.5bn). The
UK Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 net pension surplus of £4.1bn (December
2022: £4.7bn). The movement for the UKRF was mainly driven by: actual price inflation being higher than assumed, future
long-term price inflation expected to be higher than assumed at the start of the year, assets underperforming relative to the
discount rate, partially offset by an increase in discount rate.
UKRF funding valuations
The latest triennial actuarial valuation of the UKRF with an effective date of 30 September 2022 was completed in February
2023. The valuation showed a funding surplus of £2bn (2021 update: £0.6bn surplus).
As the UKRF had a funding surplus at the valuation date, the 2023 deficit reduction contribution (£286m), agreed as part of
the 2019 triennial actuarial valuation, is no longer required, and no recovery plan is needed.
14. Other reserves
As at
30.06.23
As at
31.12.22
£m £m
Currency translation reserve 3,599 4,772
Fair value through other comprehensive income reserve (1,485) (1,560)
Cash flow hedging reserve (7,990) (7,235)
Own credit reserve (27) 467
Other reserves and treasury shares 1,446 1,364
Total (4,457) (2,192)
Currency translation reserve
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net
investment in foreign operations, net of the effects of hedging.
As at 30 June 2023, there was a cumulative gain of £3,599m (December 2022: £4,772m gain) in the currency translation
reserve, a loss during the period of £1,173m. This principally reflects the strengthening of GBP against USD and EUR during
the period.
Fair value through other comprehensive income reserve
The fair value through other comprehensive income reserve represents the total of unrealised gains and losses on fair value
through other comprehensive income investments since initial recognition.
As at 30 June 2023, there was a cumulative loss of £1,485m (December 2022: £1,560m loss) in the reserve, a gain during the
period of £75m. This is principally driven by a gain of £131m from the increase in fair value of bonds (net of hedges) due to
decreasing bond yields which was partially offset by a net gain of £25m transferred to the income statement and a tax
charge of £31m.
Cash flow hedging reserve
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that
will be recycled to the income statement when the hedged transactions affect profit or loss.
As at 30 June 2023, there was a cumulative loss of £7,990m (December 2022: £7,235m loss) in the cash flow hedging
reserve, a loss during the period of £755m. This principally reflects a £1,793m loss from the fair value movement of interest
rate swaps held for hedging purposes as major interest rate forward curves increased offset by £741m of losses transferred
to the income statement and a tax credit of £297m.
Financial Statement Notes
Barclays PLC 81
-- 83 of 98 --
Own credit reserve
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the
own credit reserve are not recycled to profit or loss in future periods.
As at 30 June 2023, there was a cumulative loss of £27m (December 2022: £467m gain) in the own credit reserve, a loss of
£494m during the period. This principally reflects a £682m loss from tightening of credit spreads partially offset by tax
credit of £188m.
Other reserves and treasury shares
Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays
PLC shares held principally in relation to the Group’s various share schemes.
As at 30 June 2023, there was a balance of £1,446m (December 2022: £1,364m gain). This principally reflects an increase of
£86m due to the repurchase of 343m shares as part of the share buybacks conducted in 2023 offset by a £4m movement in
the treasury shares balance held in relation to employee share schemes.
15. Contingent liabilities and commitments
As at
30.06.23
As at
31.12.22
Contingent liabilities and financial guarantees £m £m
Guarantees and letters of credit pledged as collateral security 18,720 17,760
Performance guarantees, acceptances and endorsements 6,777 6,445
Total 25,497 24,205
Commitments
Documentary credits and other short-term trade related transactions 1,356 1,748
Standby facilities, credit lines and other commitments 380,197 393,760
Total 381,553 395,508
Further details on contingent liabilities, where it is not practicable to disclose an estimate of the potential financial effect on
Barclays relating to legal and competition and regulatory matters can be found in Note 16.
16. Legal, competition and regulatory matters
The Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the
impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition
and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision,
or both, depending on the relevant facts and circumstances.
The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance
with the relevant accounting policies applicable to Note 12, Provisions. We have not disclosed an estimate of the potential
financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various matters
detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed, such
claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those matters.
Matters are ordered under headings corresponding to the financial statements in which they are disclosed.
1. Barclays PLC and Barclays Bank PLC
Investigations into certain advisory services agreements
FCA proceedings
In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The
Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays
PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the
announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Warning
Notices) finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing
rules, and that Barclays PLC was also in breach of Listing Principle 3. The financial penalty provided in the Warning Notices
was £50m. Barclays PLC and Barclays Bank PLC contested the findings. In September 2022, the FCA’s Regulatory Decisions
Committee (RDC) issued Decision Notices finding that Barclays PLC and Barclays Bank PLC breached certain disclosure-
related listing rules. The RDC also found that in relation to the disclosures made in the Capital Raising of November 2008,
Barclays PLC and Barclays Bank PLC acted recklessly, and that Barclays PLC breached Listing Principle 3. The RDC upheld the
combined penalty of £50m on Barclays PLC and Barclays Bank PLC, the same penalty as in the Warning Notices. Barclays
PLC and Barclays Bank PLC have referred the RDC’s findings to the Upper Tribunal for reconsideration.
Financial Statement Notes
Barclays PLC 82
-- 84 of 98 --
Investigations into LIBOR and other benchmarks and related civil actions
Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have
conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks,
such as LIBOR. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against
the Group and other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks.
USD LIBOR civil actions
The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial
purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and
allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions
individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange
Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the US Securities Exchange Act of 1934 and
various state laws by manipulating USD LIBOR rates.
Putative class actions and individual actions seek unspecified damages with the exception of one lawsuit, in which the
plaintiffs are seeking no less than $100m in actual damages and additional punitive damages against all defendants,
including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays
Bank PLC has previously settled certain claims. The financial impact of these settlements is not material to the Group’s
operating results, cash flows or financial position.
Sterling LIBOR civil actions
In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks
alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA
and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs have
appealed the dismissal.
Japanese Yen LIBOR civil actions
In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks
by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen
Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the
Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the
plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims.
In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against
Barclays PLC, Barclays Bank PLC and BCI. Barclays and the plaintiffs reached a settlement of $17.75m for both actions, which
received final court approval in March 2023. This matter is now concluded.
ICE LIBOR civil action
In August 2020, an action related to the LIBOR benchmark administered by the Intercontinental Exchange Inc. and certain of
its affiliates (ICE) was filed by a group of individual plaintiffs in the US District Court for the Northern District of California on
behalf of individual borrowers and consumers of loans and credit cards with variable interest rates linked to USD ICE LIBOR.
The plaintiffs’ motion seeking, among other things, preliminary and permanent injunctions to enjoin the defendants from
continuing to set LIBOR or enforce any financial instrument that relies in whole or in part on USD LIBOR was denied. The
defendants’ motion to dismiss the case was granted in September 2022. The plaintiffs have filed an amended complaint,
which the defendants have moved to dismiss.
Non-US benchmarks civil actions
There remains one claim, issued in 2017, against Barclays Bank PLC and other banks in the UK in connection with alleged
manipulation of LIBOR. Proceedings have also been brought in a number of other jurisdictions in Europe, Argentina and
Israel relating to alleged manipulation of LIBOR and EURIBOR. Additional proceedings in other jurisdictions may be brought
in the future.
Credit Default Swap civil action
A putative antitrust class action is pending in New Mexico federal court against Barclays Bank PLC, BCI and various other
financial institutions. The plaintiffs, the New Mexico State Investment Council and certain New Mexico pension funds, allege
that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at
settlement (i.e. the CDS final auction price). The plaintiffs allege violations of US antitrust laws and the CEA, and unjust
enrichment under state law. The defendants’ motion to dismiss was denied in June 2023.
Financial Statement Notes
Barclays PLC 83
-- 85 of 98 --
Foreign Exchange investigations and related civil actions
The Group has been the subject of investigations in various jurisdictions in relation to certain sales and trading practices in
the Foreign Exchange market. Settlements were reached in various jurisdictions in connection with these investigations,
including the EU and US. The financial impact of any remaining ongoing investigations is not expected to be material to the
Group’s operating results, cash flows or financial position. Various individuals and corporates in a range of jurisdictions have
threatened or brought civil actions against the Group and other banks in relation to alleged manipulation of Foreign
Exchange markets.
US FX opt out civil action
In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign
Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs, who opted out
of the Consolidated FX Action, filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other
defendants. Some of the plaintiffs’ claims were dismissed in 2020. Barclays PLC, Barclays Bank PLC, and BCI have reached a
settlement of all claims against them in the matter. A settlement payment was made in April 2023 and the matter is now
concluded. The financial impact of this settlement is not material to the Group’s operating results, cash flows or financial
position.
US retail basis civil action
In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a
proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY
has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court
subsequently dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs filed an amended
complaint. The defendants’ motion for summary judgment was granted in March 2023, dismissing the plaintiffs’ remaining
claims. The plaintiffs are appealing the decision.
Non-US FX civil actions
Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution
Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of other jurisdictions
in Europe, Israel, Brazil and Australia. Additional proceedings may be brought in the future.
The above-mentioned proceedings include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX,
BCI and other financial institutions in the UK Competition Appeal Tribunal (CAT) in 2019. The CAT refused to certify these
claims in the first quarter of 2022. In July 2023, the Court of Appeal overturned the CAT’s decision and found that the claims
should be certified on an opt out basis. The Court of Appeal upheld the CAT’s determination as to which of the two
purported class representatives should be chosen to bring the claim. Subject to any further appeal, only the claim brought by
the chosen class representative will now proceed in the CAT. Also in 2019, a separate claim was filed in the UK in the High
Court of Justice (High Court), and subsequently transferred to the CAT, by various banks and asset management firms
against Barclays Bank PLC and other financial institutions alleging breaches of European and UK competition laws related to
FX trading. This claim has been settled as part of the settlement payment referred to under the US FX opt out civil action
above and the matter is now concluded.
Metals-related civil actions
A US civil complaint alleging manipulation of the price of silver in violation of the CEA, the Antitrust Act and state antitrust
and consumer protection laws was brought by a proposed class of plaintiffs against a number of banks, including Barclays
Bank PLC, BCI and BX, and transferred to the SDNY. The complaint was dismissed against these Barclays entities and certain
other defendants in 2018, and against the remaining defendants in May 2023. The plaintiffs have appealed the dismissal of
the complaint against all defendants.
Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc.
and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices.
US residential mortgage related civil actions
There are two US Residential Mortgage-Backed Securities (RMBS) related civil actions arising from unresolved repurchase
requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and warranties
(R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007. In one action, the parties have agreed to settle the
litigation. The financial impact of the settlement is not material to the Group’s operating results, cash flows or financial
position. The other repurchase action is pending.
Financial Statement Notes
Barclays PLC 84
-- 86 of 98 --
Government and agency securities civil actions
Treasury auction securities civil actions
Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial
institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US
Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to
boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs filed an amended
complaint. The defendants’ motion to dismiss the amended complaint was granted in March 2022. The plaintiffs are
appealing this decision.
In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that
defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and
state common law. This action remains stayed.
Supranational, Sovereign and Agency bonds civil actions
Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI,
BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc.
and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for
US dollar-denominated Supranational, Sovereign and Agency bonds. The SDNY actions were dismissed and these matters
are now concluded.
In the Federal Court of Canada action, the parties have reached a settlement in principle, which will require court approval.
The financial impact of the settlement is not expected to be material to the Group’s operating results, cash flows or financial
position.
Variable Rate Demand Obligations civil actions
Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants
conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are
municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have
been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints have
been consolidated in the SDNY. In the consolidated SDNY class action, certain of the plaintiffs’ claims were dismissed in
November 2020 and June 2022 and the plaintiffs’ motion for class certification is pending. In the California action, the
California appeals court reversed the dismissal of the plaintiffs’ claims in April 2023. In the Illinois action, the defendants
have reached a settlement in principle with the Attorney General for the State of Illinois to resolve the litigation, which is
subject to approval by the court. The financial impact of the settlement is not material to the Group’s operating results, cash
flows or financial position.
Odd-lot corporate bonds antitrust class action
In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint
alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. The plaintiffs demand
unspecified money damages. The defendants’ motion to dismiss was granted in 2021 and the plaintiffs have appealed the
dismissal.
Interest rate swap and credit default swap US civil actions
Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate
swaps (IRS), are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The
complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand unspecified
money damages.
In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays
PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In
2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases
also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018 and 2019, respectively, the
court dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss
the federal and state antitrust claims, which remain pending.
BDC Finance L.L.C.
In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court),
demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of
total return swaps governed by an ISDA Master Agreement (the Master Agreement). Following a trial, the court ruled in
2018 that Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered
judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs. BDC appealed. In
January 2022, the appellate court reversed the trial court’s summary judgment decision in favour of Barclays Bank PLC and
Financial Statement Notes
Barclays PLC 85
-- 87 of 98 --
remanded the case to the lower court for further proceedings. The parties have filed cross-motions on the scope of trial. The
trial has been adjourned pending a decision on the motions and any subsequent appeal.
In 2011, BDC’s investment advisor, BDCM Fund Adviser, LLC and its parent company, Black Diamond Capital Holdings, LLC,
also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays
Bank PLC’s conduct relating to the Master Agreement, asserting claims for violation of the Connecticut Unfair Trade
Practices Act and tortious interference with business and prospective business relations. This case is currently stayed.
Civil actions in respect of the US Anti-Terrorism Act
There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court
in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The
complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-
denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism that
injured or killed the plaintiffs or the plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and
mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages.
The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. The plaintiffs appealed in one
action and the dismissal was affirmed, and judgment was entered, in January 2023. The court later gave the plaintiffs until
December 2023 to make a motion to vacate the judgment. The plaintiffs have also petitioned for US Supreme Court review.
In the other two dismissed actions in the EDNY, the court gave plaintiffs until September 2023 to serve amended complaints.
This was also the case for the fourth action in the EDNY. Those actions, as well as the two other actions in the EDNY, are
currently stayed. Out of the two actions in the SDNY, the court granted the defendants’ motion to dismiss the first action.
That action is stayed, and the second SDNY action is stayed pending any appeal on the dismissal of the first.
Shareholder derivative action
In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI
and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees
of the Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual
defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff
seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged
breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants moved to dismiss. The
motion to dismiss was granted in April 2022. The plaintiff appealed the decision, and the dismissal was unanimously
affirmed in June 2023 by the First Judicial Department in New York. The plaintiff has sought leave to appeal the First Judicial
Department’s decision to the New York Court of Appeals.
Derivative transactions civil action
In 2021, Vestia, a Dutch housing association, brought a claim against Barclays Bank PLC in the UK in the High Court in
relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2011, seeking damages
of £329m. Barclays Bank PLC is defending the claim and has made a counterclaim.
Skilled person review in relation to historic timeshare loans and associated matters
Clydesdale Financial Services Limited (CFS), which trades as Barclays Partner Finance and houses Barclays’ point-of-sale
finance business, was required by the FCA to undertake a skilled person review in 2020 following concerns about historic
affordability assessments for certain loans to customers in connection with timeshare purchases. The skilled person review
was concluded in 2021. CFS complied fully with the skilled person review requirements, including carrying out certain
remediation measures. CFS was not required to conduct a full back book review. Instead, CFS reviewed limited historic
lending to ascertain whether its practices caused customer harm and is remediating any examples of harm. This work is
expected to be substantially completed during 2023, utilising provisions booked to account for any remediations.
Over-issuance of securities in the US
In March 2022, executive management became aware that Barclays Bank PLC had issued securities materially in excess of
the set amount under its US shelf registration statements. As a result, Barclays Bank PLC commenced a rescission offer on 1
August 2022, by which Barclays Bank PLC offered to repurchase relevant affected securities from certain holders, which
expired on 12 September 2022. Further, in September 2022, the SEC announced the resolution of its investigation of
Barclays PLC and Barclays Bank PLC relating to such over-issuance of securities. The Group has engaged with, and
responded to inquiries and requests for information from, various other regulators who may seek to impose fines, penalties
and/or other sanctions as a result of this matter.
Furthermore, Barclays Bank PLC and/or its affiliates may incur costs and liabilities in relation to private civil claims which
have been filed and may face other potential private civil claims, class actions or other enforcement actions in relation to the
over-issuance of securities. By way of example, in September 2022, a purported class action claim was filed in the US District
Court in Manhattan seeking to hold Barclays PLC, Barclays Bank PLC and former and current executives responsible for
declines in the prices of Barclays PLC’s American depositary receipts, which the plaintiffs claim occurred as a result of alleged
misstatements and omissions in its public disclosures. The defendants have moved to dismiss the case. In addition, holders
Financial Statement Notes
Barclays PLC 86
-- 88 of 98 --
of a series of ETNs have brought claims against Barclays PLC, Barclays Bank PLC, and former and current executives and
board members in the US alleging, among other things, that Barclays’ failure to disclose that these ETNs were unregistered
securities misled investors and that, as a result, Barclays is liable for the holders’ alleged losses following the suspension of
further sales and issuances of such series of ETNs. Two such actions are purported class actions that the plaintiffs have
moved to consolidate into a single action in federal court in New York.
A contingent liability exists in relation to civil claims or any further enforcement actions taken against Barclays Bank PLC
and/or its affiliates, but Barclays Bank PLC is unable to assess the likelihood of liabilities that may arise out of such claims or
actions.
Any liabilities, claims or actions in connection with the over-issuance of securities under Barclays Bank PLC’s US shelf
registration statements could have an adverse effect on the Group’s business, financial condition, results of operations and
reputation as a frequent issuer in the securities markets.
2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax
In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK
from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have
retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to
attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has
been appealed to the First Tier Tribunal (Tax Chamber).
FCA investigation into transaction monitoring
The FCA has been investigating Barclays’ compliance with UK money laundering regulations and the FCA’s rules and
Principles for Businesses in an investigation which is focussed on aspects of Barclays’ transaction monitoring in relation to
certain business lines now in Barclays Bank UK PLC. Barclays has been co-operating with the investigation and responding to
information requests.
3. Barclays PLC
Alternative trading systems
In 2020, a claim was brought against Barclays PLC in the UK in the High Court by various shareholders regarding Barclays
PLC’s share price based on the allegations contained within a complaint by the New York State Attorney General (NYAG) in
2014. Such claim was settled in 2016, as previously disclosed. The more recent claim seeks unquantified damages and
Barclays is defending the claim. The NYAG complaint was filed against Barclays PLC and BCI in the NY Supreme Court
alleging, among other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX,
BCI’s SEC-registered alternative trading system.
General
The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other
overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course
of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection,
consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property, money
laundering, financial crime, employment, environmental and other statutory and common law issues.
The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other
proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer
protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and
business activities in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and
keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an
ongoing basis.
At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material
adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the
matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters
(including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s
results, operations or cash flows for a particular period, depending on, among other things, the amount of the loss resulting
from the matter(s) and the amount of profit otherwise reported for the reporting period.
Financial Statement Notes
Barclays PLC 87
-- 89 of 98 --
17. Related party transactions
Related party transactions in the half year ended 30 June 2023 were similar in nature to those disclosed in the Barclays PLC
Annual Report 2022. No related party transactions that have taken place in the half year ended 30 June 2023 have materially
affected the financial position or the performance of the Group during this period.
On 1 May 2023, the Wealth Management & Investments business was transferred from Barclays UK to CC&P, please see
Other matters on page 7 for more information.
18. Interest rate benchmark reform
Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR became a priority for
global regulators. The FCA and other global regulators instructed market participants to prepare for the cessation of most
LIBOR rates after the end of 2021, and to adopt “Risk Free Rates” (RFRs).
Barclays established a Group-wide LIBOR Transition Programme, which aims to drive strategic execution and identify,
manage and resolve keys risks and issues as they arise.
Whilst EUR and CHF LIBOR ceased to be published after 31 December 2021, a synthetic version of GBP and JPY LIBOR was
made available for certain tenors for a limited period of time to mitigate the risk of widespread disruption to legacy contracts
which had not transitioned by end-2021.
• Synthetic JPY LIBOR tenors ceased permanently at the end of 2022 in line with an announcement made by the FCA on 29
September 2022.
• 1- and 6-month synthetic GBP LIBOR tenors ceased permanently after 31 March 2023 in line with the announcement
made by the FCA on 29 September 2022.
• 3-month synthetic GBP LIBOR remains available until 31 March 2024 as per an announcement made by the FCA on 23
November 2022.
In addition, GBP LIBOR ICE Swap Rate and JPY LIBOR Tokyo Swap Rate ceased to be published at the end of 2021.
All of the Group’s exposure to JPY LIBOR and JPY LIBOR Tokyo Swap Rate and to 1- and 6-month GBP LIBOR have now been
remediated with only residual exposure remaining to 3-month synthetic GBP LIBOR and GBP LIBOR ICE Swap Rate.
For USD LIBOR, certain actively used tenors continued to be published after 2021. However, in line with the US banking
regulators’ joint statement, the Group ceased issuing or entering into new contracts that use USD LIBOR as a reference rate
from 31 December 2021, other than in relation to those allowable use cases set out under the FCA’s prohibition notice (ref
21A). The overnight and 12-month USD LIBOR tenors ceased to be published after 30 June 2023, with synthetic versions of
the 1-, 3- and 6-month USD LIBOR tenors made available for a limited period of time until 30 September 2024. The synthetic
versions are for use in legacy contracts only, to help ensure an orderly wind-down of USD LIBOR, as outlined in a statement
made by the FCA on 3 April 2023.
In addition, the USD LIBOR ICE Swap Rate ceased to be published at the end of June 2023.
During H123, the Barclays Group-wide LIBOR Transition Programme focused on the remediation of its exposure to the
benchmarks which ceased at the end of June 2023 . The majority of the Group’s exposure to those rates is now considered
remediated contractually via central clearing counterparties (CCP) led conversions for cleared derivatives and actively
negotiated conversion or insertion of fallbacks to RFRs for other products. In addition to this, whilst active transition and
fallback insertion were attempted in most cases, there were also exposures under certain US law governed contracts which
were transitioned pursuant to the US Federal Legislation (the Adjustable Interest Rate (LIBOR) Act) at the end of June 2023.
The Group continues to (i) identify, manage and mitigate key risks and issues as they arise, (ii) work with clients and
counterparties to remediate any trades which remain on synthetic LIBOR or on the GBP or USD LIBOR ICE Swap Rate and (iii)
remain on track to meet the associated industry deadlines.
Financial Statement Notes
Barclays PLC 88
-- 90 of 98 --
The Group’s management believes that the non-IFRS performance measures included in this document provide valuable
information to the readers of the financial statements as they enable the reader to identify a more consistent basis for
comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of
performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of
the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is
monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should
consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure Definition
Loan: deposit ratio Total loans and advances at amortised cost divided by total deposits at amortised cost. The
components of the calculation have been included on the page 51.
Period end allocated tangible equity Allocated tangible equity is calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted
for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the
Group uses for capital planning purposes. Head Office allocated tangible equity represents the
difference between the Group’s tangible shareholders’ equity and the amounts allocated to
businesses.
Average tangible shareholders’
equity
Calculated as the average of the previous month’s period end tangible equity and the current
month’s period end tangible equity. The average tangible shareholders’ equity for the period is the
average of the monthly averages within that period.
Average allocated tangible equity Calculated as the average of the previous month’s period end allocated tangible equity and the
current month’s period end allocated tangible equity. The average allocated tangible equity for the
period is the average of the monthly averages within that period.
Return on average tangible
shareholders’ equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average shareholders’ equity excluding non-controlling interests and other equity instruments
adjusted for the deduction of intangible assets and goodwill. The components of the calculation
have been included on pages 90 to 92.
Return on average allocated tangible
equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average allocated tangible equity. The components of the calculation have been included on pages
90 to 93.
Operating expenses excluding
litigation and conduct
A measure of total operating expenses excluding litigation and conduct charges.
Operating costs A measure of total operating expenses excluding litigation and conduct charges and UK bank levy.
Cost: income ratio Total operating expenses divided by total income.
Loan loss rate Quoted in basis points and represents total impairment charges divided by total gross loans and
advances held at amortised cost at the balance sheet date. The components of the calculation have
been included on page 26.
Net interest margin Annualised net interest income divided by the sum of average customer assets. The components of
the calculation have been included on page 24.
Tangible net asset value per share Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity
instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The
components of the calculation have been included on page 94.
Performance measures excluding
the impact of the Over-issuance of
Securities
Calculated by excluding the impact of the Over-issuance of Securities from performance measures.
The components of the calculations have been included on page 94.
Profit before impairment Calculated by excluding credit impairment charges or releases from profit before tax.
Appendix: Non-IFRS Performance Measures
Barclays PLC 89
-- 91 of 98 --
Returns
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a
proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible
equity has been calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding
goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average
allocated tangible equity represents the difference between the Group’s average tangible shareholders’ equity and the
amounts allocated to businesses.
Profit/(loss)
attributable to
ordinary
equity
holders of the
parent
Average
tangible
equity
Return on
average
tangible
equity
Half year ended 30.06.23 £m £bn %
Barclays UK 1,049 10.3 20.4
Corporate and Investment Bank 2,007 31.8 12.6
Consumer, Cards and Payments 294 5.3 11.1
Barclays International 2,301 37.1 12.4
Head Office (239) (0.2) n/m
Barclays Group 3,111 47.2 13.2
Half year ended 30.06.22
Barclays UK 854 10.0 17.0
Corporate and Investment Bank 1,895 31.8 11.9
Consumer, Cards and Payments 188 4.4 8.5
Barclays International 2,083 36.2 11.5
Head Office (462) 2.7 n/m
Barclays Group 2,475 48.9 10.1
Appendix: Non-IFRS Performance Measures
Barclays PLC 90
-- 92 of 98 --
Half year ended 30.06.23
Barclays UK
Corporate
and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Return on average tangible
shareholders' equity £m £m £m £m £m £m
Attributable profit/(loss) 1,049 2,007 294 2,301 (239) 3,111
£bn £bn £bn £bn £bn £bn
Average shareholders' equity 14.0 31.8 6.2 38.0 3.6 55.6
Average goodwill and intangibles (3.7) — (0.9) (0.9) (3.8) (8.4)
Average tangible shareholders' equity 10.3 31.8 5.3 37.1 (0.2) 47.2
Return on average tangible
shareholders' equity 20.4% 12.6% 11.1% 12.4% n/m 13.2%
Half year ended 30.06.22
Barclays UK
Corporate
and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Return on average tangible
shareholders' equity £m £m £m £m £m £m
Attributable profit/(loss) 854 1,895 188 2,083 (462) 2,475
£bn £bn £bn £bn £bn £bn
Average shareholders' equity 13.6 31.8 5.3 37.1 6.3 57.0
Average goodwill and intangibles (3.6) — (0.9) (0.9) (3.6) (8.1)
Average tangible shareholders' equity 10.0 31.8 4.4 36.2 2.7 48.9
Return on average tangible
shareholders' equity 17.0% 11.9% 8.5% 11.5% n/m 10.1%
Appendix: Non-IFRS Performance Measures
Barclays PLC 91
-- 93 of 98 --
Barclays Group
Return on average tangible shareholders'
equity
Q223 Q123 Q422 Q322 Q222 Q122 Q4211 Q3211
£m £m £m £m £m £m £m £m
Attributable profit 1,328 1,783 1,036 1,512 1,071 1,404 1,079 1,374
£bn £bn £bn £bn £bn £bn £bn £bn
Average shareholders' equity 55.4 55.9 54.9 56.8 57.1 56.9 56.1 56.5
Average goodwill and intangibles (8.7) (8.3) (8.2) (8.2) (8.1) (8.1) (8.1) (8.2)
Average tangible shareholders' equity 46.7 47.6 46.7 48.6 49.0 48.8 48.0 48.3
Return on average tangible shareholders'
equity 11.4% 15.0% 8.9% 12.5% 8.7% 11.5% 9.0% 11.4%
Barclays UK
Return on average allocated tangible
equity
Q223 Q123 Q422 Q322 Q222 Q122 Q421 Q321
£m £m £m £m £m £m £m £m
Attributable profit 534 515 474 549 458 396 420 317
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 14.2 13.9 13.7 13.5 13.6 13.7 13.6 13.6
Average goodwill and intangibles (4.0) (3.6) (3.5) (3.6) (3.6) (3.6) (3.6) (3.6)
Average allocated tangible equity 10.2 10.3 10.2 9.9 10.0 10.1 10.0 10.0
Return on average allocated tangible
equity 20.9% 20.0% 18.7% 22.1% 18.4% 15.6% 16.8% 12.7%
1 The comparative capital and financial metrics relating to Q321 and Q421 have been restated to reflect the impact of the Over-issuance of Securities.
Appendix: Non-IFRS Performance Measures
Barclays PLC 92
-- 94 of 98 --
Barclays International
Return on average allocated tangible
equity
Q223 Q123 Q422 Q322 Q222 Q122 Q4211 Q3211
£m £m £m £m £m £m £m £m
Attributable profit 953 1,348 625 1,136 783 1,300 818 1,191
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 38.0 38.1 39.9 40.1 38.2 36.0 33.8 32.7
Average goodwill and intangibles (0.9) (1.0) (1.0) (1.0) (0.9) (0.9) (0.9) (0.9)
Average allocated tangible equity 37.1 37.1 38.9 39.1 37.3 35.1 32.9 31.8
Return on average allocated tangible
equity 10.3% 14.5% 6.4% 11.6% 8.4% 14.8% 9.9% 14.9%
Corporate and Investment Bank
Return on average allocated tangible
equity
Q223 Q123 Q422 Q322 Q222 Q122 Q4211 Q3211
£m £m £m £m £m £m £m £m
Attributable profit 798 1,209 454 1,015 579 1,316 695 1,085
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 31.8 31.8 33.7 34.0 32.7 30.8 28.7 27.8
Average goodwill and intangibles — — — — — — — —
Average allocated tangible equity 31.8 31.8 33.7 34.0 32.7 30.8 28.7 27.8
Return on average allocated tangible
equity 10.0% 15.2% 5.4% 11.9% 7.1% 17.1% 9.7% 15.6%
Consumer, Cards and Payments
Return on average allocated tangible
equity
Q223 Q123 Q422 Q322 Q222 Q122 Q421 Q321
£m £m £m £m £m £m £m £m
Attributable profit/(loss) 155 139 171 121 204 (16) 123 106
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 6.2 6.3 6.2 6.1 5.5 5.2 5.1 4.9
Average goodwill and intangibles (0.9) (1.0) (1.0) (1.0) (0.9) (0.9) (0.9) (0.9)
Average allocated tangible equity 5.3 5.3 5.2 5.1 4.6 4.3 4.2 4.0
Return on average allocated tangible
equity 11.8% 10.5% 13.0% 9.5% 17.8% (1.5)% 11.7% 10.5%
1 The comparative capital and financial metrics relating to Q321 and Q421 have been restated to reflect the impact of the Over-issuance of Securities.
Appendix: Non-IFRS Performance Measures
Barclays PLC 93
-- 95 of 98 --
Tangible net asset value per share As at
30.06.23
As at
31.12.22
As at
30.06.22
£m £m £m
Total equity excluding non-controlling interests 67,669 68,292 69,627
Other equity instruments (13,759) (13,284) (12,357)
Goodwill and intangibles (8,607) (8,239) (8,245)
Tangible shareholders' equity attributable to ordinary shareholders of the parent 45,303 46,769 49,025
m m m
Shares in issue 15,556 15,871 16,531
p p p
Tangible net asset value per share 291 295 297
Performance measures excluding the impact of the Over-issuance of Securities
Barclays Group Q223 Q123 Q422 Q322 Q222 Q122 Q4211 Q3211
£m £m £m £m £m £m £m £m
Statutory attributable profit 1,328 1,783 1,036 1,512 1,071 1,404 1,079 1,374
Net impact of the Over-issuance of Securities — — — 29 (341) (240) (38) (72)
Attributable profit excluding the impact of the Over-
issuance of Securities 1,328 1,783 1,036 1,483 1,412 1,644 1,117 1,446
Average tangible shareholders' equity (£bn) 46.7 47.6 46.7 48.6 49.0 48.8 48.0 48.3
Return on average tangible shareholders' equity
excluding the impact of the Over-issuance of Securities 11.4% 15.0% 8.9% 12.2% 11.5% 13.5% 9.3% 12.0%
1 The comparative capital and financial metrics relating to Q321 and Q421 have been restated to reflect the impact of the Over-issuance of Securities.
Appendix: Non-IFRS Performance Measures
Barclays PLC 94
-- 96 of 98 --
Notable Items Half year ended 30.06.23 Half year ended 30.06.22
£m Profit before tax Attributable profit Profit before tax Attributable profit
Statutory 4,562 3,111 3,733 2,475
Net impact from the Over-issuance of Securities — — (711) (581)
Customer remediation costs on legacy loan portfolio — — (181) (147)
Settlements in principle in respect of industry-wide
devices investigations by SEC and CFTC — — (165) (165)
Other litigation and conduct (32) (21) (42) (37)
Re-measurement of UK DTAs — — — (346)
Excluding the impact of notable items 4,594 3,132 4,832 3,751
Three months ended 30.06.23 Three months ended 30.06.22
£m Profit before tax Attributable profit Profit before tax Attributable profit
Statutory 1,964 1,328 1,499 1,071
Net impact from the Over-issuance of Securities — — (391) (341)
Settlements in principle in respect of industry-wide
devices investigations by SEC and CFTC — — (165) (165)
Other litigation and conduct (33) (24) (20) (18)
Excluding the impact of notable items 1,997 1,352 2,075 1,595
The Group’s management believes that the non-IFRS performance measures excluding notable items, included in the table
above, provide valuable information to enable users of the financial statements to assess the performance of the Group. The
notable items are separately identified within the Group’s results disclosures which, when excluded from Barclays’ statutory
financials, provide an underlying profit and loss performance of the Group and enables consistent comparison of
performance from one period to another.
These non-IFRS performance measures excluding notable items are included as a reference point only and are not
incorporated within any of the key financial metrics used in our Group Targets, which are measured on a statutory basis.
Appendix: Non-IFRS Performance Measures
Barclays PLC 95
-- 97 of 98 --
Results timetable1 Date
Ex-dividend date 10 August 2023
Dividend record date 11 August 2023
Cut off time of 5:00pm (UK time) for the receipt of Dividend Re-
investment Programme (DRIP) Application Form Mandate
25 August 2023
Dividend payment date 15 September 2023
Q3 2023 Results Announcement 24 October 2023
For qualifying US and Canadian resident ADR holders, the half year dividend of 2.7p per ordinary share becomes 10.8p per ADS
(representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above.
DRIP participants will usually receive their additional ordinary shares (in lieu of a cash dividend) three to four days after the dividend
payment date.
Barclays PLC ordinary shares ISIN code: GB0031348658
% Change3
Exchange rates2 30.06.23 31.12.22 30.06.22 31.12.22 30.06.22
Period end - USD/GBP 1.27 1.21 1.22 5% 4%
6 month average - USD/GBP 1.23 1.18 1.30 4% (5)%
3 month average - USD/GBP 1.25 1.17 1.26 7% (1)%
Period end - EUR/GBP 1.16 1.13 1.16 3% —
6 month average - EUR/GBP 1.14 1.16 1.19 (2)% (4)%
3 month average - EUR/GBP 1.15 1.15 1.18 — (3)%
Share price data
Barclays PLC (p) 153.38 158.52 153.12
Barclays PLC number of shares (m) 15,556 15,871 16,531
For further information please contact
Investor relations Media relations
Adam Strachan +1 212 526 8442 Tom Hoskin +44 (0) 20 7116 4755
James Johnson +44 (0) 20 7116 7233
More information on Barclays can be found on our website: home.barclays
Registered office
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.
Registrar
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.
Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas.
American Depositary Receipts (ADRs)
EQ Shareowner Services
P.O. Box 64504
St. Paul, MN 55164-0504
United States of America
shareowneronline.com
Toll Free Number: +1 800-990-1135
Outside the US +1 651-453-2128
Delivery of ADR certificates and overnight mail
EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA.
1 Note that these dates are provisional and subject to change.
2 The average rates shown above are derived from daily spot rates during the year.
3 The change is the impact to GBP reported information.
4 Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.
Shareholder Information
Barclays PLC 96
-- 98 of 98 --